Physical O
mapping O
220 O
kb O
centromeric O
of O
the O
human B
MHC I
and O
DNA O
sequence O
analysis O
of O
the O
43 O
- O
kb O
segment O
including O
the O
RING1 B
, O
HKE6 B
, O
and O
HKE4 B
genes I
. O

Physical O
mapping O
220 O
kb O
centromeric O
of O
the O
human B
MHC I
and O
DNA O
sequence O
analysis O
of O
the O
43 O
- O
kb O
segment O
including O
the O
RING1 B
, O
HKE6 B
, O
and O
HKE4 B
genes I
. O

Radioimmunoassay O
of O
plasma B
gonadotropins I
; O
problems O
of O
specificity O

To O
clarify O
the O
difference O
, O
both O
the O
Crk B
II I
and O
Crk B
II I
- I
23 I
, O
proteins O
were O
expressed O
in O
E O
. O
coli O
and O
examined O
their O
binding O
capacity O
in O
vitro O
. O

Thus O
, O
in O
V O
. O
furnissii O
, O
the O
E B
. I
coli I
manX I
equivalent I
comprises O
two O
genes O
, O
which O
are O
separated O
in O
the O
genome O
by O
two O
other O
genes O
of O
the O
ptsM B
complex I
. O

Characterization O
of O
insertion O
mutations O
in O
the O
Saccharomyces B
cerevisiae I
MSH1 I
and O
MSH2 B
genes I
: O
evidence O
for O
separate O
mitochondrial O
and O
nuclear O
functions O
. O

Transcription O
of O
FN B
promoter I
- O
chloramphenicol B
acetyltransferase I
fusion O
genes O
carrying O
the O
base O
substitution O
in O
one O
or O
more O
of O
these O
G O
- O
rich O
sequences O
both O
in O
vivo O
and O
in O
vitro O
revealed O
that O
the O
base O
substitution O
in O
any O
G O
- O
rich O
sequence O
results O
in O
reduction O
of O
promoter O
activity O
, O
although O
the O
downstream O
GC O
box O
( O
GCd O
) O
plays O
a O
primary O
role O
. O

Transcription O
of O
FN B
promoter I
- O
chloramphenicol B
acetyltransferase I
fusion O
genes O
carrying O
the O
base O
substitution O
in O
one O
or O
more O
of O
these O
G O
- O
rich O
sequences O
both O
in O
vivo O
and O
in O
vitro O
revealed O
that O
the O
base O
substitution O
in O
any O
G O
- O
rich O
sequence O
results O
in O
reduction O
of O
promoter O
activity O
, O
although O
the O
downstream O
GC O
box O
( O
GCd O
) O
plays O
a O
primary O
role O
. O

The O
XPR2 B
gene I
from O
Yarrowia O
lipolytica O
encodes O
an O
inducible O
alkaline B
extracellular I
protease I
. O

Previous O
analysis O
of O
this O
motif O
in O
the O
lactose B
permease I
( O
A O
. O

Effects O
of O
long O
- O
term O
use O
of O
raloxifene O
, O
a O
selective O
estrogen B
receptor I
modulator O
, O
on O
thyroid O
function O
test O
profiles O
. O

In O
this O
reconstituted O
system O
, O
RNAP B
IIA I
, O
but O
not O
RNAP B
IIB I
, O
can O
transcribe O
from O
the O
DHFR B
promoter I
. O

In O
this O
reconstituted O
system O
, O
RNAP B
IIA I
, O
but O
not O
RNAP B
IIB I
, O
can O
transcribe O
from O
the O
DHFR B
promoter I
. O

In O
this O
reconstituted O
system O
, O
RNAP B
IIA I
, O
but O
not O
RNAP B
IIB I
, O
can O
transcribe O
from O
the O
DHFR B
promoter I
. O

A O
Meis1 B
cDNA I
clone O
that O
encoded O
a O
novel O
member O
of O
the O
homeobox B
gene I
family I
was O
identified O
. O

Glutathione B
reductase I
activities O
in O
liver O
, O
kidney O
, O
lung O
, O
and O
brain O
were O
not O
affected O
by O
diet O
. O

Importin B
beta I
mediates O
nuclear O
translocation O
of O
Smad B
3 I
. O

Importin B
beta I
mediates O
nuclear O
translocation O
of O
Smad B
3 I
. O

Expression O
of O
FNCAT B
increased O
on O
serum O
treatment O
indicating O
that O
the O
region O
of O
the O
FN B
gene I
between O
positions O
+ O
69 O
and O
- O
510 O
bp O
mediated O
serum O
responsiveness O
. O

Simvastatin O
decreased O
levels O
of O
total O
cholesterol O
by O
20 O
. O
8 O
% O
, O
LDL B
cholesterol I
by O
29 O
. O
7 O
% O
, O
triglycerides O
by O
13 O
. O
6 O
% O
, O
apolipoprotein B
B I
by O
22 O
. O
4 O
% O
, O
alpha O
- O
tocopherol O
by O
16 O
. O
2 O
% O
, O
beta O
- O
carotene O
by O
19 O
. O
5 O
% O
, O
and O
ubiquinol O
- O
10 O
by O
22 O
. O
0 O
% O
( O
P O
< O
. O
001 O
for O
all O
) O
and O
increased O
levels O
of O
HDL B
cholesterol I
by O
7 O
. O
0 O
% O
( O
P O
< O
. O
001 O
) O
and O
serum B
insulin I
by O
13 O

Simvastatin O
decreased O
levels O
of O
total O
cholesterol O
by O
20 O
. O
8 O
% O
, O
LDL B
cholesterol I
by O
29 O
. O
7 O
% O
, O
triglycerides O
by O
13 O
. O
6 O
% O
, O
apolipoprotein B
B I
by O
22 O
. O
4 O
% O
, O
alpha O
- O
tocopherol O
by O
16 O
. O
2 O
% O
, O
beta O
- O
carotene O
by O
19 O
. O
5 O
% O
, O
and O
ubiquinol O
- O
10 O
by O
22 O
. O
0 O
% O
( O
P O
< O
. O
001 O
for O
all O
) O
and O
increased O
levels O
of O
HDL B
cholesterol I
by O
7 O
. O
0 O
% O
( O
P O
< O
. O
001 O
) O
and O
serum B
insulin I
by O
13 O

Simvastatin O
decreased O
levels O
of O
total O
cholesterol O
by O
20 O
. O
8 O
% O
, O
LDL B
cholesterol I
by O
29 O
. O
7 O
% O
, O
triglycerides O
by O
13 O
. O
6 O
% O
, O
apolipoprotein B
B I
by O
22 O
. O
4 O
% O
, O
alpha O
- O
tocopherol O
by O
16 O
. O
2 O
% O
, O
beta O
- O
carotene O
by O
19 O
. O
5 O
% O
, O
and O
ubiquinol O
- O
10 O
by O
22 O
. O
0 O
% O
( O
P O
< O
. O
001 O
for O
all O
) O
and O
increased O
levels O
of O
HDL B
cholesterol I
by O
7 O
. O
0 O
% O
( O
P O
< O
. O
001 O
) O
and O
serum B
insulin I
by O
13 O

Simvastatin O
decreased O
levels O
of O
total O
cholesterol O
by O
20 O
. O
8 O
% O
, O
LDL B
cholesterol I
by O
29 O
. O
7 O
% O
, O
triglycerides O
by O
13 O
. O
6 O
% O
, O
apolipoprotein B
B I
by O
22 O
. O
4 O
% O
, O
alpha O
- O
tocopherol O
by O
16 O
. O
2 O
% O
, O
beta O
- O
carotene O
by O
19 O
. O
5 O
% O
, O
and O
ubiquinol O
- O
10 O
by O
22 O
. O
0 O
% O
( O
P O
< O
. O
001 O
for O
all O
) O
and O
increased O
levels O
of O
HDL B
cholesterol I
by O
7 O
. O
0 O
% O
( O
P O
< O
. O
001 O
) O
and O
serum B
insulin I
by O
13 O

The O
more O
severe O
the O
CRF O
, O
the O
more O
likely O
that O
total O
HDL B
and O
HDL2 B
cholesterol I
will O
be O
low O
. O

This O
is O
consistent O
with O
the O
need O
for O
a O
nuclear O
retinoid B
receptor I
function O
in O
RA O
- O
induced O
ERK2 B
activation O
. O

In O
the O
virus O
- O
infected O
cells O
, O
translation O
of O
the O
M1 B
protein I
was O
reduced O
to O
10 O
to O
20 O
% O
of O
that O
of O
the O
wild O
- O
type O
virus O
; O
however O
, O
the O
translation O
of O
neither O
the O
nucleoprotein O
nor O
NS1 B
was O
significantly O
interfered O
with O
, O
indicating O
the O
important O
role O
of O
NS1 B
in O
translational O
stimulation O
of O
the O
M1 B
protein I
. O

In O
the O
virus O
- O
infected O
cells O
, O
translation O
of O
the O
M1 B
protein I
was O
reduced O
to O
10 O
to O
20 O
% O
of O
that O
of O
the O
wild O
- O
type O
virus O
; O
however O
, O
the O
translation O
of O
neither O
the O
nucleoprotein O
nor O
NS1 B
was O
significantly O
interfered O
with O
, O
indicating O
the O
important O
role O
of O
NS1 B
in O
translational O
stimulation O
of O
the O
M1 B
protein I
. O

A O
novel O
Cdc42Hs B
mutant I
induces O
cellular O
transformation O
. O

In O
conclusion O
, O
ORCA3 B
regulates O
jasmonate O
- O
responsive O
expression O
of O
the O
Str B
gene I
via O
direct O
interaction O
with O
the O
JERE O
. O

TFEC B
RNA I
is O
found O
in O
many O
tissues O
of O
adult O
rats O
, O
but O
the O
relative O
concentrations O
of O
TFEC B
and O
TFE3 B
RNAs I
vary O
considerably O
in O
these O
different O
tissues O
. O

TFEC B
RNA I
is O
found O
in O
many O
tissues O
of O
adult O
rats O
, O
but O
the O
relative O
concentrations O
of O
TFEC B
and O
TFE3 B
RNAs I
vary O
considerably O
in O
these O
different O
tissues O
. O

Our O
results O
show O
that O
unlike O
the O
case O
for O
sos1 B
, O
sos2 B
gene I
function O
is O
dispensable O
for O
normal O
mouse O
development O
, O
growth O
, O
and O
fertility O
. O

The O
effect O
on O
FIV B
LTR I
promoter I
activity O
of O
progressively O
deleting O
these O
nuclear O
factor O
binding O
sites O
was O
examined O
by O
linking O
LTR O
deletion O
mutants O
to O
the O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
gene O
. O

A O
series O
of O
sequence O
fragments O
were O
placed O
5 O
' O
to O
the O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
reporter O
gene O
and O
ability O
to O
mediate O
transcription O
of O
CAT B
in O
response O
to O
IFN B
gamma I
or O
LPS O
treatment O
was O
studied O
following O
transient O
transfection O
in O
the O
macrophage O
- O
like O
cell O
line O
RAW O
264 O
. O
7 O
. O

A O
series O
of O
sequence O
fragments O
were O
placed O
5 O
' O
to O
the O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
reporter O
gene O
and O
ability O
to O
mediate O
transcription O
of O
CAT B
in O
response O
to O
IFN B
gamma I
or O
LPS O
treatment O
was O
studied O
following O
transient O
transfection O
in O
the O
macrophage O
- O
like O
cell O
line O
RAW O
264 O
. O
7 O
. O

Module O
2 O
of O
RifA B
lacks O
a O
beta B
- I
ketoacyl I
: I
acyl I
carrier I
protein I
reductase I
( O
KR B
) O
domain O
and O
the O
one O
in O
module O
3 O
has O
an O
apparently O
inactive O
NADPH B
binding I
motif I
, O
similar O
to O
one O
found O
in O
the O
Er B
PKS I
, O
while O
the O
other O
eight O
KR B
domains I
of O
the O
Rf B
PKS I
should O
be O
functional O
. O

Module O
2 O
of O
RifA B
lacks O
a O
beta B
- I
ketoacyl I
: I
acyl I
carrier I
protein I
reductase I
( O
KR B
) O
domain O
and O
the O
one O
in O
module O
3 O
has O
an O
apparently O
inactive O
NADPH B
binding I
motif I
, O
similar O
to O
one O
found O
in O
the O
Er B
PKS I
, O
while O
the O
other O
eight O
KR B
domains I
of O
the O
Rf B
PKS I
should O
be O
functional O
. O

Module O
2 O
of O
RifA B
lacks O
a O
beta B
- I
ketoacyl I
: I
acyl I
carrier I
protein I
reductase I
( O
KR B
) O
domain O
and O
the O
one O
in O
module O
3 O
has O
an O
apparently O
inactive O
NADPH B
binding I
motif I
, O
similar O
to O
one O
found O
in O
the O
Er B
PKS I
, O
while O
the O
other O
eight O
KR B
domains I
of O
the O
Rf B
PKS I
should O
be O
functional O
. O

The O
GST B
- O
CBL B
- O
LZIP B
fusion O
protein O
contains O
a O
binding O
site O
for O
the O
SH2 B
domain I
of O
the O
p85 B
subunit I
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
which O
mapped O
to O
Tyr731 O
, O
which O
is O
present O
in O
the O
sequence O
YEAM O
. O

The O
GST B
- O
CBL B
- O
LZIP B
fusion O
protein O
contains O
a O
binding O
site O
for O
the O
SH2 B
domain I
of O
the O
p85 B
subunit I
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
which O
mapped O
to O
Tyr731 O
, O
which O
is O
present O
in O
the O
sequence O
YEAM O
. O

A O
Brassica O
cDNA O
clone O
encoding O
a O
bifunctional O
hydroxymethylpyrimidine B
kinase I
/ O
thiamin B
- I
phosphate I
pyrophosphorylase I
involved O
in O
thiamin O
biosynthesis O
. O

Titres O
of O
antistreptolysin B
O I
in O
mothers O
of O
children O
affected O
with O
Down O
' O
s O
syndrome O
. O

We O
have O
previously O
described O
the O
partial O
purification O
of O
Ap4A B
hydrolase I
from O
S O
. O
pombe O
[ O
Robinson O
, O
de O
la O
Pena O
and O
Barnes O
( O
1993 O
) O
Biochim O
. O

In O
addition O
, O
wild O
- O
type O
and O
mutated O
DNA O
templates O
were O
used O
as O
probes O
in O
DNase B
I I
protection O
experiments O
to O
determine O
sites O
of O
protein O
- O
DNA O
interaction O
. O

Previous O
work O
has O
shown O
that O
glucose O
repression O
of O
PRB1 B
transcription O
is O
not O
mediated O
by O
HXK2 B
or O
by O
the O
SNF1 B
, O
SNF4 B
, O
and O
SNF6 B
genes I
( O
C O
. O

Comparison O
of O
the O
encoded O
ERCC3Dm B
protein I
with O
the O
homologous O
proteins O
of O
mouse O
and O
man O
shows O
a O
strong O
amino O
acid O
conservation O
( O
71 O
% O
identity O
) O
, O
especially O
in O
the O
postulated O
DNA O
binding O
region O
and O
seven O
' B
helicase I
' I
domains I
. O

Serum B
prolactin I
and O
oestradiol O
levels O
at O
different O
stages O
of O
puberty O
. O

This O
enzyme O
is O
distinct O
from O
other O
known O
E3s B
, O
including O
E3 B
alpha I
/ O
UBR1 B
, O
E3 B
beta I
, O
and O
E6 B
- I
AP I
. O

This O
enzyme O
is O
distinct O
from O
other O
known O
E3s B
, O
including O
E3 B
alpha I
/ O
UBR1 B
, O
E3 B
beta I
, O
and O
E6 B
- I
AP I
. O

This O
evidence O
, O
together O
with O
the O
ability O
of O
a O
carboxyl O
- O
terminal O
coding O
sequence O
starting O
from O
the O
BamHI B
site I
to O
complement O
a O
shy1 B
mutant I
, O
suggests O
that O
the O
Shy1p B
contains O
two O
domains O
that O
can O
be O
separately O
expressed O
to O
form O
a O
functional O
protein O
. O

This O
evidence O
, O
together O
with O
the O
ability O
of O
a O
carboxyl O
- O
terminal O
coding O
sequence O
starting O
from O
the O
BamHI B
site I
to O
complement O
a O
shy1 B
mutant I
, O
suggests O
that O
the O
Shy1p B
contains O
two O
domains O
that O
can O
be O
separately O
expressed O
to O
form O
a O
functional O
protein O
. O

The O
zinc B
finger I
protein I
A20 I
is O
a O
tumor B
necrosis I
factor I
( O
TNF B
) O
- O
and O
interleukin B
1 I
( O
IL B
- I
1 I
) O
- O
inducible O
protein O
that O
negatively O
regulates O
nuclear B
factor I
- I
kappa I
B I
( O
NF B
- I
kappaB I
) O
- O
dependent O
gene O
expression O
. O

Immunoblot O
analysis O
of O
purified O
and O
protease O
- O
digested O
intracellular O
mature O
virus O
( O
IMV O
) O
and O
extracellular O
enveloped O
virus O
( O
EEV O
) O
showed O
that O
the O
A36R B
proteins I
were O
present O
on O
the O
surface O
of O
EEV O
with O
type O
II O
membrane O
topology O
, O
but O
were O
absent O
from O
IMV O
. O

Serum B
angiogenin I
concentrations O
in O
young O
patients O
with O
diabetes O
mellitus O
. O

The O
Aspergillus B
uvsH I
gene I
encodes O
a O
product O
homologous O
to O
yeast B
RAD18 I
and O
Neurospora B
UVS I
- I
2 I
. O

VAV B
and O
SOCS1 B
form O
a O
protein O
complex O
through O
interactions O
between O
the O
VAV B
NH I
( I
2 I
) I
- I
terminal I
regulatory I
region I
and O
the O
SH2 B
domain I
of O
SOCS1 B
in O
a O
phosphotyrosine O
- O
independent O
manner O
. O

Transcription O
analysis O
of O
the O
EcoRI B
D I
region I
of O
the O
baculovirus O
Autographa O
californica O
nuclear O
polyhedrosis O
virus O
identifies O
an O
early O
4 O
- O
kilobase O
RNA O
encoding O
the O
essential O
p143 B
gene I
. O

The O
goals O
of O
these O
experiments O
were O
to O
determine O
whether O
lactational O
anestrus O
would O
be O
prolonged O
by O
a O
48 O
- O
h O
fast O
at O
days O
13 O
and O
14 O
postpartum O
( O
pp O
) O
and O
, O
if O
so O
, O
to O
determine O
whether O
this O
effect O
could O
be O
reversed O
by O
treatment O
with O
the O
Ob B
protein I
leptin B
. O

In O
pituitary O
GH3 O
cells O
, O
vitamin O
D O
increases O
the O
levels O
of O
PRL B
transcripts I
and O
stimulates O
the O
PRL B
promoter I
. O

In O
pituitary O
GH3 O
cells O
, O
vitamin O
D O
increases O
the O
levels O
of O
PRL B
transcripts I
and O
stimulates O
the O
PRL B
promoter I
. O

However O
, O
electron O
microscopy O
revealed O
that O
while O
sec4 B
mutant I
cells O
accumulate O
secretory O
vesicles O
, O
ypt31 B
/ I
32 I
mutant I
cells O
accumulate O
aberrant O
Golgi O
structures O
. O

The O
presence O
of O
a O
short O
( O
70 O
bp O
) O
intron O
near O
the O
N O
- O
terminus O
of O
the O
atX B
gene I
was O
predicted O
that O
contains O
the O
canonical O
GT O
and O
AG O
dinucleotides O
at O
its O
5 O
' O
- O
and O
3 O
' O
- O
splicing O
junctions O
. O

Moreover O
, O
a O
hybrid O
protein O
composed O
of O
a O
PvALF B
activation I
domain I
and O
the O
DNA O
binding O
and O
dimerization O
domain O
of O
ROM2 B
activated O
gene O
expression O
, O
indicating O
that O
ROM2 B
recognizes O
the O
DLEC2 B
enhancer I
in O
vivo O
; O
consequently O
, O
ROM2 B
functions O
as O
a O
DNA O
binding O
site O
- O
dependent O
repressor O
. O

On O
the O
other O
hand O
, O
NE O
transport O
and O
antagonist O
( O
[ O
125I O
] O
RTI O
- O
55 O
) O
binding O
assays O
on O
whole O
LLC O
- O
NET O
cells O
treated O
with O
tunicamycin O
reveal O
a O
pronounced O
reduction O
in O
NE O
transport O
activity O
and O
hNET B
membrane O
density O
paralleled O
by O
an O
inability O
of O
NET B
proteins I
to O
replenish O
the O
higher O
M O
( O
r O
) O
hNET B
pool O
. O

DNase B
I I
protection O
analysis O
as O
well O
as O
oligonucleotide O
competition O
experiments O
indicate O
that O
this O
binding O
is O
sequence O
specific O
. O

In O
transient O
transfections O
using O
luciferase B
reporter I
genes I
driven O
by O
1 O
kb O
of O
the O
5 O
' O
flanking O
DNA O
of O
the O
three O
CALM B
genes I
, O
the O
promoter O
activity O
correlated O
with O
the O
endogenous B
CALM I
transcriptional O
activity O
, O
but O
only O
when O
the O
5 O
' O
untranslated O
regions O
were O
included O
in O
the O
constructs O
. O

In O
transient O
transfections O
using O
luciferase B
reporter I
genes I
driven O
by O
1 O
kb O
of O
the O
5 O
' O
flanking O
DNA O
of O
the O
three O
CALM B
genes I
, O
the O
promoter O
activity O
correlated O
with O
the O
endogenous B
CALM I
transcriptional O
activity O
, O
but O
only O
when O
the O
5 O
' O
untranslated O
regions O
were O
included O
in O
the O
constructs O
. O

The O
derepressed O
expression O
of O
fixN B
was O
not O
observed O
in O
a O
purH B
mutant I
. O

Non O
- O
finger O
- O
coding O
modules O
conserved O
among O
members O
of O
subfamilies O
of O
zinc B
finger I
genes I
have O
been O
described O
in O
the O
murine O
genome O
( O
finger O
- O
associated O
boxes O
, O
or O
FAX O
domain O
) O
and O
the O
human O
genome O
( O
Kruppel B
- I
associated I
boxes I
, O
or O
KRAB B
domain I
) O
. O

Genetic O
analysis O
places O
CWH43 B
upstream O
of O
the O
BCK2 B
branch O
of O
the O
PKC1 B
signalling O
pathway O
, O
since O
cwh43 B
mutations O
were O
synthetic O
lethal O
with O
pkc1 B
deletion O
, O
whereas O
the O
cwh43 B
defects O
could O
be O
rescued O
by O
overexpression O
of O
BCK2 B
and O
not O
by O
high O
- O
copy O
- O
number O
expression O
of O
genes O
encoding O
downstream O
proteins O
of O
the O
PKC1 B
pathway O
However O
, O
unlike O
BCK2 B
, O
whose O
disruption O
in O
a O
cln3 B
mutant I
resulted O
in O
growth O
arrest O
in O
G O
( O
1 O
) O
, O
no O
growth O
defect O
was O
observed O
in O
a O
double O
cwh43 B
cln3 B
mutants I
. O

Genetic O
analysis O
places O
CWH43 B
upstream O
of O
the O
BCK2 B
branch O
of O
the O
PKC1 B
signalling O
pathway O
, O
since O
cwh43 B
mutations O
were O
synthetic O
lethal O
with O
pkc1 B
deletion O
, O
whereas O
the O
cwh43 B
defects O
could O
be O
rescued O
by O
overexpression O
of O
BCK2 B
and O
not O
by O
high O
- O
copy O
- O
number O
expression O
of O
genes O
encoding O
downstream O
proteins O
of O
the O
PKC1 B
pathway O
However O
, O
unlike O
BCK2 B
, O
whose O
disruption O
in O
a O
cln3 B
mutant I
resulted O
in O
growth O
arrest O
in O
G O
( O
1 O
) O
, O
no O
growth O
defect O
was O
observed O
in O
a O
double O
cwh43 B
cln3 B
mutants I
. O

Reversal O
of O
' O
refractory O
septic O
shock O
' O
by O
infusion O
of O
amrinone O
and O
angiotensin B
II I
in O
an O
anthracycline O
- O
treated O
patient O
. O

Normal O
replication O
of O
DNA B
A I
still O
carrying O
the O
AC3 B
ORF I
mutation O
was O
found O
in O
extracts O
from O
these O
plants O
. O

Normal O
replication O
of O
DNA B
A I
still O
carrying O
the O
AC3 B
ORF I
mutation O
was O
found O
in O
extracts O
from O
these O
plants O
. O

Muscle O
and O
liver O
biopsies O
demonstrated O
the O
same O
anomalies O
, O
again O
without O
branching B
enzyme I
deficiency O
in O
the O
liver O
. O

It O
was O
previously O
shown O
that O
Vi B
antigen I
expression O
was O
regulated O
by O
a O
system O
similar O
to O
the O
rcs B
regulatory O
system O
involved O
in O
colanic O
acid O
synthesis O
in O
Escherichia O
coli O
. O

To O
identify O
the O
GRK6 B
homologue I
on O
chromsome O
13 O
, O
several O
sets O
of O
closely O
- O
spaced O
primers O
were O
designed O
based O
on O
the O
GRK6 B
cDNA I
sequence I
and O
then O
used O
to O
amplify O
human O
genomic O
DNA O
by O
PCR O
. O

Serum B
alpha I
- I
amylase I
, O
trypsin B
, O
trypsin B
inhibitor I
, O
lipase B
and O
total O
protease O
activity O
in O
the O
pancreatic O
tissue O
was O
studied O
as O
indicator O
of O
the O
treatment O
efficacy O
with O
5 O
- O
fluorouracil O
electro O
- O
cumulation O
. O

This O
effect O
is O
independent O
of O
the O
Gal4 B
protein I
, O
as O
it O
operates O
in O
a O
gal4 B
mutant I
background O
as O
well O
. O

This O
effect O
is O
independent O
of O
the O
Gal4 B
protein I
, O
as O
it O
operates O
in O
a O
gal4 B
mutant I
background O
as O
well O
. O

Amplification O
of O
4q21 O
- O
q22 O
and O
the O
MXR B
gene I
in O
independently O
derived O
mitoxantrone O
- O
resistant O
cell O
lines O
. O

Critical O
review O
of O
tests O
for O
the O
HBs B
antigen I
in O
the O
detection O
of O
infectious O
blood O

Although O
mutant B
pex5delta I
cells O
expressing O
a O
yeast B
/ I
tobacco I
Pex5p I
chimaera I
failed O
to O
import O
a O
GFP B
- O
Eci1p B
reporter O
protein O
, O
they O
were O
able O
to O
grow O
on O
oleic O
acid O
. O

Consistent O
with O
this O
observation O
, O
introduction O
of O
Smad B
sites I
into O
a O
TGFbeta B
- O
insensitive O
LEF1 B
/ O
TCF B
target O
gene O
confers O
cooperative O
TGFbeta B
and O
Wnt B
responsiveness O
to O
the O
promoter O
. O

In O
analogy O
to O
human B
CD70 I
, O
mCD70 B
transcript I
levels O
are O
strongly O
but O
transiently O
up O
- O
regulated O
during O
lymphocyte O
activation O
, O
which O
is O
in O
line O
with O
a O
role O
for O
the O
CD27 B
- I
CD70 I
receptor I
pair O
early O
in O
the O
immune O
response O
. O

In O
analogy O
to O
human B
CD70 I
, O
mCD70 B
transcript I
levels O
are O
strongly O
but O
transiently O
up O
- O
regulated O
during O
lymphocyte O
activation O
, O
which O
is O
in O
line O
with O
a O
role O
for O
the O
CD27 B
- I
CD70 I
receptor I
pair O
early O
in O
the O
immune O
response O
. O

Serum B
IgM I
levels O
showed O
a O
highly O
significant O
increase O
in O
all O
types O
of O
brain O
tumour O
when O
compared O
to O
controls O
. O

The O
first O
operon O
, O
orf1 O
- O
tolQRA B
, O
is O
iron O
regulated O
throughout O
growth O
, O
but O
iron O
- O
regulated O
expression O
of O
tolB B
and O
oprL B
fusions I
occurs O
only O
in O
late O
log O
phase O
. O

These O
data O
suggested O
that O
mutant B
PS1 I
may O
cause O
disease O
as O
a O
result O
of O
reduction O
in O
PS1 B
function O
. O

Mammalian O
ribonucleotide B
reductase I
shows O
S O
- O
phase O
specific O
expression O
and O
consists O
of O
two O
non O
- O
identical O
subunits O
, O
proteins B
R1 I
( O
large O
subunit O
) O
and O
R2 B
( O
small O
subunit O
) O
. O

Mammalian O
ribonucleotide B
reductase I
shows O
S O
- O
phase O
specific O
expression O
and O
consists O
of O
two O
non O
- O
identical O
subunits O
, O
proteins B
R1 I
( O
large O
subunit O
) O
and O
R2 B
( O
small O
subunit O
) O
. O

Recombinant B
MsERK1 I
( O
rMsERK1 B
) O
, O
when O
overexpressed O
in O
Escherichia O
coli O
, O
is O
recognized O
by O
antibodies O
raised O
against O
MAP B
kinases I
from I
rat I
, I
Xenopus I
, I
and I
sea I
star I
and O
by O
anti B
- I
phosphotyrosine I
antibodies I
. O

The O
expected O
products O
of O
the O
cloned O
bph B
genes I
, O
except O
bphA3 B
, O
were O
observed O
in O
E O
. O
coli O
in O
an O
in O
vitro O
transcription O
- O
translation O
system O
. O

The O
consensus O
mammalian O
ER O
stress O
response O
element O
( O
ERSE O
) O
conserved O
among O
grp B
promoters I
consists O
of O
a O
tripartite O
structure O
CCAAT O
( O
N9 O
) O
CCACG O
, O
with O
N O
being O
a O
strikingly O
GC O
- O
rich O
region O
of O
9 O
bp O
. O

Unlike O
CSK B
, O
the O
SH3 B
domain I
of O
HYL B
was O
unique O
since O
the O
ALYDY O
motif O
was O
absent O
. O

Fus3p B
and O
Kss1p B
together O
increase O
the O
expression O
of O
CLN3 B
and O
PCL2 B
genes I
that O
promote O
budding O
, O
and O
Kss1p B
inhibits O
the O
MAP B
kinase I
cascade O
. O

Fus3p B
and O
Kss1p B
together O
increase O
the O
expression O
of O
CLN3 B
and O
PCL2 B
genes I
that O
promote O
budding O
, O
and O
Kss1p B
inhibits O
the O
MAP B
kinase I
cascade O
. O

We O
found O
4 O
highly O
conserved O
regions O
to O
vertebrate B
Hsp90 I
exclusively O
and O
27 O
amino O
acids O
conserved O
among O
but O
differing O
between O
Hsp90 B
alpha I
and O
Hsp90 B
beta I
sequences I
. O

We O
found O
4 O
highly O
conserved O
regions O
to O
vertebrate B
Hsp90 I
exclusively O
and O
27 O
amino O
acids O
conserved O
among O
but O
differing O
between O
Hsp90 B
alpha I
and O
Hsp90 B
beta I
sequences I
. O

We O
present O
here O
the O
complete O
primary O
structure O
of O
human B
gp330 I
, O
the O
human O
variant O
of O
the O
principal O
kidney O
autoantigen O
causing O
Heymann O
membranous O
glomerulonephritis O
in O
rats O
. O

These O
mutant B
rps7 I
leaders O
were O
ligated O
into O
an O
aadA O
expression O
cassette O
and O
transformed O
into O
the O
chloroplast O
of O
C O
. O
reinhardtii O
and O
into O
E O
. O
coli O
. O

Down O
- O
regulation O
of O
Id1 B
mRNA I
correlated O
with O
mitogenesis O
and O
occurred O
when O
quiescent O
cells O
were O
treated O
with O
growth O
factors O
that O
activate O
G B
protein I
- I
coupled I
receptors I
and O
receptor B
protein I
tyrosine I
kinases I
but O
not O
with O
a O
non O
- O
mitogenic O
cAMP O
analog O
. O

Secretogranin B
II I
( O
SgII B
) O
is O
a O
secretory O
polypeptide O
stored O
in O
large O
dense O
core O
vesicles O
of O
neuroendocrine O
and O
neuronal O
cells O
. O

BK B
- O
induced O
translocation O
and O
overexpression O
of O
PKC B
isoforms I
as O
well O
as O
coexpression O
of O
inactive O
or O
constitutively O
active O
mutants O
of O
different O
PKC B
isozymes I
provided O
evidence O
for O
a O
role O
of O
the O
diacylglycerol O
- O
sensitive O
PKCs B
alpha I
and I
epsilon I
in O
BK B
signaling O
toward O
MAPK B
. O

BK B
- O
induced O
translocation O
and O
overexpression O
of O
PKC B
isoforms I
as O
well O
as O
coexpression O
of O
inactive O
or O
constitutively O
active O
mutants O
of O
different O
PKC B
isozymes I
provided O
evidence O
for O
a O
role O
of O
the O
diacylglycerol O
- O
sensitive O
PKCs B
alpha I
and I
epsilon I
in O
BK B
signaling O
toward O
MAPK B
. O

A O
lead O
phthalocyanin O
method O
for O
the O
demonstration O
of O
acid B
hydrolases I
in O
plant O
and O
animal O
tissues O
. O

Interestingly O
, O
unlike O
PAK65 B
, O
HPK1 B
does O
not O
contain O
the O
small B
GTPase I
Rac1 B
/ O
Cdc42 B
- O
binding O
domain O
and O
does O
not O
bind O
to O
either O
Rac1 B
or O
Cdc42 B
, O
suggesting O
that O
HPK1 B
. O
activation O
is O
Rac1 B
/ O
Cdc42 B
- O
independent O
. O

However O
, O
only O
plasma B
fibrinogen I
concentrations O
showed O
statistically O
significant O
positive O
associations O
with O
IMT O
in O
both O
groups O
. O

All O
such O
polypeptides O
containing O
263 O
or O
more O
residues O
derived O
from O
the O
C O
- O
terminus O
of O
P130gag B
- O
fps B
( O
i O
. O
e O
. O
residues O
920 O
- O
1182 O
) O
were O
enzymatically O
active O
as O
tyrosine B
kinases I
. O

The O
recombinant O
containing O
the O
full O
- O
length O
polyhedrin B
leader O
sequence O
gave O
levels O
of O
N B
mRNA I
comparable O
to O
those O
of O
AcNPV B
polyhedrin I
mRNA I
. O

Each O
receptor O
must O
therefore O
engage O
a O
unique O
subset O
of O
the O
available O
signaling O
elements O
- O
- O
at O
least O
partly O
through O
the O
selection O
of O
proteins O
with O
src B
- I
homology I
2 I
domains I
( O
SH2 B
proteins I
) O
. O

When O
recombinant B
gE I
produced O
in O
HeLa O
cells O
was O
probed O
with O
the O
same O
antiphosphotyrosine O
antibody O
, O
a O
dimeric B
gE I
form O
at O
130 O
kDa O
was O
detected O
on O
the O
cell O
surface O
. O

When O
recombinant B
gE I
produced O
in O
HeLa O
cells O
was O
probed O
with O
the O
same O
antiphosphotyrosine O
antibody O
, O
a O
dimeric B
gE I
form O
at O
130 O
kDa O
was O
detected O
on O
the O
cell O
surface O
. O

The O
results O
suggest O
that O
both O
superficial O
and O
deep O
cortical O
venous O
drainage O
of O
the O
cat O
kidney O
should O
be O
considered O
when O
measuring O
renal B
renin I
release O
. O

Mutations O
that O
extend O
the O
specificity O
of O
the O
endonuclease O
activity O
of O
lambda B
terminase I
. O

Hetero O
- O
oligomerization O
of O
Smad4 B
with O
the O
pathway O
- O
restricted O
SMAD B
proteins I
is O
essential O
for O
Smad4 B
- O
mediated O
transcription O
. O

Analysis O
of O
the O
5 O
' O
and O
3 O
' O
termini O
of O
the O
transcripts O
produced O
in O
vivo O
from O
the O
puf B
operon I
of I
R I
. I
sphaeroides I
PUF B
delta I
348 I
- I
420 I
( O
three O
transcripts O
; O
0 O
. O
59 O
, O
0 O
. O
64 O
, O
and O
2 O
. O
63 O
kilobases O
) O
lacking O
the O
puf O
- O
intercistronic O
terminator O
structure O
were O
identical O
to O
those O
of O
the O
corresponding O
puf B
transcripts I
derived O
from O
wild O
- O
type O
R O
. O
sphaeroides O
2 O
. O
4 O
. O
1 O
( O
four O
transcripts O
; O
0 O
. O
50 O
, O
0 O
. O
66 O
, O
0 O
. O
71 O
, O
and O
2 O
. O
7 O
kilobases O
) O
showing O

Four O
families O
of O
homing B
endonucleases I
have O
been O
identified O
, O
including O
the O
LAGLIDADG B
, O
the O
His B
- I
Cys I
box I
, O
the O
GIY B
- I
YIG I
and O
the O
H B
- I
N I
- I
H I
endonucleases I
. O

The O
GvpE B
protein I
involved O
in O
the O
regulation O
of O
gas O
vesicles O
synthesis O
in O
halophilic O
archaea O
has O
been O
identified O
as O
the O
transcriptional O
activator O
for O
the O
promoter O
located O
upstream O
of O
the O
gvpA B
gene I
encoding O
the O
major O
gas O
vesicle O
structural O
protein O
GvpA B
. O

The O
GvpE B
protein I
involved O
in O
the O
regulation O
of O
gas O
vesicles O
synthesis O
in O
halophilic O
archaea O
has O
been O
identified O
as O
the O
transcriptional O
activator O
for O
the O
promoter O
located O
upstream O
of O
the O
gvpA B
gene I
encoding O
the O
major O
gas O
vesicle O
structural O
protein O
GvpA B
. O

The O
yeast B
mitochondrial I
Hsp70 I
, O
Ssc1p B
, O
functions O
as O
a O
molecular O
chaperone O
with O
its O
partner O
proteins O
, O
Mdj1p B
( O
DnaJ B
homologue I
) O
and O
Yge1p B
( O
GrpE B
homologue I
) O
. O

The O
yeast B
mitochondrial I
Hsp70 I
, O
Ssc1p B
, O
functions O
as O
a O
molecular O
chaperone O
with O
its O
partner O
proteins O
, O
Mdj1p B
( O
DnaJ B
homologue I
) O
and O
Yge1p B
( O
GrpE B
homologue I
) O
. O

However O
, O
and O
in O
contrast O
to O
other O
MMP B
genes I
, O
no O
significative O
synergistic O
effect O
on O
CAT B
activity O
between O
the O
AP B
- I
1 I
and O
PEA B
- I
3 I
elements I
found O
in O
the O
collagenase B
- I
3 I
gene I
promoter I
was O
found O
. O

In O
contrast O
, O
postmitotic O
neurons O
possessed O
extremely O
low O
levels O
of O
E2F1 B
protein I
as O
assessed O
by O
the O
electrophoretic O
mobility O
shift O
assay O
and O
Western O
blotting O
. O

To O
examine O
the O
effect O
of O
the O
cAMP O
signal O
transduction O
pathway O
on O
transcription O
of O
the O
gene O
encoding O
the O
catalytic O
subunit O
of O
glucose B
- I
6 I
- I
phosphatase I
( O
G6Pase B
) O
, O
G6Pase B
- O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
fusion O
genes O
were O
transiently O
transfected O
into O
either O
the O
liver O
- O
derived O
HepG2 O
or O
kidney O
- O
derived O
LLC O
- O
PK O
cell O
line O
. O

( O
We O
observed O
a O
ferritin B
value O
as O
high O
as O
47 O
mg O
/ O
L O
in O
one O
patient O
. O
) O
Results O
with O
all O
these O
kits O
did O
not O
inter O
- O
compare O
well O
for O
ferritin B
concentrations O
greater O
than O
300 O
micrograms O
/ O
L O
, O
a O
finding O
that O
casts O
further O
doubt O
on O
the O
controversial O
use O
of O
serum B
ferritin I
measurement O
in O
cases O
of O
iron O
overload O
. O

ER B
beta I
was O
less O
potent O
than O
ER B
alpha I
in O
activating O
E2 O
- O
stimulated O
ERELuc B
activity O
( O
4 O
- O
vs O
. O

ER B
beta I
was O
less O
potent O
than O
ER B
alpha I
in O
activating O
E2 O
- O
stimulated O
ERELuc B
activity O
( O
4 O
- O
vs O
. O

Twelve O
patients O
of O
leprosy O
with O
arthritis O
and O
161 O
patients O
without O
arthritis O
were O
studied O
for O
immunological O
parameters O
like O
immunoglobulins B
( O
IgG B
, O
IgM B
, O
IgA B
) O
, O
C B
- I
reactive I
proteins I
and O
rheumatoid B
factor I
. O

The O
NrfC B
polypeptide I
, O
M B
( I
r I
) I
24 I
, I
567 I
, O
contains O
16 O
cysteine O
residues O
arranged O
in O
four O
clusters O
typical O
of O
the O
CooF B
super I
- I
family I
of O
non O
- O
haem O
iron O
- O
sulphur O
proteins O
. O

Its O
activity O
was O
twice O
that O
of O
a O
construct O
where O
the O
CAT B
gene I
was O
driven O
by O
the O
H B
- I
2Kb I
5 I
' I
enhancer I
region I
( O
H2TF1 B
/ O
KBF1 B
site O
) O
and O
comparable O
to O
that O
of O
pRSVCAT O
construct B
carrying I
the I
strong I
Rous I
sarcoma I
virus I
LTR I
enhancer I
. O

The O
D O
. O
discoideum O
proteins O
were O
entirely O
conserved O
over O
the O
four O
regions O
known O
to O
be O
important O
for O
GTP O
binding O
and O
all O
contained O
the O
C O
- O
terminal O
CAAX O
aa O
motifs O
shared O
by O
other O
Rho B
proteins I
. O

An O
81 O
- O
nt O
tandem O
duplication O
of O
the O
C O
- O
terminal O
coding O
region O
is O
located O
adjacent O
to O
the O
termination O
codon O
of O
the O
CyIIIb B
gene I
, O
a O
potential O
relic O
of O
a O
slipped O
mispairing O
and O
replication O
event O
. O

Here O
we O
examine O
the O
population O
of O
gammaS B
transcripts I
in O
adult O
human O
lens O
and O
the O
structure O
of O
the O
human B
CRYGS I
genes I
. O

Cbl B
is O
a O
signaling O
molecule O
with O
multiple O
functional O
domains O
: O
an O
SH2 B
domain I
which O
binds O
phosphotyrosine O
residues O
, O
a O
RING O
finger O
domain O
which O
acts O
as O
a O
ubiquitin B
ligase I
, O
a O
proline O
- O
rich O
region O
which O
serves O
as O
a O
docking O
site O
for O
SH3 B
- I
containing I
proteins I
, O
phosphotyrosine O
residues O
which O
serve O
as O
docking O
sites O
for O
SH2 B
- I
containing I
proteins I
such O
a O
CrkL B
and O
the O
p85 B
subunit I
of O
PI B
3 I
- I
kinase I
, O
and O
a O
nuclear O
localization O
signal O
. O

Cbl B
is O
a O
signaling O
molecule O
with O
multiple O
functional O
domains O
: O
an O
SH2 B
domain I
which O
binds O
phosphotyrosine O
residues O
, O
a O
RING O
finger O
domain O
which O
acts O
as O
a O
ubiquitin B
ligase I
, O
a O
proline O
- O
rich O
region O
which O
serves O
as O
a O
docking O
site O
for O
SH3 B
- I
containing I
proteins I
, O
phosphotyrosine O
residues O
which O
serve O
as O
docking O
sites O
for O
SH2 B
- I
containing I
proteins I
such O
a O
CrkL B
and O
the O
p85 B
subunit I
of O
PI B
3 I
- I
kinase I
, O
and O
a O
nuclear O
localization O
signal O
. O

Cbl B
is O
a O
signaling O
molecule O
with O
multiple O
functional O
domains O
: O
an O
SH2 B
domain I
which O
binds O
phosphotyrosine O
residues O
, O
a O
RING O
finger O
domain O
which O
acts O
as O
a O
ubiquitin B
ligase I
, O
a O
proline O
- O
rich O
region O
which O
serves O
as O
a O
docking O
site O
for O
SH3 B
- I
containing I
proteins I
, O
phosphotyrosine O
residues O
which O
serve O
as O
docking O
sites O
for O
SH2 B
- I
containing I
proteins I
such O
a O
CrkL B
and O
the O
p85 B
subunit I
of O
PI B
3 I
- I
kinase I
, O
and O
a O
nuclear O
localization O
signal O
. O

Surprisingly O
, O
apo B
- I
iso I
- I
1 I
- I
cytochrome I
c I
is O
absent O
in O
cyc3 B
- I
strains O
, O
although O
apo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
present O
at O
approximately O
the O
same O
level O
at O
which O
holo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
found O
in O
CYC3 B
+ I
strains O
. O

Surprisingly O
, O
apo B
- I
iso I
- I
1 I
- I
cytochrome I
c I
is O
absent O
in O
cyc3 B
- I
strains O
, O
although O
apo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
present O
at O
approximately O
the O
same O
level O
at O
which O
holo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
found O
in O
CYC3 B
+ I
strains O
. O

Creatinine O
and O
creatine B
phosphokinase I
( O
CPK B
) O
. O

The O
hematopoietic O
form O
of O
PTPN6 B
transcript I
is O
initiated O
at O
a O
downstream O
promoter O
separated O
by O
7 O
kb O
from O
the O
first O
. O

GAGA B
factor I
is O
known O
to O
remodel O
the O
chromatin O
structure O
in O
concert O
with O
nucleosome B
- I
remodeling I
factor I
NURF B
in O
a O
Drosophila O
embryonic O
S150 O
extract O
. O

Herein O
, O
we O
report O
that O
CRE O
- O
decoy O
oligonucleotide O
treatment O
results O
in O
an O
increase O
in O
the O
p53 B
protein I
level O
in O
MCF O
- O
7 O
human O
breast O
cancer O
cells O
that O
express O
wild O
- O
type O
p53 B
. O

The O
primary O
structure O
of O
cholesterol B
esterase I
displayed O
no O
significant O
homology O
with O
other O
lipases B
, O
although O
the O
putative O
lipid O
interfacial O
recognition O
site O
of O
G O
- O
X O
- O
S O
- O
X O
- O
G O
is O
present O
in O
the O
cholesterol B
esterase I
sequence I
. O

Visualization O
of O
the O
cells O
by O
phase O
contrast O
microscopy O
indicated O
that O
murine B
PKCepsilon I
expression O
in O
the O
presence O
of O
glycerol O
resulted O
in O
a O
significant O
increase O
in O
the O
number O
of O
yeast O
cells O
exhibiting O
very O
small O
buds O
. O

Highly O
significant O
similarities O
were O
detected O
between O
the O
N O
- O
terminal O
region O
of O
P30 B
and O
those O
of O
GENA B
[ O
the O
product O
of O
another O
unidentified O
gene O
( O
geneA B
) O
located O
upstream O
of O
the O
aceEF B
- O
lpd B
operon O
] O
, O
and O
GNTR B
( O
a O
putative O
transcriptional O
repressor O
of O
the O
gluconate B
operon I
of O
Bacillus O
subtilis O
) O
. O

claR B
and O
car B
were O
not O
significantly O
expressed O
in O
mutants O
disrupted O
in O
the O
ccaR B
gene I
, O
a O
regulatory O
gene O
that O
controls O
positively O
clavulanic O
acid O
and O
cephamycin O
biosynthesis O
. O

Whereas O
mutant B
6C4 I
specified O
a O
wild B
- I
type I
- I
size I
Pol I
protein I
, O
we O
detected O
no O
full B
- I
length I
Pol I
protein I
in O
7E4 O
- O
infected O
cell O
extracts O
. O

Being O
implicated O
in O
insulin B
and O
GK B
gene I
regulations O
as O
a O
common O
transcription O
factor O
, O
IPF1 B
/ O
STF B
- I
1 I
/ O
PDX B
- I
1 I
is O
likely O
to O
play O
an O
essential O
role O
in O
maintaining O
normal O
beta O
- O
cell O
functions O
. O

To O
determine O
the O
transactivation O
potential O
of O
each O
of O
the O
four O
Ahr B
Sp1 B
sites I
, O
we O
fused O
the O
Ahr B
promoter I
to O
a O
luciferase B
( O
LUC B
) O
reporter O
gene O
and O
transfected O
the O
construct O
into O
the O
Drosophila O
cell O
line O
Schneider O
- O
2 O
, O
which O
contains O
no O
Sp1 B
or O
Sp1 B
- I
like I
factors I
. O

To O
determine O
the O
transactivation O
potential O
of O
each O
of O
the O
four O
Ahr B
Sp1 B
sites I
, O
we O
fused O
the O
Ahr B
promoter I
to O
a O
luciferase B
( O
LUC B
) O
reporter O
gene O
and O
transfected O
the O
construct O
into O
the O
Drosophila O
cell O
line O
Schneider O
- O
2 O
, O
which O
contains O
no O
Sp1 B
or O
Sp1 B
- I
like I
factors I
. O

This O
growth O
- O
inhibitory O
effect O
was O
suppressed O
by O
the O
mpk1 B
delta I
mutation O
, O
suggesting O
that O
hyperactivation O
of O
the O
Mpk1 B
pathway O
is O
toxic O
to O
cells O
. O

We O
determined O
the O
complete O
nucleotide O
sequence O
of O
the O
gypsy B
element I
present O
at O
the O
forked B
locus I
of O
Drosophila O
melanogaster O
in O
the O
f1 O
allele O
. O

We O
determined O
the O
complete O
nucleotide O
sequence O
of O
the O
gypsy B
element I
present O
at O
the O
forked B
locus I
of O
Drosophila O
melanogaster O
in O
the O
f1 O
allele O
. O

The O
same O
high O
degree O
of O
sequence O
homology O
between O
the O
two O
F O
. O
diplosiphon O
PC B
alpha I
and O
PC B
beta I
sequences I
( O
85 O
and O
77 O
% O
, O
respectively O
) O
was O
found O
at O
both O
the O
nucleotide O
and O
amino O
acid O
levels O
, O
and O
similar O
results O
were O
obtained O
for O
interspecies O
comparisons O
. O

A O
group O
of O
factors O
known O
as O
activating B
transcription I
factors I
( O
ATF B
) O
have O
been O
found O
to O
bind O
to O
the O
latter O
and O
related O
sequences O
found O
upstream O
of O
early O
adenovirus O
promoters O
induced O
by O
E1A B
, O
and O
these O
factors O
are O
highly O
homologous O
to O
the O
CREB B
protein I
. O

Some O
of O
these O
DNA O
: O
protein O
complexes O
were O
also O
present O
, O
but O
at O
lower O
levels O
, O
in O
nuclear O
extracts O
from O
untransformed O
rat O
cells O
suggesting O
the O
possible O
involvement O
of O
cellular O
factors O
in O
the O
mechanism O
of O
down O
- O
regulation O
mediated O
by O
Ad12 B
E1A I
. O

Hypocalcemia O
is O
usually O
due O
to O
either O
a O
disturbance O
in O
the O
parathyroid B
hormone I
- O
adenylate B
cyclase I
system O
or O
a O
disturbance O
in O
vitamin O
D O
metabolism O
. O

Hypocalcemia O
is O
usually O
due O
to O
either O
a O
disturbance O
in O
the O
parathyroid B
hormone I
- O
adenylate B
cyclase I
system O
or O
a O
disturbance O
in O
vitamin O
D O
metabolism O
. O

In O
seven O
patients O
( O
7 O
. O
8 O
% O
) O
with O
new O
Q O
- O
waves O
and O
a O
pathologic O
CK B
- I
MB I
profile O
( O
group O
II O
) O
troponin B
T I
reached O
median O
levels O
of O
10 O
. O
47 O
micrograms O
/ O
l O
( O
quartile O
6 O
. O
34 O
- O
12 O
. O
50 O
micrograms O
/ O
l O
) O
( O
P O
< O
0 O
. O
001 O
I O
vs O
II O
) O
. O

The O
132 B
- I
bp I
PHO8p I
fragment I
, O
connected O
at O
position O
- O
281 O
of O
the O
5 O
' O
upstream O
region O
of O
a O
HIS5 B
' I
- O
' B
lacZ I
fused O
gene O
, O
could O
sense O
Pi O
signals O
in O
vivo O
, O
but O
a O
20 O
- O
bp O
synthetic O
oligonucleotide O
having O
the O
same O
sequence O
from O
- O
544 O
to O
- O
525 O
of O
the O
PHO8p B
DNA I
could O
not O
. O

The O
132 B
- I
bp I
PHO8p I
fragment I
, O
connected O
at O
position O
- O
281 O
of O
the O
5 O
' O
upstream O
region O
of O
a O
HIS5 B
' I
- O
' B
lacZ I
fused O
gene O
, O
could O
sense O
Pi O
signals O
in O
vivo O
, O
but O
a O
20 O
- O
bp O
synthetic O
oligonucleotide O
having O
the O
same O
sequence O
from O
- O
544 O
to O
- O
525 O
of O
the O
PHO8p B
DNA I
could O
not O
. O

The O
132 B
- I
bp I
PHO8p I
fragment I
, O
connected O
at O
position O
- O
281 O
of O
the O
5 O
' O
upstream O
region O
of O
a O
HIS5 B
' I
- O
' B
lacZ I
fused O
gene O
, O
could O
sense O
Pi O
signals O
in O
vivo O
, O
but O
a O
20 O
- O
bp O
synthetic O
oligonucleotide O
having O
the O
same O
sequence O
from O
- O
544 O
to O
- O
525 O
of O
the O
PHO8p B
DNA I
could O
not O
. O

Sequences O
within O
the O
UAS2 O
element O
of O
the O
ENO2 B
gene I
bound O
a O
second O
protein O
which O
corresponded O
to O
the O
ABFI B
( O
autonomously B
replicating I
sequence I
- I
binding I
factor I
) O
protein O
. O

Gel O
shift O
analysis O
of O
protein O
binding O
from O
nuclear O
extracts O
to O
these O
caveolin B
promoter I
DNA I
sequences I
, O
together O
with O
DNase B
I I
footprinting O
, O
confirmed O
nucleoprotein O
binding O
to O
the O
SRE O
- O
like O
elements O
as O
part O
of O
the O
transcriptional O
response O
to O
LDL B
- I
FC I
. O

The O
phP1 B
mutation O
was O
induced O
by O
insertion O
of O
a O
1 O
. O
2 O
- O
kb O
P B
element I
into O
the O
5 O
' O
transcribed O
nontranslated O
region O
of O
the O
proximal O
polyhomeotic B
gene I
. O

The O
phP1 B
mutation O
was O
induced O
by O
insertion O
of O
a O
1 O
. O
2 O
- O
kb O
P B
element I
into O
the O
5 O
' O
transcribed O
nontranslated O
region O
of O
the O
proximal O
polyhomeotic B
gene I
. O

Initial O
computer O
based O
similarity O
searches O
identified O
human B
retinoblastoma I
binding I
protein I
1 I
( O
RBP B
- I
1 I
) O
, O
Drosophila B
melanogaster I
male I
specific I
lethal I
- I
3 I
( O
Msl B
- I
3 I
) O
, O
S B
. I
pombe I
altered I
polarity I
- I
13 I
( O
Alp13 B
) O
and O
S B
. I
cerevisiae I
Eaf3p I
, O
a O
component O
of O
the O
yeast B
NuA4 I
HAT B
complex O
( O
Galarneau O
et O
al O
. O
, O
2000 O
. O

No O
transactivation O
of O
the O
ovalbumin B
promoter I
( O
pLovTATA B
) O
template O
control O
was O
observed O
. O

Both O
purH B
and O
purD B
genes I
constitute O
a O
single O
operon O
and O
are O
coregulated O
in O
expression O
by O
purines O
as O
other O
purine B
genes I
are O
. O

Both O
purH B
and O
purD B
genes I
constitute O
a O
single O
operon O
and O
are O
coregulated O
in O
expression O
by O
purines O
as O
other O
purine B
genes I
are O
. O

In O
situ O
hybridization O
reveals O
strong O
signals O
for O
Zep B
mRNA I
in O
the O
cerebellum O
and O
olfactory O
bulb O
with O
moderate O
signals O
detected O
in O
the O
hippocampus O
and O
cortex O
. O

At O
promoters O
that O
initiate O
with O
+ O
1 O
GGG O
, O
T7 B
RNAP I
synthesizes O
a O
ladder O
of O
poly O
( O
G O
) O
products O
as O
a O
result O
of O
slippage O
of O
the O
transcript O
on O
the O
three O
C O
residues O
in O
the O
template O
strand O
from O
+ O
1 O
to O
+ O
3 O
. O

The O
UL3 B
ORF I
of O
204 O
amino O
acids O
shows O
significant O
homology O
to O
UL3 B
( O
nuclear O
phosphoprotein O
) O
of O
HSV O
- O
1 O
( O
62 O
% O
) O
and O
PRV O
( O
53 O
% O
) O
. O

The O
remaining O
77 O
nucleotides O
at O
the O
3 O
' O
end O
of O
domain O
II O
and O
all O
of O
domains O
III O
( O
655 O
nucleotides O
) O
and O
IV O
( O
770 O
nucleotides O
) O
are O
not O
present O
in O
DIssE B
RNA I
. O

The O
gp41 B
peptide I
( I
Glu I
- I
Leu I
- I
Asp I
- I
Lys I
- I
Trp I
- I
Ala I
) I
fused O
to O
the O
C O
- O
terminus O
of O
Sj B
GST I
forms O
a O
loop O
stabilized O
by O
symmetry O
- O
related O
GSTs B
. O

The O
high O
degree O
of O
sequence O
conservation O
together O
with O
the O
ability O
to O
direct O
nucleolar O
protein O
transport O
supports O
the O
hypothesis O
that O
MAK16 B
proteins I
play O
a O
key O
role O
in O
the O
biogenesis O
of O
60S B
subunits I
. O

The O
high O
degree O
of O
sequence O
conservation O
together O
with O
the O
ability O
to O
direct O
nucleolar O
protein O
transport O
supports O
the O
hypothesis O
that O
MAK16 B
proteins I
play O
a O
key O
role O
in O
the O
biogenesis O
of O
60S B
subunits I
. O

Here O
we O
show O
that O
the O
sck1 B
gene I
, O
cloned O
as O
a O
high O
copy O
number O
suppressor O
of O
a O
mutation O
in O
git3 B
, O
is O
able O
to O
suppress O
the O
defects O
conferred O
by O
a O
mutation O
in O
any O
of O
these O
git B
genes I
. O

Here O
we O
show O
that O
the O
sck1 B
gene I
, O
cloned O
as O
a O
high O
copy O
number O
suppressor O
of O
a O
mutation O
in O
git3 B
, O
is O
able O
to O
suppress O
the O
defects O
conferred O
by O
a O
mutation O
in O
any O
of O
these O
git B
genes I
. O

The O
longest O
cDNA O
insert O
identified O
was O
2 O
. O
2 O
kb O
and O
encoded O
the O
entire O
462 O
- O
amino O
acid O
open O
reading O
frame O
of O
rat B
CgA I
including O
an O
18 O
- O
amino O
acid O
hydrophobic O
signal O
peptide O
. O

In O
addition O
, O
the O
authors O
found O
one O
an3 B
allele I
( O
an3 B
- I
W138A I
) O
in O
which O
a O
dTph1 B
element I
had O
inserted O
30 O
bp O
upstream O
the O
translation O
start O
, O
without O
inactivating O
the O
gene O
. O

In O
addition O
, O
the O
authors O
found O
one O
an3 B
allele I
( O
an3 B
- I
W138A I
) O
in O
which O
a O
dTph1 B
element I
had O
inserted O
30 O
bp O
upstream O
the O
translation O
start O
, O
without O
inactivating O
the O
gene O
. O

To O
investigate O
the O
role O
of O
bHLH B
proteins I
in O
MC3T3 O
- O
E1 O
osteoblasts O
, O
which O
undergo O
a O
developmental O
sequence O
in O
vitro O
, O
we O
analyzed O
the O
transcriptional O
control O
of O
osteocalcin B
gene I
expression O
by O
stable O
transfection O
of O
an O
osteocalcin B
promoter I
- O
luciferase B
chimeric O
gene O
( O
p637OC B
- I
luc I
) O
and O
assessed O
the O
role O
of O
E O
- O
box O
cis O
- O
acting O
elements O
in O
osteocalcin B
promoter I
by O
DNA O
binding O
assays O
. O

To O
investigate O
the O
role O
of O
bHLH B
proteins I
in O
MC3T3 O
- O
E1 O
osteoblasts O
, O
which O
undergo O
a O
developmental O
sequence O
in O
vitro O
, O
we O
analyzed O
the O
transcriptional O
control O
of O
osteocalcin B
gene I
expression O
by O
stable O
transfection O
of O
an O
osteocalcin B
promoter I
- O
luciferase B
chimeric O
gene O
( O
p637OC B
- I
luc I
) O
and O
assessed O
the O
role O
of O
E O
- O
box O
cis O
- O
acting O
elements O
in O
osteocalcin B
promoter I
by O
DNA O
binding O
assays O
. O

To O
investigate O
the O
role O
of O
bHLH B
proteins I
in O
MC3T3 O
- O
E1 O
osteoblasts O
, O
which O
undergo O
a O
developmental O
sequence O
in O
vitro O
, O
we O
analyzed O
the O
transcriptional O
control O
of O
osteocalcin B
gene I
expression O
by O
stable O
transfection O
of O
an O
osteocalcin B
promoter I
- O
luciferase B
chimeric O
gene O
( O
p637OC B
- I
luc I
) O
and O
assessed O
the O
role O
of O
E O
- O
box O
cis O
- O
acting O
elements O
in O
osteocalcin B
promoter I
by O
DNA O
binding O
assays O
. O

To O
investigate O
the O
role O
of O
bHLH B
proteins I
in O
MC3T3 O
- O
E1 O
osteoblasts O
, O
which O
undergo O
a O
developmental O
sequence O
in O
vitro O
, O
we O
analyzed O
the O
transcriptional O
control O
of O
osteocalcin B
gene I
expression O
by O
stable O
transfection O
of O
an O
osteocalcin B
promoter I
- O
luciferase B
chimeric O
gene O
( O
p637OC B
- I
luc I
) O
and O
assessed O
the O
role O
of O
E O
- O
box O
cis O
- O
acting O
elements O
in O
osteocalcin B
promoter I
by O
DNA O
binding O
assays O
. O

In O
this O
study O
, O
we O
show O
that O
HNF B
- I
4 I
, O
a O
member O
of O
the O
steroid B
hormone I
receptor I
superfamily I
, O
binds O
the O
AF B
- I
1 I
site I
on O
the O
apoB B
promoter I
and O
through O
it O
activates O
transcription O
in O
transient O
transfection O
assays O
in O
both O
liver O
and O
non O
- O
liver O
cell O
lines O
, O
HepG2 O
and O
HeLa O
, O
respectively O
. O

Our O
current O
study O
aims O
at O
clarifying O
the O
role O
of O
myristoylation O
in O
caveolar O
targeting O
using O
well O
- O
characterized O
acylation O
mutants O
of O
two O
model O
proteins O
, O
namely O
Gi1 B
alpha I
and O
c B
- I
Src I
. O

The O
Rep B
proteins I
of O
adeno O
- O
associated O
virus O
type O
2 O
( O
AAV O
) O
are O
known O
to O
bind O
to O
Rep B
recognition I
sequences I
( O
RRSs B
) O
in O
the O
AAV O
inverted O
terminal O
repeats O
( O
ITRs O
) O
, O
the O
AAV B
p5 I
promoter I
, O
and O
the O
preferred O
AAV O
integration O
site O
in O
human O
chromosome O
19 O
, O
called O
AAVS1 O
. O

The O
levels O
of O
TPAR1 B
mRNAs I
were O
dramatically O
down O
- O
regulated O
in O
regenerating O
rat O
liver O
when O
compared O
to O
normal O
adult O
liver O
. O

The O
authors O
suggest O
that O
alprazolam O
may O
have O
enhanced O
specificity O
for O
a O
subpopulation O
of O
benzodiazepine B
receptors I
. O

Southern O
hybridization O
analysis O
of O
BenR B
and O
BenS B
transformants I
suggested O
that O
plasmid O
integration O
occurred O
most O
frequently O
at O
the O
chromosomal O
bens B
locus I
, O
however O
evidence O
for O
gene O
conversion O
and O
heterologous O
recombination O
was O
also O
observed O
. O

Southern O
hybridization O
analysis O
of O
BenR B
and O
BenS B
transformants I
suggested O
that O
plasmid O
integration O
occurred O
most O
frequently O
at O
the O
chromosomal O
bens B
locus I
, O
however O
evidence O
for O
gene O
conversion O
and O
heterologous O
recombination O
was O
also O
observed O
. O

The O
analysis O
of O
the O
effects O
of O
eight O
signaling O
molecules O
in O
the O
TGFbeta B
, O
FGF B
, O
Hh B
, O
Wnt B
, O
and O
EGF B
families I
in O
tooth O
explant O
cultures O
revealed O
that O
the O
expression O
of O
edar B
was O
induced O
by O
activinbetaA B
, O
whereas O
Wnt6 B
induced O
ectodysplasin B
expression O
. O

This O
deletion O
disrupts O
the O
PU B
. I
1 I
Ets B
domain I
. O

In O
turn O
, O
production O
of O
sufficient O
amounts O
of O
TraR B
apparently O
is O
sensitive O
to O
a O
cellular O
function O
requiring O
RNase B
D I
. O

Phytohemagglutinin B
( O
PHA B
) O
, O
the O
seed B
lectin I
of O
the O
common O
bean O
, O
accumulates O
in O
protein O
storage O
vacuoles O
of O
storage O
parenchyma O
cells O
in O
cotyledons O
. O

Overexpression O
of O
p50 B
in O
transient O
cotransfection O
studies O
using O
the O
proximal O
CRP B
promoter I
( O
- O
125 O
/ O
+ O
9 O
) O
linked O
to O
a O
luciferase B
reporter I
caused O
a O
3 O
- O
fold O
increase O
of O
luciferase B
activity O
, O
while O
C B
/ I
EBPbeta I
overexpression O
caused O
an O
18 O
- O
fold O
increase O
; O
simultaneous O
overexpression O
of O
both O
transcription O
factors O
increased O
luciferase B
activity O
approximately O
600 O
- O
fold O
. O

Overexpression O
of O
p50 B
in O
transient O
cotransfection O
studies O
using O
the O
proximal O
CRP B
promoter I
( O
- O
125 O
/ O
+ O
9 O
) O
linked O
to O
a O
luciferase B
reporter I
caused O
a O
3 O
- O
fold O
increase O
of O
luciferase B
activity O
, O
while O
C B
/ I
EBPbeta I
overexpression O
caused O
an O
18 O
- O
fold O
increase O
; O
simultaneous O
overexpression O
of O
both O
transcription O
factors O
increased O
luciferase B
activity O
approximately O
600 O
- O
fold O
. O

A O
survey O
of O
children O
with O
HBsAg B
markers I
related O
to O
their O
parents O
HBV O
markers O
. O

By O
computed O
homology O
search O
, O
we O
noticed O
significant O
similarities O
between O
US3 B
PK I
and O
p21 B
- I
activated I
kinase I
( O
PAK B
) O
, O
which O
is O
activated O
by O
the O
Cdc42 B
or O
Rac B
. O

These O
8 B
- I
oxoguanine I
DNA I
glycosylases I
, O
hOgg1 B
( O
human O
) O
and O
mOgg1 B
( O
murine O
) O
, O
are O
homologous O
to O
each O
other O
and O
to O
yeast B
Ogg1 I
. O

The O
CHED B
protein I
includes O
the O
consensus O
ATP O
binding O
and O
phosphorylation O
domains O
characteristic O
of O
kinases O
, O
displays O
34 O
- O
42 O
% O
identically O
aligned O
amino O
acid O
residues O
with O
other O
cdc2 B
- I
related I
kinases I
, O
and O
is O
considerably O
longer O
at O
its O
amino O
and O
carboxyl O
termini O
. O

In O
the O
present O
study O
we O
use O
a O
tnaC B
- O
UGA O
- O
' B
lacZ I
construct O
lacking O
the O
tnaC B
- O
tnaA B
spacer O
region O
to O
analyze O
the O
effect O
of O
TnaC B
synthesis O
on O
the O
behavior O
of O
the O
ribosome O
that O
translates O
tnaC B
. O

In O
serum O
- O
starved O
NIH O
3T3 O
cells O
, O
v B
- I
raf I
increased O
mdr1 B
promoter I
activity O
approximately O
10 O
- O
fold O
compared O
to O
a O
v B
- I
raf I
frame O
- O
shift O
control O
. O

Searching O
the O
human O
DNA O
data O
base O
of O
expressed O
sequence O
tags O
( O
EST O
) O
revealed O
novel O
partial O
sequences O
similar O
to O
, O
but O
distinct O
from O
, O
the O
sequences O
of O
the O
previously O
known O
PEF B
proteins I
. O

The O
effective O
use O
of O
superoxide B
dismutase I
from O
human O
erythrocytes O
in O
the O
late O
stages O
of O
experimental O
influenza O
infection O

3 O
- O
5 O
- O
fold O
increases O
in O
EGF B
receptor I
but O
not O
p185 B
( O
neu B
) O
tyrosine O
phosphorylation O
occur O
following O
Gi B
- I
coupled I
receptor I
stimulation O
. O

Next O
, O
to O
examine O
the O
regulation O
mechanism O
of O
CD44 B
/ O
ERM B
interaction O
in O
vivo O
, O
we O
reexamined O
the O
immunoprecipitated O
CD44 B
/ O
ERM B
complex O
from O
BHK O
cells O
and O
found O
that O
it O
contains O
Rho B
- I
GDP I
dissociation I
inhibitor I
( O
GDI B
) O
, O
a O
regulator O
of O
Rho B
GTPase I
. O

TNF B
- I
alpha I
stimulated O
these O
changes O
in O
part O
by O
increasing O
transcription O
and O
stabilization O
of O
RNA O
for O
amphiregulin B
, O
an O
EGF B
receptor I
ligand O
, O
and O
amphiregulin B
directly O
increased O
HPV O
- O
16 O
E6 B
/ O
E7 B
and O
cyclin B
A I
RNAs I
. O

The O
full O
- O
length O
cDNA O
was O
cloned O
and O
sequenced O
, O
and O
the O
inferred O
amino O
acid O
sequence O
was O
found O
to O
encode O
a O
novel O
protein O
, O
which O
we O
named O
cystatin B
M I
, O
with O
40 O
% O
homology O
to O
human B
family I
2 I
cystatins I
and O
similar O
overall O
structure O
. O

BAG B
- I
1 I
also O
prevented O
growth O
arrest O
following O
UV O
- O
irradiation O
- O
induced O
genotoxic O
injury O
without O
interfering O
with O
accumulation O
of O
p53 B
protein I
or O
p21 B
( O
waf B
- I
1 I
) O
expression O
. O

These O
larger O
sizes O
, O
however O
, O
are O
consistent O
with O
predictions O
from O
the O
DNA O
sequence O
of O
the O
pol B
gene I
. O

P53 B
mutations I
also O
offer O
new O
approaches O
to O
the O
study O
of O
the O
origins O
of O
mutations O
in O
human O
cancer O
. O

Particle O
bombardment O
of O
barley O
aleurone O
with O
a O
B22EL8 B
promoter I
- O
GUS B
( O
beta B
- I
glucuronidase I
) O
construct O
demonstrates O
that O
the O
promoter O
( O
3 O
kb O
) O
is O
active O
in O
developing O
barley O
grains O
. O

Sox8 B
maps O
to O
the O
t B
complex I
on O
mouse O
chromosome O
17 O
and O
to O
human O
chromosome O
16p13 O
. O
3 O
, O
a O
region O
associated O
with O
the O
microphthalmia O
- O
cataract O
syndrome O
CATM O
and O
the O
alpha O
- O
thalassemia O
/ O
mental O
retardation O
syndrome O
ATR O
- O
16 O
. O

The O
STP1 B
locus I
is O
located O
on O
chromosome O
IV O
close O
to O
at O
least O
two O
other O
genes O
involved O
in O
RNA O
splicing O
: O
PRP3 B
and O
SPP41 B
. O

The O
WEB2 B
gene I
encodes O
a O
1 O
, O
522 O
- O
amino O
- O
acid O
protein O
with O
homology O
to O
nucleic B
acid I
- I
dependent I
ATPases I
. O

Evidence O
that O
the O
AT1A B
receptor I
activates O
transcription B
factor I
- I
Stat91 I
and O
/ O
or O
a O
related O
protein O
. O

Spen B
is O
the O
only O
known O
homeotic B
protein I
with O
RNP O
binding O
motifs O
, O
which O
indicates O
that O
splicing O
, O
transport O
, O
or O
other O
RNA O
regulatory O
steps O
are O
involved O
in O
the O
diversification O
of O
segmental O
morphology O
. O

Consistently O
, O
we O
show O
that O
phosphorylation O
by O
protein B
kinase I
A I
inhibits O
Sfl1 B
DNA O
binding O
in O
vitro O
, O
and O
that O
a O
tpk2Delta B
mutation O
increases O
the O
levels O
of O
Sfl1 B
protein I
associated O
with O
specific O
promoter O
elements O
in O
vivo O
. O

The O
response O
sequences O
were O
localized O
between O
- O
67 O
and O
+ O
30 O
in O
the O
simian O
cytomegalovirus O
IE94 B
promoter I
and O
upstream O
of O
position O
+ O
9 O
in O
the O
HCMV B
IE68 I
promoter I
. O

Legionella B
antibodies I
in O
domestic O
animals O

There O
is O
little O
similarity O
among O
the O
sequences O
upstream O
from O
the O
CAP O
site O
of O
the O
Spec2 B
genes I
except O
the O
TATA O
consensus O
sequence O
and O
a O
repeating O
trinucleotide O
, O
AAC O
. O

The O
reconstituted O
RNA B
polymerases I
containing O
the O
mutant O
alpha O
subunits O
were O
examined O
for O
their O
response O
to O
transcription O
activation O
by O
cAMP B
- I
CRP I
and O
the O
rrnBP1 B
UP I
element I
. O

Tax B
was O
demonstrated O
to O
interact O
directly O
with O
CREB1 B
but O
not O
with O
other O
bZIP B
proteins I
, O
including O
CREB2 B
and O
Jun B
. O

We O
also O
demonstrate O
that O
a O
p110RB1 B
mutant I
, O
which O
is O
refractory O
to O
cell O
cycle O
phosphorylation O
but O
intact O
in O
E1a B
/ O
large B
T I
antigen I
- O
binding O
properties O
, O
represses O
EIIaE B
with O
50 O
- O
to O
80 O
- O
fold O
greater O
efficiency O
than O
wild B
- I
type I
p110RB1 I
. O

We O
also O
demonstrate O
that O
a O
p110RB1 B
mutant I
, O
which O
is O
refractory O
to O
cell O
cycle O
phosphorylation O
but O
intact O
in O
E1a B
/ O
large B
T I
antigen I
- O
binding O
properties O
, O
represses O
EIIaE B
with O
50 O
- O
to O
80 O
- O
fold O
greater O
efficiency O
than O
wild B
- I
type I
p110RB1 I
. O

Constructs O
containing O
fragments O
of O
the O
upstream O
region O
of O
the O
cytotactin B
gene I
fused O
to O
a O
promoterless O
gene O
for O
chloramphenicol B
acetyltransferase I
were O
transiently O
transfected O
into O
chicken O
embryo O
fibroblasts O
to O
define O
functional O
promoter O
sequences O
. O

Constructs O
containing O
fragments O
of O
the O
upstream O
region O
of O
the O
cytotactin B
gene I
fused O
to O
a O
promoterless O
gene O
for O
chloramphenicol B
acetyltransferase I
were O
transiently O
transfected O
into O
chicken O
embryo O
fibroblasts O
to O
define O
functional O
promoter O
sequences O
. O

Our O
data O
suggest O
that O
the O
ZF B
- I
HD I
class O
of O
homeodomain B
proteins I
may O
be O
involved O
in O
the O
establishment O
of O
the O
characteristic O
expression O
pattern O
of O
the O
C4 B
PEPCase I
gene I
. O

We O
investigated O
whether O
two O
WT1 B
splice I
variants I
lacking O
or O
including O
a O
three O
- O
amino O
- O
acid O
( O
KTS O
) O
insertion O
between O
the O
third O
and O
fourth O
zinc O
finger O
in O
the O
DNA O
- O
binding O
domain O
could O
repress O
the O
IR B
promoter I
in O
vitro O
. O

Since O
simian B
virus I
40 I
( I
SV40 I
) I
large I
T I
antigen I
and O
human B
papillomavirus I
type I
16 I
( I
HPV16 I
) I
E7 I
protein I
also O
bind O
host O
regulatory O
factors O
, O
we O
investigated O
whether O
these O
viral O
proteins O
can O
complement O
E1A B
mutants I
which O
are O
defective O
in O
early O
gene O
activation O
. O

A O
400 O
- O
bp O
fragment O
( O
bp O
- O
339 O
through O
+ O
71 O
) O
of O
the O
CD22 B
promoter I
region I
was O
subcloned O
into O
a O
pGEM O
- O
chloramphenicol B
acetyltransferase I
vector O
and O
after O
transfection O
into O
B O
and O
T O
cells O
was O
found O
to O
be O
active O
in O
both O
B O
and O
T O
cells O
. O

Here O
we O
demonstrate O
that O
CD40 B
or O
IgM B
receptor I
stimulation O
of O
primary O
B O
cells O
results O
in O
transactivation O
of O
this O
enhancer O
. O

This O
cell O
line O
expresses O
productively O
rearranged O
immunoglobulin B
genes I
as O
well O
as O
the O
Oct B
- I
2 I
gene I
at O
high O
levels O
which O
are O
comparable O
to O
those O
observed O
in O
activated O
murine O
splenic O
B O
cells O
. O

The O
relationship O
between O
CSF B
somatostatin I
and O
peripheral O
thyroid O
hormones O
was O
assessed O
in O
11 O
affectively O
ill O
patients O
before O
and O
during O
carbamazepine O
treatment O
. O

Both O
RNA14 B
and O
RNA15 B
wild I
- I
type I
genes I
, O
when O
cloned O
on O
a O
multicopy O
plasmid O
, O
are O
able O
to O
suppress O
the O
temperature O
- O
sensitive O
phenotype O
of O
strains O
bearing O
either O
the O
rna14 B
or O
the O
rna15 B
mutation I
, O
suggesting O
that O
the O
encoded O
proteins O
could O
interact O
with O
each O
other O
. O

Vibrio O
cholerae O
iron O
transport O
: O
haem O
transport O
genes O
are O
linked O
to O
one O
of O
two O
sets O
of O
tonB B
, O
exbB B
, O
exbD B
genes I
. O

The O
predicted O
amino O
- O
acid O
sequence O
includes O
an O
N O
- O
terminal O
signal O
sequence O
of O
27 O
amino O
acids O
, O
a O
27 O
amino O
- O
acid O
pro O
- O
region O
, O
a O
251 O
amino O
- O
acid O
catalytic O
domain O
typical O
of O
a O
serine B
protease I
with O
trypsin B
- O
like O
specificity O
, O
and O
a O
C O
- O
terminal O
hydrophobic O
extension O
which O
is O
predicted O
to O
function O
as O
a O
membrane O
anchor O
. O

To O
examine O
the O
biochemical O
mechanism O
of O
Tax1 B
transactivation O
, O
we O
have O
developed O
an O
in O
vitro O
transactivation O
assay O
in O
which O
wild O
- O
type O
Tax1 B
is O
able O
to O
specifically O
transactivate O
a O
polymerase B
II I
promoter O
through O
upstream O
Tax1 B
- I
responsive I
elements I
. O

This O
study O
demonstrates O
a O
novel O
link O
between O
alterations O
in O
platelet B
- I
derived I
growth I
factor I
( O
PDGF B
) O
regulation O
of O
ornithine B
decarboxylase I
( O
ODC B
) O
expression O
during O
malignant O
conversion O
. O

A O
new O
simple O
identification O
of O
rheumatoid B
factor I
on O
nitrocellulose O
was O
developed O
that O
allows O
quantitative O
detection O
. O

Previous O
studies O
have O
shown O
that O
the O
IME1 B
gene I
is O
required O
for O
sporulation O
and O
the O
expression O
of O
meiosis O
specific O
genes O
in O
Saccharomyces O
cerevisiae O
. O

In O
the O
absence O
of O
c B
- I
fos I
gene I
expression O
, O
c B
- I
Fos I
protein I
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos B
family I
( O
Fra B
- I
1 I
) O
and O
ATF B
family I
( O
ATF B
- I
2 I
and O
ATFa B
) O
. O

In O
the O
absence O
of O
c B
- I
fos I
gene I
expression O
, O
c B
- I
Fos I
protein I
appears O
to O
be O
replaced O
by O
proteins O
of O
Fos B
family I
( O
Fra B
- I
1 I
) O
and O
ATF B
family I
( O
ATF B
- I
2 I
and O
ATFa B
) O
. O

Using O
yeast O
two O
- O
hybrid O
screening O
, O
we O
isolated O
histone B
H3 I
as O
an O
interacting O
factor O
of O
CIA B
. O

Gene O
expression O
is O
in O
part O
controlled O
by O
chromatin O
remodeling O
factors O
and O
the O
acetylation O
state O
of O
nucleosomal B
histones I
. O

When O
a O
longer O
- O
714 O
to O
+ O
78 O
fragment O
of O
the O
PBGD B
promoter I
is O
used O
, O
the O
- O
70 O
GATA O
mutant O
still O
displays O
erythroid O
- O
specific O
activity O
and O
is O
cis O
- O
activated O
by O
the O
5 B
' I
HS I
- I
2 I
enhancer I
, O
while O
the O
- O
100 O
CCACC O
mutant O
is O
completely O
inactive O
in O
the O
absence O
or O
in O
the O
presence O
of O
the O
5 B
' I
HS I
- I
2 I
enhancer I
. O

Surprisingly O
, O
in O
adult O
animals O
, O
the O
suprabasal O
expression O
of O
dnRXR B
alpha I
significantly O
reduced O
the O
ability O
of O
topically O
applied O
tRA O
to O
stimulate O
proliferation O
of O
undifferentiated O
keratinocytes O
in O
the O
basal O
layer O
of O
epidermis O
. O

From O
this O
comparison O
of O
aa O
sequences O
, O
the O
ATPK7 B
protein I
is O
considered O
to O
be O
a O
member O
of O
a O
novel O
subfamily O
of O
Ser B
/ I
Thr I
PKs I
in O
plants O
. O

Patients O
in O
the O
mucinous O
cyst O
group O
had O
significantly O
lower O
CA B
125 I
cystic O
fluid O
levels O
compared O
with O
women O
with O
endometriomas O
and O
dermoids O
( O
P O
& O
lt O
; O
0 O
. O
05 O
) O
. O

Plasma B
prolactin I
concentrations O
in O
pinealectomized O
ewes O
receiving O
melatonin O
treatment O
and O
in O
pineal O
intact O
ewes O
maintained O
under O
a O
non O
- O
24 O
- O
hour O
photoperiod O
. O

The O
transcriptional O
start O
site O
, O
identified O
by O
primer O
extension O
and O
S1 B
nuclease I
assay O
, O
is O
34 O
nt O
upstream O
of O
the O
translation O
initiation O
codon O
. O

This O
cDNA O
corresponded O
to O
FGF B
- I
binding I
protein I
( O
FGF B
- I
BP I
) O
, O
a O
secreted O
protein O
previously O
shown O
to O
bind O
acidic O
and O
basic B
FGF I
and O
to O
modulate O
their O
activities O
. O

Similar O
to O
what O
was O
observed O
for O
P O
. O
putida O
, O
a O
psrA B
null O
mutant O
of O
P O
. O
aeruginosa O
also O
showed O
a O
90 O
% O
reduction O
in O
rpoS B
promoter I
activity O
; O
both O
mutants O
could O
be O
complemented O
for O
rpoS B
promoter I
activity O
when O
the O
psrA B
gene I
was O
provided O
in O
trans O
. O

Similar O
to O
what O
was O
observed O
for O
P O
. O
putida O
, O
a O
psrA B
null O
mutant O
of O
P O
. O
aeruginosa O
also O
showed O
a O
90 O
% O
reduction O
in O
rpoS B
promoter I
activity O
; O
both O
mutants O
could O
be O
complemented O
for O
rpoS B
promoter I
activity O
when O
the O
psrA B
gene I
was O
provided O
in O
trans O
. O

Similar O
to O
what O
was O
observed O
for O
P O
. O
putida O
, O
a O
psrA B
null O
mutant O
of O
P O
. O
aeruginosa O
also O
showed O
a O
90 O
% O
reduction O
in O
rpoS B
promoter I
activity O
; O
both O
mutants O
could O
be O
complemented O
for O
rpoS B
promoter I
activity O
when O
the O
psrA B
gene I
was O
provided O
in O
trans O
. O

psrA B
mutants I
of O
both O
Pseudomonas O
species O
lost O
the O
ability O
to O
induce O
rpoS B
expression O
at O
stationary O
phase O
, O
but O
they O
retained O
the O
ability O
to O
produce O
quorum O
- O
sensing O
autoinducer O
molecules O
. O

This O
new O
receptor O
, O
TOR B
( O
thymus B
orphan I
receptor I
) O
, O
is O
most O
closely O
related O
in O
both O
its O
DNA O
- O
binding O
domain O
and O
ligand O
- O
binding O
domain O
, O
90 O
% O
and O
53 O
% O
, O
respectively O
, O
to O
ROR B
alpha I
/ O
RZR B
alpha I
and O
clusters O
with O
these O
two O
receptors O
and O
RZR B
beta I
in O
a O
phylogenetic O
tree O
, O
when O
both O
the O
DNA O
- O
binding O
domain O
and O
the O
ligand O
- O
binding O
domain O
sequences O
of O
nuclear O
receptors O
are O
compared O
. O

This O
new O
receptor O
, O
TOR B
( O
thymus B
orphan I
receptor I
) O
, O
is O
most O
closely O
related O
in O
both O
its O
DNA O
- O
binding O
domain O
and O
ligand O
- O
binding O
domain O
, O
90 O
% O
and O
53 O
% O
, O
respectively O
, O
to O
ROR B
alpha I
/ O
RZR B
alpha I
and O
clusters O
with O
these O
two O
receptors O
and O
RZR B
beta I
in O
a O
phylogenetic O
tree O
, O
when O
both O
the O
DNA O
- O
binding O
domain O
and O
the O
ligand O
- O
binding O
domain O
sequences O
of O
nuclear O
receptors O
are O
compared O
. O

This O
new O
receptor O
, O
TOR B
( O
thymus B
orphan I
receptor I
) O
, O
is O
most O
closely O
related O
in O
both O
its O
DNA O
- O
binding O
domain O
and O
ligand O
- O
binding O
domain O
, O
90 O
% O
and O
53 O
% O
, O
respectively O
, O
to O
ROR B
alpha I
/ O
RZR B
alpha I
and O
clusters O
with O
these O
two O
receptors O
and O
RZR B
beta I
in O
a O
phylogenetic O
tree O
, O
when O
both O
the O
DNA O
- O
binding O
domain O
and O
the O
ligand O
- O
binding O
domain O
sequences O
of O
nuclear O
receptors O
are O
compared O
. O

S1 B
nuclease I
analysis O
of O
the O
RNA O
from O
a O
number O
of O
QT6 O
- O
LD O
clones O
gave O
similar O
results O
, O
indicating O
that O
the O
LD O
population O
was O
composed O
of O
viruses O
with O
similar O
but O
not O
identical O
deletion O
endpoints O
. O

The O
three O
OAS B
genes I
are O
flanked O
by O
markers B
WI I
- I
10614 I
( O
cen B
) O
and O
D12S2293 B
( O
tel B
) O
and O
are O
contained O
within O
three O
sets O
of O
overlapping O
cosmid O
clones O
. O

The O
isolation O
of O
crt5 B
- I
262 I
, O
an O
additional O
cdc B
allele I
of O
POL1 B
/ O
CDC17 B
, O
suggests O
for O
the O
first O
time O
that O
directly O
blocking O
DNA O
replication O
can O
provide O
a O
signal O
to O
induce O
the O
DNA O
damage O
response O
. O

crt2 B
mutants I
show O
a O
defect O
in O
basal O
level O
expression O
of O
RNR1 B
- O
lacZ B
reporter O
constructs O
. O

We O
prospectively O
studied O
serum B
prolactin I
( O
PRL B
) O
elevation O
after O
different O
types O
of O
documented O
seizures O
in O
17 O
patients O
. O

Recombinant B
caspases I
are O
typically O
produced O
in O
Escherichia O
coli O
expression O
systems O
with O
the O
attendant O
problems O
of O
solubilization O
, O
re O
- O
folding O
and O
activation O
of O
the O
protease O
. O

Free O
protein B
S I
deficiency O
in O
acute O
ischemic O
stroke O
. O

In O
a O
previous O
study O
of O
transforming B
growth I
factor I
- I
beta1 I
- O
mediated O
inhibition O
of O
the O
cyclin B
A I
promoter I
, O
we O
mapped O
the O
inhibitory O
effect O
to O
the O
ATF B
site I
; O
in O
the O
present O
study O
of O
IFN B
- I
gamma I
treatment O
, O
functional O
analysis O
by O
transient O
transfection O
showed O
that O
inhibition O
of O
the O
cyclin B
A I
promoter I
persisted O
despite O
mutation O
of O
the O
ATF B
, O
NF B
- I
Y I
, O
or O
CDE O
elements O
. O

This O
paper O
describes O
a O
longitudinal O
study O
in O
which O
clinical O
parameters O
and O
aspartate B
aminotransferase I
( O
AST B
) O
in O
gingival O
crevicular O
fluid O
( O
GCF O
) O
were O
monitored O
bimonthly O
over O
a O
6 O
- O
12 O
months O
period O
in O
970 O
sites O
from O
7 O
treated O
periodontitis O
patients O
. O

Furthermore O
, O
the O
data O
suggest O
an O
immunological O
non O
- O
responsiveness O
to O
enterotoxin B
A I
in O
a O
considerable O
portion O
of O
the O
patients O
. O

The O
use O
of O
specific O
somatic O
cell O
hybrids O
have O
allowed O
us O
to O
locate O
the O
YAC O
contig O
telomeric O
to O
the O
D3F15S2 B
locus I
, O
in O
a O
region O
which O
is O
frequently O
deleted O
in O
lung O
carcinomas O
. O

This O
regulation O
is O
mediated O
by O
several O
kinases O
that O
phosphorylate O
specific O
residues O
in O
the O
different O
functional O
domains O
of O
the O
p53 B
molecule I
. O

In O
four O
calves O
given O
Haemonchus O
contortus O
larvae O
, O
the O
serum B
pepsinogen I
concentration O
rose O
quickly O
to O
reach O
a O
mean O
of O
3 O
. O
5 O
iu O
tyrosine O
on O
day O
14 O
after O
infection O
. O

Optical O
rotation O
of O
the O
second O
harmonic O
radiation O
from O
retinal O
in O
bacteriorhodopsin B
monomers I
in O
Langmuir O
- O
Blodgett O
film O
: O
evidence O
for O
nonplanar O
retinal O
structure O
. O

Our O
analysis O
indicates O
that O
a O
gene O
correction O
mechanism O
has O
been O
operating O
on O
the O
Hbbs B
chromosome O
to O
keep O
beta B
s I
and O
beta B
t I
evolving O
in O
concert O
, O
whereas O
on O
the O
Hbbd B
chromosome O
, O
beta B
dmin I
has O
diverged O
considerably O
from O
beta B
dmaj I
. O

Our O
analysis O
indicates O
that O
a O
gene O
correction O
mechanism O
has O
been O
operating O
on O
the O
Hbbs B
chromosome O
to O
keep O
beta B
s I
and O
beta B
t I
evolving O
in O
concert O
, O
whereas O
on O
the O
Hbbd B
chromosome O
, O
beta B
dmin I
has O
diverged O
considerably O
from O
beta B
dmaj I
. O

Our O
analysis O
indicates O
that O
a O
gene O
correction O
mechanism O
has O
been O
operating O
on O
the O
Hbbs B
chromosome O
to O
keep O
beta B
s I
and O
beta B
t I
evolving O
in O
concert O
, O
whereas O
on O
the O
Hbbd B
chromosome O
, O
beta B
dmin I
has O
diverged O
considerably O
from O
beta B
dmaj I
. O

Our O
analysis O
indicates O
that O
a O
gene O
correction O
mechanism O
has O
been O
operating O
on O
the O
Hbbs B
chromosome O
to O
keep O
beta B
s I
and O
beta B
t I
evolving O
in O
concert O
, O
whereas O
on O
the O
Hbbd B
chromosome O
, O
beta B
dmin I
has O
diverged O
considerably O
from O
beta B
dmaj I
. O

We O
identify O
YY1 B
recognition O
sequences O
within O
the O
vitamin O
D O
response O
element O
( O
VDRE O
) O
of O
the O
osteocalcin B
gene I
that O
are O
critical O
for O
YY1 B
- O
dependent O
repression O
of O
vitamin O
D O
- O
enhanced O
promoter O
activity O
. O

From O
the O
comparison O
of O
the O
nod B
box I
sequences I
of O
( O
brady O
) O
rhizobia O
with O
a O
more O
divergent O
nod B
box I
from O
Azorhizobium O
caulinodans O
, O
we O
now O
propose O
a O
modular O
build O
- O
up O
of O
the O
nod B
box I
with O
the O
sequence O
A O
- O
T O
- O
C O
- O
N9 O
- O
G O
- O
A O
- O
T O
as O
the O
binding O
target O
of O
the O
NodD B
protein I
( O
the O
NodD B
box I
) O
. O

From O
the O
comparison O
of O
the O
nod B
box I
sequences I
of O
( O
brady O
) O
rhizobia O
with O
a O
more O
divergent O
nod B
box I
from O
Azorhizobium O
caulinodans O
, O
we O
now O
propose O
a O
modular O
build O
- O
up O
of O
the O
nod B
box I
with O
the O
sequence O
A O
- O
T O
- O
C O
- O
N9 O
- O
G O
- O
A O
- O
T O
as O
the O
binding O
target O
of O
the O
NodD B
protein I
( O
the O
NodD B
box I
) O
. O

From O
the O
comparison O
of O
the O
nod B
box I
sequences I
of O
( O
brady O
) O
rhizobia O
with O
a O
more O
divergent O
nod B
box I
from O
Azorhizobium O
caulinodans O
, O
we O
now O
propose O
a O
modular O
build O
- O
up O
of O
the O
nod B
box I
with O
the O
sequence O
A O
- O
T O
- O
C O
- O
N9 O
- O
G O
- O
A O
- O
T O
as O
the O
binding O
target O
of O
the O
NodD B
protein I
( O
the O
NodD B
box I
) O
. O

From O
the O
comparison O
of O
the O
nod B
box I
sequences I
of O
( O
brady O
) O
rhizobia O
with O
a O
more O
divergent O
nod B
box I
from O
Azorhizobium O
caulinodans O
, O
we O
now O
propose O
a O
modular O
build O
- O
up O
of O
the O
nod B
box I
with O
the O
sequence O
A O
- O
T O
- O
C O
- O
N9 O
- O
G O
- O
A O
- O
T O
as O
the O
binding O
target O
of O
the O
NodD B
protein I
( O
the O
NodD B
box I
) O
. O

The O
prgX B
gene I
is O
adjacent O
to O
prgQ B
which O
provides O
the O
promoter O
for O
prgB B
expression O
. O

A O
conventional O
N O
- O
terminal O
signal O
sequence O
was O
not O
detected O
in O
the O
NodO B
protein I
. O

This O
mutant O
also O
functions O
in O
vivo O
as O
a O
trans O
- O
acting O
dominant O
negative O
regulator O
: O
the O
transcriptional O
inducibility O
of O
the O
HIV B
long I
terminal I
repeat I
( O
which O
contains O
two O
potential O
NF B
- I
kappa I
B I
binding I
sites I
) O
by O
phorbol O
ester O
( O
PMA O
) O
is O
inhibited O
when O
it O
is O
co O
- O
transfected O
into O
CD4 B
+ I
T O
cells O
with O
the O
delta O
SP O
mutant O
. O

Expression O
of O
putative O
constitutively O
active O
forms O
of O
DdMEK1 B
in O
a O
ddmek1 B
null O
background O
is O
capable O
, O
at O
least O
partially O
, O
of O
complementing O
the O
small O
aggregate O
size O
defect O
and O
the O
ability O
to O
activate O
guanylyl B
cyclase I
. O

During O
chronic O
treatment O
with O
salmon B
calcitonin I
, O
alkaline B
phosphatase I
activity O
and O
urinary O
hydroxyproline O
excretion O
decrease O
on O
an O
average O
of O
50 O
% O
in O
patients O
with O
Paget O
' O
s O
disease O
. O

During O
chronic O
treatment O
with O
salmon B
calcitonin I
, O
alkaline B
phosphatase I
activity O
and O
urinary O
hydroxyproline O
excretion O
decrease O
on O
an O
average O
of O
50 O
% O
in O
patients O
with O
Paget O
' O
s O
disease O
. O

Insulin B
therapy O
has O
been O
expanded O
by O
development O
of O
human B
insulin I
and O
new O
modes O
of O
injection O
, O
including O
insulin B
pumps O
. O

We O
conclude O
that O
the O
BR B
- I
C I
early I
gene I
directly O
activates O
late B
gene I
transcription O
by O
interacting O
with O
late B
gene I
cis O
- O
acting O
regulatory O
elements O
and O
that O
this O
interaction O
is O
responsible O
for O
the O
temporal O
linkage O
of O
early O
and O
late O
ecdysone O
- O
induced O
gene O
expression O
. O

We O
conclude O
that O
the O
BR B
- I
C I
early I
gene I
directly O
activates O
late B
gene I
transcription O
by O
interacting O
with O
late B
gene I
cis O
- O
acting O
regulatory O
elements O
and O
that O
this O
interaction O
is O
responsible O
for O
the O
temporal O
linkage O
of O
early O
and O
late O
ecdysone O
- O
induced O
gene O
expression O
. O

We O
have O
identified O
the O
gene O
encoding O
sigma B
E I
using O
a O
genetic O
screen O
designed O
to O
isolate O
trans O
- O
acting O
mutations O
that O
abolish O
expression O
from O
either O
htrA B
or O
rpoHP3 B
, O
two O
promoters O
recognized O
uniquely O
by O
sigma B
E I
- O
containing O
RNA B
polymerase I
. O

We O
have O
identified O
the O
gene O
encoding O
sigma B
E I
using O
a O
genetic O
screen O
designed O
to O
isolate O
trans O
- O
acting O
mutations O
that O
abolish O
expression O
from O
either O
htrA B
or O
rpoHP3 B
, O
two O
promoters O
recognized O
uniquely O
by O
sigma B
E I
- O
containing O
RNA B
polymerase I
. O

We O
have O
identified O
the O
gene O
encoding O
sigma B
E I
using O
a O
genetic O
screen O
designed O
to O
isolate O
trans O
- O
acting O
mutations O
that O
abolish O
expression O
from O
either O
htrA B
or O
rpoHP3 B
, O
two O
promoters O
recognized O
uniquely O
by O
sigma B
E I
- O
containing O
RNA B
polymerase I
. O

A O
deletion O
analysis O
of O
the O
FAS1 B
promoter I
lacking O
the O
previously O
characterized O
inositol O
/ O
choline O
- O
responsive O
- O
element O
motif O
defined O
a O
region O
( O
nucleotides O
- O
760 O
to O
- O
850 O
) O
responsible O
for O
most O
of O
the O
remaining O
activation O
potency O
. O

They O
encode O
proteins O
whose O
core O
regions O
display O
great O
similarity O
to O
Aspergillus B
HAPB I
, O
HAPC B
and O
HAPE B
and O
to O
known O
HAP B
homologs I
from O
other O
organisms O
. O

They O
encode O
proteins O
whose O
core O
regions O
display O
great O
similarity O
to O
Aspergillus B
HAPB I
, O
HAPC B
and O
HAPE B
and O
to O
known O
HAP B
homologs I
from O
other O
organisms O
. O

Decreased O
plasma O
level O
of O
antithrombin B
III I
was O
assumed O
to O
be O
one O
of O
the O
major O
factors O
underlying O
hypercoagulable O
state O
in O
nephrotic O
syndrome O
. O

Genomic O
DNA O
blot O
analysis O
indicates O
that O
the O
trout B
L2 I
locus I
has O
a O
cluster O
- O
like O
organization O
similar O
to O
the O
trout B
L1 I
locus I
and O
the O
IgL B
locus I
of O
several O
teleost O
fish O
. O

Pancreatic O
expression O
of O
the O
glucagon B
gene I
depends O
on O
multiple O
transcription O
factors O
interacting O
with O
at O
least O
three O
DNA O
control O
elements O
: O
G1 O
, O
the O
upstream O
promoter O
element O
, O
and O
G2 O
and O
G3 O
, O
two O
enhancer O
- O
like O
sequences O
. O

Both O
merR B
genes I
consist O
of O
a O
408 O
bp O
ORF O
coding O
for O
135 O
amino O
acids O
. O

Amniotic O
fluid O
ionic O
concentration O
in O
response O
to O
chronic O
fetal B
vasopressin I
infusion O
. O

The O
architecture O
of O
the O
hRap1 B
Myb B
domain I
is O
very O
close O
to O
that O
of O
each O
of O
the O
Myb B
domains I
from O
TRF1 B
, O
scRap1p B
and O
c B
- I
Myb I
. O

The O
architecture O
of O
the O
hRap1 B
Myb B
domain I
is O
very O
close O
to O
that O
of O
each O
of O
the O
Myb B
domains I
from O
TRF1 B
, O
scRap1p B
and O
c B
- I
Myb I
. O

The O
phosphoprotein B
pUL69 I
of O
human O
cytomegalovirus O
( O
HCMV O
) O
, O
which O
is O
a O
herpesvirus O
of O
considerable O
medical O
importance O
in O
immunosuppressed O
patients O
and O
newborns O
, O
has O
previously O
been O
identified O
as O
an O
early B
- I
late I
viral I
protein I
that O
can O
stimulate O
several O
viral O
and O
cellular O
promoters O
and O
thus O
exerts O
a O
rather O
broad O
activation O
pattern O
. O

Plasma B
enteroglucagon I
was O
measured O
before O
and O
during O
three O
hours O
after O
a O
standard O
meal O
in O
21 O
untreated O
adult O
patients O
with O
suspected O
coeliac O
disease O
who O
all O
had O
villous O
atrophy O
of O
the O
small O
intestinal O
mucosa O
and O
malabsorption O
, O
and O
in O
nine O
control O
subjects O
. O

The O
psi B
zeta I
gene I
has O
a O
nonsense O
mutation O
in O
exon O
1 O
but O
has O
identical O
promoter O
sequence O
and O
RNA O
processing O
sites O
to O
the O
zeta B
gene I
, O
raising O
the O
possibility O
that O
both O
psi B
zeta I
and O
zeta B
are O
transcriptionally O
active O
. O

The O
psi B
zeta I
gene I
has O
a O
nonsense O
mutation O
in O
exon O
1 O
but O
has O
identical O
promoter O
sequence O
and O
RNA O
processing O
sites O
to O
the O
zeta B
gene I
, O
raising O
the O
possibility O
that O
both O
psi B
zeta I
and O
zeta B
are O
transcriptionally O
active O
. O

The O
Id4 B
protein I
contains O
a O
HLH O
domain O
highly O
conserved O
among O
the O
dnHLH B
proteins I
from O
mouse O
and O
drosophila O
. O

The O
Id4 B
protein I
contains O
a O
HLH O
domain O
highly O
conserved O
among O
the O
dnHLH B
proteins I
from O
mouse O
and O
drosophila O
. O

The O
coding O
region O
of O
nifA B
was O
determined O
using O
a O
translational O
lacZ B
fusion I
and O
by O
site O
- O
directed O
mutagenesis O
to O
identify O
which O
of O
four O
in O
frame O
AUG O
codons O
was O
used O
. O

Peptide O
competition O
studies O
have O
localized O
a O
cyclin B
A I
interaction I
site I
to O
a O
Lys381Lys382Leu383Met384Phe385 O
sequence O
within O
C O
- O
terminal O
negative O
regulatory O
domain O
of O
human B
p53 I
. O

Like O
troponin B
Cs I
and O
calmodulins B
, O
PfCPK B
also O
contains O
four O
EF O
hand O
calcium O
- O
binding O
motifs O
. O

Upstream O
of O
the O
afa B
- I
3 I
gene I
cluster I
, O
a O
1 O
. O
2 O
- O
kb O
region O
was O
found O
to O
be O
96 O
% O
identical O
to O
the O
RepFIB B
sequence I
of O
one O
of O
the O
enterotoxigenic O
E O
. O
coli O
plasmids O
( O
P307 O
) O
, O
suggesting O
a O
common O
ancestor O
plasmid O
. O

In O
F9 O
, O
which O
is O
a O
prototype O
of O
embryonal O
carcinoma O
cells O
expressing O
hst B
, O
the O
expression O
of O
hst B
gene I
is O
positively O
regulated O
by O
a O
downstream O
octamer O
motif O
that O
functions O
as O
an O
enhancer O
. O

Purified O
phosphorylated O
PhoP B
( O
PhoPP B
) O
had O
a O
half O
- O
life O
of O
approximately O
2 O
. O
5 O
h O
, O
which O
was O
reduced O
to O
about O
15 O
min O
by O
addition O
of O
the O
same O
molar O
amount O
of O
* B
PhoR I
( O
the O
cytoplasmic O
region O
of O
PhoR B
) O
. O

This O
transformation O
suppression O
by O
Rb B
was O
further O
shown O
to O
be O
due O
to O
transcriptional O
repression O
of O
neu B
using O
Rb B
expressing O
effector O
plasmid O
and O
neu B
promoter O
- O
chloramphenicol B
acetyltransferase I
reporter O
gene O
. O

Biochemical O
studies O
and O
studies O
of O
cells O
expressing O
mutant O
IL B
- I
2 I
receptors I
indicate O
that O
IL B
- I
2 I
- O
induced O
tyrosine B
kinase I
activation O
initiates O
a O
complex O
signaling O
cascade O
. O

BACKGROUND O
: O
Peripheral O
kappa B
receptor I
agonists O
may O
provide O
a O
new O
therapeutic O
approach O
for O
the O
treatment O
of O
functional O
dyspepsia O
. O

The O
yeast O
genome O
contains O
a O
single O
ORD1 B
gene I
that O
resides O
on O
chromosome O
XI O
. O

The O
N O
- O
terminal O
sequence O
of O
the O
extracellular B
MEP20 I
, O
TKVAS B
, O
was O
found O
at O
aa O
194 O
- O
198 O
within O
the O
ORF O
. O

As O
in O
IncP O
alpha O
plasmids O
, O
these O
operons O
are O
transcribed O
from O
a O
bidirectional O
promoter O
region O
consisting O
of O
trfAp B
for O
the O
trfA B
operon I
and O
trbAp B
and O
trbBp B
for O
the O
trb B
operon I
. O

As O
in O
IncP O
alpha O
plasmids O
, O
these O
operons O
are O
transcribed O
from O
a O
bidirectional O
promoter O
region O
consisting O
of O
trfAp B
for O
the O
trfA B
operon I
and O
trbAp B
and O
trbBp B
for O
the O
trb B
operon I
. O

Electrophoretic O
mobility O
shift O
analysis O
of O
protein O
- O
DNA O
complexes O
formed O
with O
nuclear O
proteins O
isolated O
from O
I3C O
- O
treated O
and O
- O
untreated O
cells O
, O
in O
combination O
with O
supershift O
assays O
using O
Sp1 B
antibodies I
, O
demonstrated O
that O
the O
Sp1 B
- I
binding I
site I
in O
the O
CDK6 B
promoter I
forms O
a O
specific O
I3C O
- O
responsive O
DNA O
- O
protein O
complex O
that O
contains O
the O
Sp1 B
transcription I
factor I
. O

Electrophoretic O
mobility O
shift O
analysis O
of O
protein O
- O
DNA O
complexes O
formed O
with O
nuclear O
proteins O
isolated O
from O
I3C O
- O
treated O
and O
- O
untreated O
cells O
, O
in O
combination O
with O
supershift O
assays O
using O
Sp1 B
antibodies I
, O
demonstrated O
that O
the O
Sp1 B
- I
binding I
site I
in O
the O
CDK6 B
promoter I
forms O
a O
specific O
I3C O
- O
responsive O
DNA O
- O
protein O
complex O
that O
contains O
the O
Sp1 B
transcription I
factor I
. O

These O
results O
suggest O
that O
both O
the O
distinct O
DNA O
binding O
properties O
of O
PMLRAR B
homodimers I
and O
the O
sequestration O
of O
RXR B
by O
PMLRARs B
may O
contribute O
to O
the O
molecular O
mechanisms O
which O
underlie O
the O
pathogenesis O
of O
APL O
. O

These O
results O
demonstrate O
that O
the O
entire O
E3L B
gene I
is O
required O
for O
pathogenesis O
in O
the O
mouse O
model O
. O

We O
have O
analyzed O
the O
role O
of O
the O
HU B
protein I
in O
invertasome O
assembly O
when O
the O
enhancer O
is O
located O
at O
variable O
positions O
close O
to O
one O
of O
the O
recombination O
sites O
. O

A O
wide O
conservation O
of O
iscSUA B
genes I
in O
nature O
and O
evidence O
that O
NifU B
and O
NifS B
participate O
in O
the O
mobilization O
of O
iron O
and O
sulfur O
for O
nitrogenase B
- O
specific O
iron O
- O
sulfur O
cluster O
formation O
suggest O
that O
the O
products O
of O
the O
iscSUA B
genes I
could O
play O
a O
general O
role O
in O
the O
formation O
or O
repair O
of O
iron O
- O
sulfur O
clusters O
. O

A O
wide O
conservation O
of O
iscSUA B
genes I
in O
nature O
and O
evidence O
that O
NifU B
and O
NifS B
participate O
in O
the O
mobilization O
of O
iron O
and O
sulfur O
for O
nitrogenase B
- O
specific O
iron O
- O
sulfur O
cluster O
formation O
suggest O
that O
the O
products O
of O
the O
iscSUA B
genes I
could O
play O
a O
general O
role O
in O
the O
formation O
or O
repair O
of O
iron O
- O
sulfur O
clusters O
. O

Prematurely O
inactivating O
p42 B
MAPK I
in O
egg O
extracts O
resulted O
in O
a O
corresponding O
hastening O
of O
the O
first O
mitosis O
. O

Hence O
the O
GAP1 B
gene I
encodes O
a O
protein O
with O
characteristics O
typical O
of O
integral O
membrane O
proteins O
translocating O
ligants O
across O
cellular O
membranes O
. O

The O
leucine O
zipper O
region O
of O
ATF B
proteins I
is O
also O
similar O
to O
that O
of O
the O
AP B
- I
1 I
/ O
c B
- I
jun I
family O
of O
transcription O
factors O
, O
whose O
DNA O
- O
binding O
site O
differs O
from O
the O
ATF B
- O
binding O
site O
at O
a O
single O
position O
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
BSMV B
coat I
protein I
is O
the O
sole O
translation O
product O
of O
the O
genomic B
RNA I
beta I
, O
whereas O
sgRNA B
beta I
1 I
serves O
as O
a O
messenger O
for O
translation O
of O
the O
beta B
b I
protein I
, O
and O
sgRNA B
beta I
2 I
functions O
as O
a O
messenger O
for O
translation O
of O
beta B
c I
and O
beta B
d I
and O
the O
newly O
discovered O
beta B
d I
' I
protein I
. O

When O
the O
measured O
beta B
- I
galactosidase I
activity O
in O
the O
pWP O
- O
transfected O
cells O
was O
normalized O
to O
the O
pCH110 O
- O
transfected O
cells O
( O
an O
appropriate O
control O
if O
the O
SV40 B
early I
region I
promoter I
functions O
constitutively O
in O
various O
cell O
lines O
) O
, O
the O
results O
suggested O
that O
the O
promoter O
region O
of O
the O
PLP B
gene I
contains O
the O
information O
necessary O
for O
initiation O
of O
transcription O
in O
a O
C6 O
cell O
- O
specific O
manner O
. O

To O
determine O
whether O
the O
transcript O
encodes O
an O
active O
enzyme O
, O
we O
developed O
a O
novel O
transient O
embryonic O
excision O
assay O
in O
which O
zebrafish O
fertilized O
eggs O
were O
co O
- O
injected O
with O
RNA O
transcribed O
in O
vitro O
using O
the O
Tol2 B
cDNA I
as O
a O
template O
and O
a O
plasmid O
DNA O
harboring O
a O
nonautonomous O
Tol2 B
element I
, O
which O
has O
a O
deletion O
in O
the O
transposase B
coding I
region I
. O

To O
determine O
whether O
the O
transcript O
encodes O
an O
active O
enzyme O
, O
we O
developed O
a O
novel O
transient O
embryonic O
excision O
assay O
in O
which O
zebrafish O
fertilized O
eggs O
were O
co O
- O
injected O
with O
RNA O
transcribed O
in O
vitro O
using O
the O
Tol2 B
cDNA I
as O
a O
template O
and O
a O
plasmid O
DNA O
harboring O
a O
nonautonomous O
Tol2 B
element I
, O
which O
has O
a O
deletion O
in O
the O
transposase B
coding I
region I
. O

Two O
SH2 B
domains I
of O
p120 B
Ras B
GTPase B
- I
activating I
protein I
bind O
synergistically O
to O
tyrosine O
phosphorylated O
p190 B
Rho O
GTPase B
- I
activating I
protein I
. O

ALT B
( O
alanine B
aminotransferase I
) O
and O
Hb B
( O
hemoglobin B
) O
appeared O
to O
be O
predictive O
for O
efficacy O
. O

Escherichia O
coli O
cells O
expressing O
a O
mutant B
glyV I
( O
glycine B
tRNA I
) O
gene O
have O
a O
UVM O
- O
constitutive O
phenotype O
: O
implications O
for O
mechanisms O
underlying O
the O
mutA B
or O
mutC B
mutator I
effect O
. O

Escherichia O
coli O
cells O
expressing O
a O
mutant B
glyV I
( O
glycine B
tRNA I
) O
gene O
have O
a O
UVM O
- O
constitutive O
phenotype O
: O
implications O
for O
mechanisms O
underlying O
the O
mutA B
or O
mutC B
mutator I
effect O
. O

Escherichia O
coli O
cells O
expressing O
a O
mutant B
glyV I
( O
glycine B
tRNA I
) O
gene O
have O
a O
UVM O
- O
constitutive O
phenotype O
: O
implications O
for O
mechanisms O
underlying O
the O
mutA B
or O
mutC B
mutator I
effect O
. O

Here O
we O
report O
the O
cloning O
of O
the O
hemF B
gene I
, O
encoding O
the O
aerobic O
coproporphyrinogen B
III I
oxidase I
from I
Escherichia I
coli I
, O
by O
functional O
complementation O
of O
a O
Saccharomyces B
cerevisiae I
HEM13 I
mutant I
. O

This O
study O
was O
undertaken O
to O
evaluate O
the O
physical O
and O
biological O
characteristics O
of O
nebulized O
interleukin B
2 I
liposomes O
. O

Previous O
studies O
showed O
that O
a O
palindromic O
sequence O
located O
at O
- O
159 O
base O
pairs O
is O
essential O
for O
induction O
of O
cutinase B
gene I
in O
Fusarium O
solani O
f O
. O

Based O
on O
PCR O
strategies O
and O
expression O
studies O
, O
we O
define O
the O
genomic O
organization O
of O
the O
FUT8b B
gene I
. O

Previous O
studies O
using O
partial O
sequences O
have O
suggested O
the O
potential O
of O
26S B
or O
large B
- I
subunit I
( O
LSU B
) O
rDNA O
for O
phylogeny O
retrieval O
at O
taxonomic O
levels O
comparable O
to O
those O
investigated O
with O
18S B
rDNA I
. O

The O
cause O
for O
the O
increase O
in O
plasma B
ANP I
levels O
in O
the O
active O
phase O
remains O
to O
be O
determined O
. O

These O
involve O
( O
1 O
) O
subcloning O
a O
promoterless O
sucCD B
fragment I
downstream O
of O
the O
lac B
promoter I
in O
M13mp10 O
, O
and O
( O
2 O
) O
precise O
splicing O
of O
the O
suc B
coding I
regions I
with O
the O
efficient O
atpE B
ribosome I
- I
binding I
site I
and O
expression O
from O
the O
thermoinducible O
lambda O
promoters O
in O
the O
pJLA503 O
vector O
. O

These O
involve O
( O
1 O
) O
subcloning O
a O
promoterless O
sucCD B
fragment I
downstream O
of O
the O
lac B
promoter I
in O
M13mp10 O
, O
and O
( O
2 O
) O
precise O
splicing O
of O
the O
suc B
coding I
regions I
with O
the O
efficient O
atpE B
ribosome I
- I
binding I
site I
and O
expression O
from O
the O
thermoinducible O
lambda O
promoters O
in O
the O
pJLA503 O
vector O
. O

Viral O
complementary O
15 B
S I
mRNA I
that O
directs O
the O
synthesis O
of O
N B
protein I
and O
hybridizes O
to O
the O
predicted O
N B
gene I
DNA O
has O
been O
identified O
in O
infected O
cell O
extracts O
. O

Viral O
complementary O
15 B
S I
mRNA I
that O
directs O
the O
synthesis O
of O
N B
protein I
and O
hybridizes O
to O
the O
predicted O
N B
gene I
DNA O
has O
been O
identified O
in O
infected O
cell O
extracts O
. O

Electrophoretic O
mobility O
shift O
assays O
and O
DNase B
I I
protection O
analyses O
revealed O
that O
FP B
I I
was O
bound O
by O
the O
transcription O
factor O
PU B
. I
1 I
/ O
Spi B
- I
1 I
. O

Electrophoretic O
mobility O
shift O
assays O
and O
DNase B
I I
protection O
analyses O
revealed O
that O
FP B
I I
was O
bound O
by O
the O
transcription O
factor O
PU B
. I
1 I
/ O
Spi B
- I
1 I
. O

The O
addition O
of O
novel O
techniques O
, O
such O
as O
histopathologic O
ultrastaging O
, O
immunohistochemistry O
staining O
, O
and O
reverse B
transcriptase I
polymerase O
chain O
reaction O
assays O
, O
will O
help O
increase O
the O
accuracy O
and O
rate O
of O
detection O
of O
disease O
. O

Several O
of O
the O
drugs O
used O
in O
the O
management O
of O
MAC O
have O
been O
associated O
with O
significant O
drug O
interactions O
involving O
the O
cytochrome B
P450 I
( O
CYP B
) O
enzyme O
system O
. O

Both O
the O
p38 B
kinase I
inhibitor O
SB205380 O
( O
SB O
) O
and O
cotransfection O
of O
a O
dominant O
- O
negative O
mutant O
of O
p38 B
kinase I
reduced O
IL B
- I
1beta I
stimulation O
of O
the O
hBNP B
promoter I
. O

Both O
the O
p38 B
kinase I
inhibitor O
SB205380 O
( O
SB O
) O
and O
cotransfection O
of O
a O
dominant O
- O
negative O
mutant O
of O
p38 B
kinase I
reduced O
IL B
- I
1beta I
stimulation O
of O
the O
hBNP B
promoter I
. O

Both O
the O
p38 B
kinase I
inhibitor O
SB205380 O
( O
SB O
) O
and O
cotransfection O
of O
a O
dominant O
- O
negative O
mutant O
of O
p38 B
kinase I
reduced O
IL B
- I
1beta I
stimulation O
of O
the O
hBNP B
promoter I
. O

In O
addition O
, O
because O
SB203580 O
had O
no O
effect O
of O
TNF B
- O
or O
ceramide O
- O
induced O
apoptosis O
, O
our O
results O
strongly O
argue O
against O
a O
role O
for O
p38 B
MAPK I
in O
the O
induction O
of O
TNF B
- O
- O
or O
ceramide O
- O
induced O
apoptosis O
. O

Differential O
transcription O
of O
plastome O
- O
encoded O
genes O
in O
the O
mesophyll O
and O
bundle O
- O
sheath O
chloroplasts O
of O
the O
monocotyledonous O
NADP O
- O
malic B
enzyme I
- O
type O
C4 O
plants O
maize O
and O
Sorghum O
. O

Sequential O
immunoprecipitation O
showed O
all O
detectable O
p53 B
to O
be O
of O
the O
PAb246 B
+ I
class O
in O
each O
LPV O
- O
transformed O
cell O
line O
, O
suggesting O
that O
the O
stable O
p53 B
was O
indeed O
wild O
type O
. O

To O
better O
understand O
the O
relationship O
between O
expression O
of O
an O
oncogene O
and O
genetic O
instability O
, O
we O
have O
studied O
a O
cell O
line O
expressing O
an O
activated B
human I
Ha I
- I
ras I
under O
the O
control O
of O
bacterial B
lactose I
operon I
regulatory I
elements I
for O
changes O
in O
methotrexate O
resistance O
and O
dihydrofolate B
reductase I
( O
dhfr B
) O
gene O
amplification O
following O
mutant B
Ha I
- I
ras I
induction O
. O

The O
human B
PAX8 I
gene I
generates O
at O
least O
five O
different O
alternatively O
spliced O
transcripts O
encoding O
different O
PAX8 B
isoforms I
. O

These O
data O
show O
that O
both O
Sp1 B
and O
Sp3 B
transcription I
factors I
upregulate O
HGF B
promoter I
activity O
by O
binding O
to O
the O
Sp1 B
binding I
site I
at O
position O
- O
318 O
to O
- O
303 O
bp O
in O
the O
HGF B
gene I
promoter I
. O

The O
S3 B
protein I
also O
contains O
a O
DNA O
repair O
activity O
, O
efficiently O
processing O
8 O
- O
oxoguanine O
residues O
in O
DNA O
via O
an O
N B
- I
glycosylase I
/ O
apurinic B
- I
apyrimidinic I
( I
AP I
) I
lyase I
activity O
. O

The O
encoded O
Arabidopsis B
U3 I
snRNAs I
can O
be O
folded O
into O
a O
secondary O
structure O
which O
is O
more O
similar O
to O
that O
of O
U3 B
RNAs I
from O
lower O
eukaryotes O
rather O
than O
from O
metazoa O
. O

Mutations O
abolishing O
MalK B
function O
not O
only O
result O
in O
inability O
to O
transport O
maltose O
but O
also O
cause O
constitutive O
expression O
of O
the O
maltose B
regulon I
. O

Cell O
rounding O
was O
abrogated O
by O
expression O
of O
either O
kinase O
- O
dead O
forms O
of O
US3 B
PK I
or O
a O
mutant O
protein O
lacking O
the O
acidic O
cluster O
in O
the O
kinase O
regulatory O
domain O
. O

Three O
distinct O
human B
HDACs I
are O
homologous O
to O
RPD3 B
, O
a O
yeast O
transcriptional O
regulator O
. O

The O
pra2 B
gene I
encodes O
a O
pea B
( I
Pisum I
sativum I
) I
small I
GTPase I
belonging O
to O
the O
YPT B
/ O
rab B
family O
, O
and O
its O
expression O
is O
down O
- O
regulated O
by O
light O
, O
mediated O
by O
phytochrome B
. O

To O
explore O
further O
the O
role O
of O
the O
carboxyl O
- O
terminal O
domain O
in O
determining O
the O
cell O
cycle O
function O
of O
CDC34 B
, O
we O
constructed O
and O
characterized O
genes O
encoding O
chimeric B
E2s I
incorporating O
sequences O
from O
CDC34 B
and O
the O
related O
but O
functionally O
distinct O
E2 B
RAD6 B
( O
UBC2 B
) O
. O

MAPKK B
kinase I
/ O
MEKK B
phosphorylates O
and O
activates O
its O
downstream O
protein O
kinase O
, O
MAPK B
kinase I
/ O
MEK B
, O
which O
in O
turn O
activates O
MAPK B
. O

MAPKK B
kinase I
/ O
MEKK B
phosphorylates O
and O
activates O
its O
downstream O
protein O
kinase O
, O
MAPK B
kinase I
/ O
MEK B
, O
which O
in O
turn O
activates O
MAPK B
. O

However O
, O
ADAR1 B
and O
the O
related O
deaminase B
ADAR2 I
showed O
significant O
expression O
in O
all O
regions O
of O
the O
brain O
examined O
, O
including O
cortex O
, O
hippocampus O
, O
olfactory O
bulb O
, O
and O
striatum O
, O
where O
the O
5 B
- I
HT2CR I
pre I
- I
mRNA I
was O
extensively O
edited O
. O

Temporal O
recruitment O
of O
the O
mSin3A B
- O
histone B
deacetylase I
corepressor O
complex O
to O
the O
ETS B
domain I
transcription I
factor I
Elk B
- I
1 I
. O

In O
addition O
, O
FOP B
- O
FGFR1 B
- O
expressing O
cells O
show O
constitutive O
phosphorylation O
of O
the O
positive O
regulator O
of O
translation O
p70S6 B
kinase I
; O
this O
phosphorylation O
is O
inhibited O
by O
PI3 B
- I
kinase I
and O
mTOR B
( O
mammalian B
target I
of I
rapamycin I
) O
inhibitors O
. O

We O
identified O
clones O
of O
Chlamydomonas O
genomic O
DNA O
that O
rescued O
the O
Ca O
( O
2 O
+ O
) O
- O
dependent O
axonemal O
microtubule O
severing O
defect O
of O
fa1 B
mutants I
. O

Plasma B
hemopexin I
homeostasis O
during O
the O
acute O
phase O
response O
. O

The O
nramp2 B
gene I
is O
comprised O
of O
17 O
exons O
and O
spans O
more O
than O
36 O
kb O
. O

The O
majority O
of O
putative O
TSC2 B
mutations I
were O
found O
in O
sporadic O
rather O
than O
TSC2 B
- O
linked O
families O
. O

We O
found O
that O
the O
PRP20 B
gene I
is O
identical O
to O
the O
yeast B
SRM1 I
gene I
( O
Clark O
and O
Sprague O
1989 O
) O
. O

Deletion O
analysis O
defines O
distinct O
functional O
domains O
for O
protein O
- O
protein O
and O
nucleic O
acid O
interactions O
in O
the O
ORF1 B
protein I
of O
mouse O
LINE B
- I
1 I
. O

PMA O
produced O
similar O
results O
, O
but O
the O
induction O
of O
the O
WT B
AP1 I
c B
- I
jun I
promoter O
- O
CAT O
plasmid O
was O
smaller O
. O

The O
determination O
of O
antithrombin B
III I
( O
AT B
III I
) O
and O
its O
clinical O
significance O

The O
determination O
of O
antithrombin B
III I
( O
AT B
III I
) O
and O
its O
clinical O
significance O

Deletion O
of O
CDC5 B
was O
lethal O
and O
resulted O
in O
a O
dumbbell O
- O
shaped O
terminal O
morphology O
, O
with O
the O
nuclei O
almost O
divided O
but O
still O
connected O
. O

The O
generation O
of O
dorso O
- O
ventral O
polarity O
during O
Drosophila O
embryogenesis O
is O
regulated O
by O
the O
action O
of O
12 O
maternally O
expressed O
gene O
products O
, O
the O
dorsal B
group I
. O

However O
, O
in O
a O
variation O
of O
this O
assay O
in O
which O
the O
protease O
is O
omitted O
, O
the O
mutant O
enzymes O
exhibited O
substantial O
levels O
of O
prolyl B
isomerase I
activity O
( O
5 O
- O
20 O
% O
of O
wild O
- O
type O
) O
, O
revealing O
that O
these O
mutations O
confer O
sensitivity O
to O
protease O
digestion O
and O
that O
the O
classic O
in O
vitro O
assay O
for O
prolyl B
isomerase I
activity O
may O
be O
misleading O
. O

However O
, O
in O
a O
variation O
of O
this O
assay O
in O
which O
the O
protease O
is O
omitted O
, O
the O
mutant O
enzymes O
exhibited O
substantial O
levels O
of O
prolyl B
isomerase I
activity O
( O
5 O
- O
20 O
% O
of O
wild O
- O
type O
) O
, O
revealing O
that O
these O
mutations O
confer O
sensitivity O
to O
protease O
digestion O
and O
that O
the O
classic O
in O
vitro O
assay O
for O
prolyl B
isomerase I
activity O
may O
be O
misleading O
. O

Nucleotide O
sequence O
of O
the O
gag B
gene I
and O
gag B
- O
pol B
junction O
of O
feline O
leukemia O
virus O
. O

We O
cloned O
the O
BamHI B
- I
F I
fragment I
from O
the O
left O
end O
of O
Ad4 O
in O
pUC13 O
- O
1 O
between O
the O
SalI B
and O
BamHI B
sites I
in O
order O
to O
carry O
out O
the O
structural O
analysis O
of O
the O
E1A B
region I
of I
Ad4 I
. O

In O
both O
RAW O
cells O
and O
the O
microglia O
cell O
line O
EOC20 O
, O
two O
IFN B
- I
gamma I
- O
activated O
transcription O
factors O
, O
STAT B
- I
1alpha I
and O
IRF B
- I
1 I
, O
bind O
the O
GAS B
and O
IRF B
elements I
, O
respectively O
. O

After O
inhibition O
of O
monoamine B
oxidase I
with O
pargyline O
( O
10 O
mg O
/ O
kg O
. O
i O
. O
v O
. O
) O
, O
the O
effects O
of O
tyramine O
( O
1000 O
micrograms O
) O
injected O
into O
the O
hepatic O
artery O
were O
potentiated O
. O

Although O
hSSTR5 B
displays O
approximately O
75 O
% O
sequence O
identity O
with O
rat B
SSTR5 I
, O
the O
two O
receptors O
display O
significantly O
different O
pharmacological O
profiles O
, O
especially O
with O
respect O
to O
their O
binding O
affinities O
for O
the O
SST B
analogue O
SMS O
201 O
- O
995 O
. O

Although O
several O
other O
signal O
transduction O
molecules O
also O
contain O
tandemly O
occurring O
SH3 B
and O
SH2 B
domains I
, O
the O
function O
of O
these O
closely O
spaced O
domains O
is O
not O
well O
understood O
. O

But O
if O
one O
equalizes O
the O
upper O
limits O
of O
normal O
for O
both O
markers O
to O
a O
common O
95 O
% O
specificity O
, O
the O
tumour O
- O
indicating O
sensitivity O
of O
CA B
19 I
- I
9 I
clearly O
surpasses O
that O
of O
CA B
50 I
. O

The O
ZAG1 B
protein I
from O
in O
vitro O
translations O
binds O
to O
a O
consensus O
target O
site O
that O
is O
recognized O
by O
the O
AG B
protein I
. O

The O
ZAG1 B
protein I
from O
in O
vitro O
translations O
binds O
to O
a O
consensus O
target O
site O
that O
is O
recognized O
by O
the O
AG B
protein I
. O

The O
uap100 B
cis O
- O
acting O
, O
up O
- O
promoter O
, O
constitutive O
mutation O
is O
a O
duplication O
that O
comprises O
two O
GATA O
sites O
and O
suppresses O
weakly O
the O
AREA B
zinc I
finger I
mutation I
but O
does O
not O
alleviate O
the O
need O
for O
functional O
UAY B
and O
AREA B
proteins I
. O

We O
have O
produced O
the O
Ure2 B
protein I
to O
high O
yield O
in O
Escherichia O
coli O
from O
a O
synthetic O
gene O
. O

Transfection O
of O
both O
Calu O
- O
6 O
and O
JEG O
- O
3 O
cells O
with O
a O
PKA B
expression O
vector O
resulted O
in O
a O
10 O
- O
fold O
induction O
of O
human B
renin I
transcriptional O
activity O
in O
constructs O
containing O
the O
native O
or O
consensus O
CRE O
and O
5 O
- O
fold O
activation O
in O
a O
construct O
containing O
a O
nonfunctional O
CRE O
. O

Organization O
of O
exons O
suggests O
that O
, O
similar O
to O
the O
human B
VEGF I
gene I
, O
alternative O
splicing O
generates O
the O
120 O
- O
, O
164 O
- O
, O
and O
188 O
- O
amino O
acid O
isoforms O
, O
but O
does O
not O
predict O
a O
fourth O
VEGF B
isoform I
corresponding O
to O
human B
VEGF206 I
. O

Organization O
of O
exons O
suggests O
that O
, O
similar O
to O
the O
human B
VEGF I
gene I
, O
alternative O
splicing O
generates O
the O
120 O
- O
, O
164 O
- O
, O
and O
188 O
- O
amino O
acid O
isoforms O
, O
but O
does O
not O
predict O
a O
fourth O
VEGF B
isoform I
corresponding O
to O
human B
VEGF206 I
. O

Postheparin O
lipoprotein B
lipase I
, O
measured O
using O
fat O
emulsion O
as O
substrate O
, O
also O
was O
significantly O
greater O
in O
female O
rats O
compared O
with O
males O
. O

In O
addition O
, O
putative O
binding O
sites O
for O
SH3 B
and O
SH2 B
domains I
are O
present O
in O
the O
amino O
- O
terminal O
half O
of O
the O
molecule O
. O

Since O
nearly O
all O
transformants O
involving O
homeologous O
DNAs O
carried O
a O
single O
recombinant O
plasmid O
in O
both O
Pms B
+ I
and O
Pms B
- I
strains O
, O
stable O
heteroduplex O
DNA O
appears O
less O
likely O
than O
for O
homologous O
DNAs O
. O

Since O
nearly O
all O
transformants O
involving O
homeologous O
DNAs O
carried O
a O
single O
recombinant O
plasmid O
in O
both O
Pms B
+ I
and O
Pms B
- I
strains O
, O
stable O
heteroduplex O
DNA O
appears O
less O
likely O
than O
for O
homologous O
DNAs O
. O

The O
MAP B
kinase I
kinase I
kinase I
MLK2 B
co O
- O
localizes O
with O
activated O
JNK B
along O
microtubules O
and O
associates O
with O
kinesin B
superfamily I
motor O
KIF3 B
. O

They O
are O
transduced O
through O
TM O
to O
the O
cytoplasmic O
portion O
( O
cytoloops O
and O
the O
C O
- O
terminal O
tail O
) O
of O
the O
receptor O
and O
then O
, O
transferred O
to O
cytoplasmic O
signaling O
molecules O
, O
such O
as O
G B
protein I
. O

Serum B
alkaline I
phosphatase I
and O
creatine B
kinase I
activities O
were O
significantly O
increased O
in O
the O
A O
praelongus O
- O
fed O
pigs O
and O
significantly O
decreased O
in O
Na2SeO4 O
- O
fed O
pigs O
. O

Although O
polyubiquitin B
chains I
linked O
through O
Lys O
( O
29 O
) O
of O
ubiquitin B
have O
been O
implicated O
in O
the O
targeting O
of O
certain O
substrates O
to O
proteasomes O
, O
the O
signaling O
properties O
of O
these O
chains O
are O
poorly O
understood O
. O

PCC O
6803 O
mutant O
impaired O
in O
cytochrome B
c I
maturation O
. O

In O
rats O
exposed O
to O
Cd O
for O
30 O
d O
, O
the O
levels O
of O
urinary O
excretion O
of O
cAMP O
after O
treatment O
with O
parathyroid B
hormone I
( O
PTH B
) O
, O
parathyroidectomy O
( O
PTX O
) O
, O
or O
1 O
alpha O
- O
hydroxycholecalciferol O
( O
1 O
alpha O
- O
OH O
- O
D3 O
) O
showed O
almost O
the O
same O
patterns O
as O
those O
of O
control O
rats O
: O
the O
response O
of O
urinary O
cAMP O
to O
treatment O
with O
PTH B
was O
not O
influenced O
by O
continuous O
oral O
administration O
of O
Cd O
. O

The O
Htf9 B
- I
a I
gene I
encodes O
the O
RanBP1 B
protein I
, O
a O
major O
partner O
of O
the O
Ran B
GTPase I
. O

The O
Htf9 B
- I
a I
gene I
encodes O
the O
RanBP1 B
protein I
, O
a O
major O
partner O
of O
the O
Ran B
GTPase I
. O

The O
human B
SHBG I
proximal I
promoter I
was O
analyzed O
by O
DNase B
I I
footprinting O
, O
and O
the O
functional O
significance O
of O
6 O
footprinted O
regions O
( O
FP1 O
- O
FP6 O
) O
within O
the O
proximal O
promoter O
was O
studied O
in O
human O
HepG2 O
hepatoblastoma O
cells O
. O

Previously O
identified O
mutations O
in O
this O
variant O
have O
been O
within O
or O
close O
to O
the O
coding O
region O
of O
exon O
1 O
of O
the O
HMBS B
gene I
, O
the O
only O
exon O
that O
is O
expressed O
solely O
in O
the O
ubiquitous O
isoform O
. O

As O
an O
approach O
to O
the O
determination O
of O
structure O
- O
function O
relationships O
in O
the O
PRP4 B
protein I
, O
we O
have O
isolated O
more O
than O
fifty O
new O
alleles O
of O
the O
PRP4 B
gene I
through O
random O
and O
site O
- O
directed O
mutagenesis O
, O
and O
have O
analyzed O
the O
phenotypes O
of O
many O
of O
them O
. O

As O
an O
approach O
to O
the O
determination O
of O
structure O
- O
function O
relationships O
in O
the O
PRP4 B
protein I
, O
we O
have O
isolated O
more O
than O
fifty O
new O
alleles O
of O
the O
PRP4 B
gene I
through O
random O
and O
site O
- O
directed O
mutagenesis O
, O
and O
have O
analyzed O
the O
phenotypes O
of O
many O
of O
them O
. O

To O
test O
for O
progesterone B
receptor I
- O
mediated O
activation O
of O
transcription O
in O
yeast O
, O
reporter O
plasmids O
were O
constructed O
to O
transform O
yeast O
cells O
expressing O
PRB B
or O
C1C2 B
receptors I
. O

To O
test O
for O
progesterone B
receptor I
- O
mediated O
activation O
of O
transcription O
in O
yeast O
, O
reporter O
plasmids O
were O
constructed O
to O
transform O
yeast O
cells O
expressing O
PRB B
or O
C1C2 B
receptors I
. O

Long O
- O
range O
mapping O
by O
pulse O
- O
field O
gel O
electrophoresis O
indicated O
that O
the O
three O
mdr B
genes I
are O
closely O
linked O
on O
a O
genomic O
DNA O
segment O
of O
approximately O
625 O
kilobases O
. O

These O
sequences O
were O
further O
tested O
for O
the O
presence O
of O
an O
enhancer O
element O
, O
by O
their O
ability O
to O
activate O
a O
fusion O
reporter O
gene O
consisting O
of O
the O
CAT B
gene I
linked O
to O
the O
gamma B
- I
globin I
gene I
promoter I
, O
in O
erythroid O
( O
K562 O
) O
and O
non O
- O
erythroid O
( O
HeLa O
) O
cells O
. O

Soluble O
recombinant O
RI B
and O
soluble O
recombinant O
C B
alpha I
can O
associate O
in O
vitro O
and O
be O
activated O
by O
cyclic O
AMP O
. O

The O
newly O
identified O
NF B
kappa I
B I
enhancer I
( O
TGGAAATTCC O
) O
is O
bound O
by O
a O
TNF B
alpha I
- O
induced O
nuclear O
protein O
and O
appears O
to O
be O
the O
key O
element O
in O
rapid O
transcription O
induction O
by O
TNF B
alpha I
( O
and O
TPA O
) O
, O
while O
transactivation O
of O
this O
element O
is O
repressed O
by O
the O
ligand O
- O
bound O
glucocorticoid B
receptor I
. O

The O
newly O
identified O
NF B
kappa I
B I
enhancer I
( O
TGGAAATTCC O
) O
is O
bound O
by O
a O
TNF B
alpha I
- O
induced O
nuclear O
protein O
and O
appears O
to O
be O
the O
key O
element O
in O
rapid O
transcription O
induction O
by O
TNF B
alpha I
( O
and O
TPA O
) O
, O
while O
transactivation O
of O
this O
element O
is O
repressed O
by O
the O
ligand O
- O
bound O
glucocorticoid B
receptor I
. O

The O
newly O
identified O
NF B
kappa I
B I
enhancer I
( O
TGGAAATTCC O
) O
is O
bound O
by O
a O
TNF B
alpha I
- O
induced O
nuclear O
protein O
and O
appears O
to O
be O
the O
key O
element O
in O
rapid O
transcription O
induction O
by O
TNF B
alpha I
( O
and O
TPA O
) O
, O
while O
transactivation O
of O
this O
element O
is O
repressed O
by O
the O
ligand O
- O
bound O
glucocorticoid B
receptor I
. O

The O
polypeptide O
encoded O
by O
the O
cDNA O
contained O
450 O
amino O
acids O
with O
a O
calculated O
M O
( O
r O
) O
of O
52 O
, O
057 O
, O
and O
showed O
significant O
homology O
with O
human O
and O
mouse B
CAD I
( O
22 O
% O
identity O
) O
. O

As O
much O
thrombin B
was O
formed O
during O
cardiopulmonary O
bypass O
( O
measured O
by O
the O
prothrombin B
activation I
fragment I
F1 I
+ I
2 I
and O
thrombin B
- O
antithrombin B
complexes O
) O
as O
in O
normal O
patients O
, O
showing O
that O
factor B
XII I
was O
not O
necessary O
for O
thrombin B
generation O
. O

Several O
positive O
clones O
were O
isolated O
, O
one O
of O
which O
encoded O
the O
C O
- O
terminal O
253 O
amino O
acids O
of O
a O
putative O
RNA B
helicase I
, O
a O
DEAD B
box I
protein I
designated O
DDX3 B
. O

Furthermore O
, O
the O
induction O
of O
cytochrome B
P I
- I
450 I
1A1 I
observed O
in O
the O
cormorant O
indicates O
that O
the O
Ah B
receptor I
- O
mediated O
process O
, O
by O
which O
TCDD O
and O
related O
chemicals O
exert O
many O
of O
their O
toxicities O
, O
has O
been O
activated O
. O

In O
this O
work O
, O
we O
determined O
the O
sequences O
of O
eight O
VirF B
- I
binding I
sites I
from O
four O
different O
genes O
, O
by O
DNase B
I I
or O
hydroxyl O
radical O
footprinting O
. O

Although O
they O
are O
similar O
to O
the O
IL9R B
gene I
( O
approximately O
90 O
% O
identity O
) O
, O
none O
of O
these O
copies O
encodes O
a O
functional O
receptor O
: O
none O
of O
them O
contains O
sequences O
homologous O
to O
the O
5 O
' O
flanking O
region O
or O
exon O
1 O
of O
the O
IL9R B
gene I
, O
and O
the O
remaining O
ORFs O
have O
been O
inactivated O
by O
various O
point O
mutations O
and O
deletions O
. O

Although O
they O
are O
similar O
to O
the O
IL9R B
gene I
( O
approximately O
90 O
% O
identity O
) O
, O
none O
of O
these O
copies O
encodes O
a O
functional O
receptor O
: O
none O
of O
them O
contains O
sequences O
homologous O
to O
the O
5 O
' O
flanking O
region O
or O
exon O
1 O
of O
the O
IL9R B
gene I
, O
and O
the O
remaining O
ORFs O
have O
been O
inactivated O
by O
various O
point O
mutations O
and O
deletions O
. O

To O
investigate O
whether O
the O
two O
RPG B
- I
boxes I
mediate O
transcription O
activation O
of O
both O
the O
L46 B
and O
S24 B
gene I
, O
two O
experimental O
strategies O
were O
followed O
: O
cloning O
of O
the O
respective O
genes O
on O
multicopy O
vectors O
and O
construction O
of O
fusion O
genes O
. O

When O
the O
opioid O
antagonist O
was O
administered O
to O
animals O
24 O
hr O
after O
termination O
of O
single O
or O
multiple O
exposures O
to O
restraint O
, O
NALT O
- O
induced O
increases O
in O
basal O
plasma B
LH I
were O
significantly O
attenuated O
in O
the O
chronically O
stressed O
rats O
compared O
to O
animals O
subjected O
to O
stress O
only O
once O
or O
not O
at O
all O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

Thus O
, O
in O
addition O
to O
the O
previously O
characterized O
FAS B
- I
binding I
factor I
1 I
interacting O
with O
the O
inositol O
/ O
choline O
- O
responsive O
- O
element O
motif O
, O
a O
second O
motif O
common O
to O
the O
promoter O
regions O
of O
both O
FAS B
genes I
could O
be O
identified O
. O

In O
EGF B
receptor I
- O
mediated O
signaling O
, O
the O
protein B
kinase I
PKB I
/ O
Akt B
and O
the O
mitogen B
- I
activated I
protein I
kinase I
c I
- I
Jun I
N I
- I
terminal I
kinase I
, O
but O
not O
extracellular B
signal I
- I
regulated I
kinase I
2 I
, O
function O
downstream O
of O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

We O
suggest O
that O
this O
effect O
of O
Myc B
is O
mediated O
by O
its O
action O
upstream O
of O
cyclin B
E I
- O
CDK2 B
, O
and O
occurs O
via O
the O
neutralization O
of O
p27 B
( O
Kip1 B
) O
family O
proteins O
, O
rather O
than O
induction O
of O
Cdc25A B
. O

However O
, O
the O
molecular O
mechanisms O
by O
which O
specific O
cis O
- O
and O
trans O
- O
acting O
factors O
control O
activity O
of O
the O
prodynorphin B
promoter I
are O
not O
as O
clearly O
defined O
. O

Finally O
, O
antisense O
mediated O
reduction O
of O
Elk B
- I
1 I
in O
GH4 O
cells O
decreased O
insulin B
- O
increased O
prolactin B
gene I
expression O
and O
confirmed O
the O
requirement O
for O
Elk B
- I
1 I
for O
insulin B
- O
increased O
prolactin B
gene I
expression O
. O

Finally O
, O
antisense O
mediated O
reduction O
of O
Elk B
- I
1 I
in O
GH4 O
cells O
decreased O
insulin B
- O
increased O
prolactin B
gene I
expression O
and O
confirmed O
the O
requirement O
for O
Elk B
- I
1 I
for O
insulin B
- O
increased O
prolactin B
gene I
expression O
. O

The O
program O
for O
myogenic O
differentiation O
is O
subject O
to O
negative O
control O
by O
several O
peptide O
growth O
factors O
and O
by O
the O
products O
of O
mutationally O
activated O
ras B
oncogenes I
, O
which O
persistently O
activate O
intracellular O
cascades O
normally O
triggered O
by O
specific O
growth O
factors O
. O

Mutation O
of O
the O
distal O
E2F B
binding I
site I
in O
the O
cdc25A B
promoter I
abolished O
E2 B
- O
induced O
repression O
, O
whereas O
mutation O
of O
the O
proximal O
E2F B
site I
or O
the O
E2 B
site I
had O
no O
effect O
. O

Mutation O
of O
the O
distal O
E2F B
binding I
site I
in O
the O
cdc25A B
promoter I
abolished O
E2 B
- O
induced O
repression O
, O
whereas O
mutation O
of O
the O
proximal O
E2F B
site I
or O
the O
E2 B
site I
had O
no O
effect O
. O

Mutation O
of O
the O
distal O
E2F B
binding I
site I
in O
the O
cdc25A B
promoter I
abolished O
E2 B
- O
induced O
repression O
, O
whereas O
mutation O
of O
the O
proximal O
E2F B
site I
or O
the O
E2 B
site I
had O
no O
effect O
. O

Plasmid O
pNK21 O
, O
in O
which O
2 O
. O
05 O
- O
kb O
sequence O
covering O
the O
region O
encoding O
the O
nitrilase B
was O
was O
placed O
under O
the O
control O
of O
the O
lac B
promoter I
, O
directed O
overproduction O
of O
enzymatically B
active I
nitrilase I
in O
response O
to O
addition O
of O
isopropyl O
beta O
- O
D O
- O
thiogalactopyranoside O
in O
Escherichia O
coli O
. O

Insertion O
of O
alternatively O
spliced O
exon O
W O
into O
CREB B
mRNA I
during O
spermatogenesis O
results O
in O
a O
polycistronic O
RNA O
that O
encodes O
two O
novel O
internally O
translated O
CREB B
repressor I
isoforms I
called O
I B
- I
CREBs I
, O
consisting O
of O
the O
carboxy O
- O
terminal O
DNA O
- O
binding O
domain O
devoid O
of O
the O
transactivation O
domains O
. O

A O
p53 B
cDNA I
deletion O
mutant O
( O
delta O
pro O
AE O
) O
, O
which O
lacks O
this O
entire O
proline O
- O
rich O
domain O
( O
deleted O
for O
amino O
acids O
62 O
- O
91 O
) O
, O
was O
created O
and O
characterized O
for O
a O
variety O
of O
p53 B
functions O
. O

Multiple O
aortic O
thrombi O
associated O
with O
protein B
C I
and O
S B
deficiency O
. O

A O
constructed O
phylogenetic O
tree O
suggests O
that O
the O
UbcP1 B
protein I
may O
represent O
a O
member O
of O
a O
distinct O
subfamily O
of O
E2s B
. O

We O
functionally O
characterised O
AtXPO1 B
by O
its O
interaction O
with O
NESs O
of O
animal O
and O
plant O
proteins O
, O
which O
is O
inhibited O
by O
the O
cytotoxin O
leptomycin O
B O
( O
LMB O
) O
, O
and O
also O
by O
its O
interaction O
with O
the O
small B
GTPase I
Ran1 B
in O
the O
yeast O
two O
- O
hybrid O
system O
. O

S1 B
nuclease I
protection O
mapping O
and O
primer O
extension O
analysis O
allowed O
us O
to O
propose O
that O
the O
A O
residue O
located O
19 O
bp O
upstream O
from O
the O
translation O
initiation O
codon O
is O
the O
site O
of O
transcription O
initiation O
. O

Various O
stimuli O
inactivate O
IkappaB B
alpha I
by O
triggering O
phosphorylation O
of O
the O
N O
- O
terminal O
residues O
Ser32 O
and O
Ser36 O
. O

Whether O
or O
not O
these O
novel O
repeated O
sequences O
throughout O
the O
SMA B
region I
are O
involved O
in O
the O
disease O
remains O
to O
be O
determined O
. O

We O
have O
thus O
cloned O
two O
yeast O
homologs O
of O
mammalian B
p220 I
. O

Acetoacetate B
decarboxylase I
( O
ADC B
) O
( O
EC4 B
. I
1 I
. I
1 I
. I
4 I
) O
of O
Clostridium O
acetobutylicum O
DSM O
792 O
was O
purified O
to O
homogeneity O
, O
and O
its O
first O
25 O
N O
- O
terminal O
amino O
acids O
were O
determined O
. O

The O
sequence O
of O
the O
127 B
residue I
NrfF I
polypeptide I
, I
M I
( I
r I
) I
14 I
, I
522 I
, O
is O
strikingly O
similar O
to O
the O
CcI2 B
protein I
of O
R O
. O
capsulatus O
, O
especially O
in O
the O
putative O
haem O
- O
binding O
motif O
, O
RCPQCQNQN O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

CAT B
assays O
demonstrated O
that O
overexpression O
of O
RXRalpha B
conferred O
the O
best O
RA O
response O
, O
consistent O
with O
our O
previous O
observation O
that O
9 O
- O
cis O
- O
RA O
is O
more O
potent O
than O
all O
- O
trans O
- O
RA O
for O
inducing O
the O
expression O
of O
the O
AFP B
gene I
. O

These O
results O
provide O
strong O
evidence O
that O
conserved O
interhelical O
packing O
interactions O
in O
the O
gp41 B
core I
are O
important O
determinants O
of O
HIV O
- O
1 O
entry O
and O
its O
inhibition O
. O

DRAP27 B
is O
recognized O
by O
CD9 B
antibodies I
. O

These O
three O
chromosomes O
share O
the O
transferrin B
gene I
( O
TF B
) O
, O
the O
myosin B
light I
polypeptide I
3 I
gene I
( O
MYL3 B
) O
, O
and O
the O
acylpeptide B
hydrolase I
gene I
( O
APEH B
) O
. O

The O
human B
BRCA1 I
promoter I
also O
contains O
a O
conserved O
E2F B
site I
and O
is O
similarly O
regulated O
by O
E2F1 B
and O
Rb B
. O

In O
this O
respect O
, O
the O
promoter O
structure O
of O
COX B
genes I
resemble O
those O
of O
many O
house O
- O
keeping O
genes O
. O

When O
severe O
hypoxia O
was O
acutely O
produced O
by O
ventilation O
with O
low O
- O
oxygen O
mixtures O
in O
experimental O
( O
PaO2 O
, O
23 O
. O
7 O
+ O
/ O
- O
1 O
. O
7 O
torr O
) O
and O
control O
animals O
( O
PaO2 O
, O
26 O
. O
3 O
+ O
/ O
- O
1 O
. O
0 O
torr O
) O
, O
plasma B
insulin I
responses O
were O
markedly O
inhibited O
in O
both O
. O

Uptake O
of O
colicins B
required O
different O
domains O
in O
TonB B
, O
for O
colicin B
B I
and I
M I
around O
residue O
160 O
and O
for O
colicin B
Ia I
, O
a O
domain O
closer O
to O
the O
C O
- O
terminal O
end O
. O

This O
mutation O
was O
associated O
with O
reduced O
or O
absent O
expression O
of O
TGF B
- I
beta I
RI I
protein I
and O
p53 B
protein I
in O
tumor O
tissues O
. O

SCAN B
boxes O
are O
found O
in O
eight O
other O
genes O
in O
the O
GenBank O
database O
, O
five O
of O
which O
are O
also O
in O
the O
Kruppel B
family I
of O
zinc B
finger I
proteins I
lacking O
KRAB B
A I
and I
B I
domains O
and O
thereby O
define O
a O
new O
subclass O
of O
zinc B
finger I
proteins I
. O

YACs O
selected O
from O
our O
contig O
will O
be O
the O
starting O
point O
for O
the O
cloning O
of O
the O
LGMD2B B
gene I
and O
thereby O
establish O
the O
biological O
basis O
for O
this O
form O
of O
muscular O
dystrophy O
and O
its O
relationship O
with O
the O
other O
limb O
- O
girdle O
muscular O
dystrophies O
. O

A O
surge O
in O
the O
rate O
of O
ascorbyl O
radical O
production O
, O
directly O
correlated O
with O
oxyradical O
stress O
and O
an O
abrupt O
fall O
in O
superoxide B
dismutase I
activity O
in O
the O
granuloma O
, O
indicates O
' O
switching O
on O
' O
of O
a O
free O
radical O
- O
dependent O
machinery O
for O
the O
formation O
of O
granuloma O
after O
vasectomy O
. O

After O
5 O
- O
h O
thermal O
induction O
of O
cells O
carrying O
the O
runaway O
recombinant O
pBS1 O
, O
protein B
B2 I
constituted O
40 O
% O
of O
the O
soluble O
protein O
fraction O
of O
the O
cells O
. O

A O
regulatory O
element O
of O
the O
empty B
spiracles I
homeobox O
gene O
is O
composed O
of O
three O
distinct O
conserved O
regions O
that O
bind O
regulatory O
proteins O
. O

Most O
interestingly O
, O
although O
the O
effector O
plasmid O
containing O
the O
ICP27 B
gene I
had O
little O
effect O
on O
its O
own O
, O
two O
different O
and O
marked O
effects O
depending O
on O
the O
target O
were O
observed O
when O
ICP27 B
was O
combined O
with O
ICP4 B
or O
ICP0 B
or O
both O
. O

Heterologous O
hybridization O
with O
a O
rps12 B
gene I
specific O
probe O
from O
Euglena O
has O
revealed O
the O
presence O
of O
rps12 B
homologous I
sequences I
within O
the O
inverted O
repeat O
of O
Spirodela O
chloroplast O
DNA O
on O
the O
fragment B
BamHI I
- I
V I
. O

This O
raises O
the O
possibility O
that O
recombination O
occurred O
between O
corresponding O
LTR O
and O
vif B
loci I
of O
the O
quasi O
- O
species O
present O
in O
the O
isolates O
described O
here O
. O

In O
HMEC O
stably O
transfected O
with O
an O
ER B
mutant I
containing O
a O
deletion O
in O
the O
second O
zinc O
finger O
of O
the O
DNA O
- O
binding O
domain O
, O
E O
and O
HT O
had O
different O
effects O
on O
EBBP B
gene I
expression O
; O
EBBP B
regulation O
by O
E O
was O
dramatically O
reduced O
while O
the O
effects O
of O
HT O
were O
augmented O
. O

In O
HMEC O
stably O
transfected O
with O
an O
ER B
mutant I
containing O
a O
deletion O
in O
the O
second O
zinc O
finger O
of O
the O
DNA O
- O
binding O
domain O
, O
E O
and O
HT O
had O
different O
effects O
on O
EBBP B
gene I
expression O
; O
EBBP B
regulation O
by O
E O
was O
dramatically O
reduced O
while O
the O
effects O
of O
HT O
were O
augmented O
. O

The O
gene B
atp6 I
, O
encoding O
subunit O
6 O
of O
the O
mitochondrial O
F0 B
- O
ATPase B
complex O
, O
has O
been O
characterized O
from O
both O
the O
normal O
( O
fertile O
) O
and O
Ogura O
( O
male O
- O
sterile O
) O
radish O
cytoplasms O
in O
order O
to O
determine O
if O
previously O
identified O
atp6 B
transcriptional O
differences O
could O
play O
a O
role O
in O
cytoplasmic O
male O
sterility O
. O

Hpr1 B
forms O
, O
together O
with O
Tho2 B
, O
Mft1 B
, O
and O
Thp2 B
, O
the O
THO B
complex I
, O
which O
controls O
transcription O
elongation O
and O
genome O
stability O
in O
Saccharomyces O
cerevisiae O
. O

UPR O
elements O
present O
in O
other O
ER O
chaperone O
genes O
, O
such O
as O
yeast B
KAR2 I
( O
BiP B
) O
, O
mammalian B
GRP78 I
( O
BiP B
) O
, O
and O
GRP94 B
, O
function O
in O
an O
analogous O
manner O
to O
that O
in O
FKB2 B
. O

UPR O
elements O
present O
in O
other O
ER O
chaperone O
genes O
, O
such O
as O
yeast B
KAR2 I
( O
BiP B
) O
, O
mammalian B
GRP78 I
( O
BiP B
) O
, O
and O
GRP94 B
, O
function O
in O
an O
analogous O
manner O
to O
that O
in O
FKB2 B
. O

Strains O
carrying O
a O
snf1 B
mutation I
are O
unable O
to O
grow O
on O
sucrose O
, O
galactose O
, O
maltose O
, O
melibiose O
, O
or O
nonfermentable O
carbon O
sources O
; O
utilization O
of O
these O
carbon O
sources O
is O
regulated O
by O
glucose O
repression O
. O

Transfection O
of O
H B
chain I
loss I
variant I
myeloma O
with O
the O
complete O
12 O
kb O
construct O
, O
termed O
238H B
- I
Cmicro I
, O
resulted O
in O
secretion O
of O
intact O
Ig O
pairing O
238H B
- I
Cmicro I
, O
with O
a O
lambda B
L I
chain I
; O
however O
, O
transfectant B
Ig I
lacked O
autoreactivity O
and O
pathogenicity O
. O

The O
highly O
conserved O
region O
of O
U6 B
snRNA I
has O
a O
structural O
similarity O
with O
the O
catalytic O
domain O
of O
the O
negative O
strand O
of O
the O
satellite O
RNA O
of O
tobacco O
ring O
spot O
virus O
[ O
( O
- O
) O
sTRSV O
] O
, O
suggesting O
that O
the O
highly O
conserved O
region O
of O
U6 B
snRNA I
forms O
the O
catalytic O
center O
. O

The O
highly O
conserved O
region O
of O
U6 B
snRNA I
has O
a O
structural O
similarity O
with O
the O
catalytic O
domain O
of O
the O
negative O
strand O
of O
the O
satellite O
RNA O
of O
tobacco O
ring O
spot O
virus O
[ O
( O
- O
) O
sTRSV O
] O
, O
suggesting O
that O
the O
highly O
conserved O
region O
of O
U6 B
snRNA I
forms O
the O
catalytic O
center O
. O

Here O
we O
show O
that O
one O
nudF B
suppressor I
also O
suppresses O
hs O
- O
mutations O
in O
nudA B
, O
nudC B
, O
and O
nudG B
and O
deletions O
in O
nudA B
and O
nudF B
. O

Excess O
recombinant B
PTB I
squelches O
the O
splicing O
switch O
and O
reestablishes O
exon O
skipping O
as O
the O
predominant O
splicing O
pathway O
. O

MDA O
- O
MB O
- O
468 O
cells O
were O
stably O
transfected O
with O
either O
a O
plasmid O
having O
a O
CMV B
promoter I
- O
driven O
rabbit B
beta I
- I
globin I
gene I
or O
plasmids O
having O
a O
CMV B
promoter I
- O
driven O
chimeric O
gadd45 B
5 O
" O
- O
UTR O
- O
rabbit B
beta I
- I
globin I
gene O
, O
where O
the O
entire B
gadd45 I
5 I
" I
- I
UTR I
( I
from I
+ I
1 I
to I
+ I
298 I
) I
or O
a O
45 O
bp O
subfragment O
of O
the O
gadd45 B
5 I
" I
- I
UTR I
( I
from I
+ I
10 I
to I
+ I
55 I
) I
was O
positioned O
at O
the O
5 O
" O
- O
end O
of O

MDA O
- O
MB O
- O
468 O
cells O
were O
stably O
transfected O
with O
either O
a O
plasmid O
having O
a O
CMV B
promoter I
- O
driven O
rabbit B
beta I
- I
globin I
gene I
or O
plasmids O
having O
a O
CMV B
promoter I
- O
driven O
chimeric O
gadd45 B
5 O
" O
- O
UTR O
- O
rabbit B
beta I
- I
globin I
gene O
, O
where O
the O
entire B
gadd45 I
5 I
" I
- I
UTR I
( I
from I
+ I
1 I
to I
+ I
298 I
) I
or O
a O
45 O
bp O
subfragment O
of O
the O
gadd45 B
5 I
" I
- I
UTR I
( I
from I
+ I
10 I
to I
+ I
55 I
) I
was O
positioned O
at O
the O
5 O
" O
- O
end O
of O

Deletion O
analysis O
of O
the O
3 O
. O
5kb O
DNA O
fragment O
revealed O
that O
the O
region O
between O
- O
125 O
to O
+ O
1 O
, O
containing O
a O
single O
Sp1 B
binding I
site I
, O
is O
essential O
for O
transcription O
of O
the O
embigin B
gene I
. O

Mutational O
analysis O
of O
yeast B
CEG1 I
demonstrated O
that O
four O
of O
the O
five O
conserved O
motifs O
are O
essential O
for O
capping B
enzyme I
function O
in O
vivo O
. O

Mutational O
analysis O
of O
yeast B
CEG1 I
demonstrated O
that O
four O
of O
the O
five O
conserved O
motifs O
are O
essential O
for O
capping B
enzyme I
function O
in O
vivo O
. O

Gel O
mobility O
shift O
analyses O
reveal O
that O
FRTL O
- O
5 O
thyroid O
cell O
nuclear O
extracts O
form O
a O
specific O
protein O
/ O
DNA O
complex O
with O
this O
region O
, O
which O
is O
prevented O
by O
the O
TTF B
- I
1 I
binding I
element I
from O
the O
TG B
promoter I
; O
FRT O
and O
BRL O
cell O
nuclear O
extracts O
do O
not O
have O
TTF B
- I
1 I
and O
do O
not O
form O
this O
complex O
. O

The O
Sty1 B
kinase I
is O
stimulated O
by O
a O
variety O
of O
different O
stress O
conditions O
including O
osmotic O
and O
oxidative O
stress O
and O
heat O
shock O
. O

Comparison O
of O
the O
genes O
coding O
for O
mouse O
and O
human O
p36 B
( O
annexin B
II I
) O
and O
mouse O
, O
rat O
and O
human O
p35 B
( O
annexin B
I I
) O
and O
pigeon O
cp35 B
( O
an O
annexin B
I I
- I
related I
protein I
) O
shows O
strong O
genomic O
structural O
conservation O
supporting O
the O
hypothesis O
that O
these O
genes O
had O
a O
common O
ancestor O
. O

Comparison O
of O
the O
genes O
coding O
for O
mouse O
and O
human O
p36 B
( O
annexin B
II I
) O
and O
mouse O
, O
rat O
and O
human O
p35 B
( O
annexin B
I I
) O
and O
pigeon O
cp35 B
( O
an O
annexin B
I I
- I
related I
protein I
) O
shows O
strong O
genomic O
structural O
conservation O
supporting O
the O
hypothesis O
that O
these O
genes O
had O
a O
common O
ancestor O
. O

The O
oxalate B
oxidase I
method O
results O
in O
a O
mean O
and O
reference O
interval O
for O
oxalate O
excretion O
that O
are O
comparable O
with O
those O
by O
isotope O
dilution O
, O
gas O
- O
chromatographic O
, O
colorimetric O
, O
and O
other O
enzymic O
procedures O
. O

The O
amino O
acid O
sequence O
of O
the O
protein O
encoded O
by O
MSK1 B
is O
homologous O
to O
yeast B
cytoplasmic I
lysyl I
- I
tRNA I
synthetase I
and O
to O
the O
product O
of O
the O
herC B
gene I
, O
which O
has O
recently O
been O
suggested O
to O
code O
for O
the O
Escherichia O
coli O
enzyme O
. O

Similar O
to O
the O
D B
, O
B B
/ O
B B
' I
and O
E B
proteins I
, O
the O
F B
and O
G B
proteins I
do O
not O
possess O
any O
of O
the O
known O
RNA O
binding O
motifs O
, O
suggesting O
that O
other O
types O
of O
RNA O
- O
protein O
interactions O
occur O
in O
the O
snRNP O
core O
. O

Similar O
to O
the O
D B
, O
B B
/ O
B B
' I
and O
E B
proteins I
, O
the O
F B
and O
G B
proteins I
do O
not O
possess O
any O
of O
the O
known O
RNA O
binding O
motifs O
, O
suggesting O
that O
other O
types O
of O
RNA O
- O
protein O
interactions O
occur O
in O
the O
snRNP O
core O
. O

Similar O
to O
the O
D B
, O
B B
/ O
B B
' I
and O
E B
proteins I
, O
the O
F B
and O
G B
proteins I
do O
not O
possess O
any O
of O
the O
known O
RNA O
binding O
motifs O
, O
suggesting O
that O
other O
types O
of O
RNA O
- O
protein O
interactions O
occur O
in O
the O
snRNP O
core O
. O

These O
observations O
suggest O
that O
clr4 B
+ I
and O
rik1 B
+ I
must O
play O
a O
role O
in O
the O
assembly O
of O
Swi6p B
into O
a O
transcriptionally O
silent O
, O
inaccessible O
chromatin O
structure O
at O
fission O
yeast O
centromeres O
which O
is O
required O
to O
facilitate O
interactions O
with O
spindle O
microtubules O
and O
to O
ensure O
normal O
chromosome O
segregation O
. O

These O
observations O
suggest O
that O
clr4 B
+ I
and O
rik1 B
+ I
must O
play O
a O
role O
in O
the O
assembly O
of O
Swi6p B
into O
a O
transcriptionally O
silent O
, O
inaccessible O
chromatin O
structure O
at O
fission O
yeast O
centromeres O
which O
is O
required O
to O
facilitate O
interactions O
with O
spindle O
microtubules O
and O
to O
ensure O
normal O
chromosome O
segregation O
. O

Characterization O
of O
a O
DEAD B
box I
ATPase I
/ O
RNA B
helicase I
protein O
of O
Arabidopsis O
thaliana O
. O

Blood O
samples O
for O
determination O
of O
fibrinolytic O
activity O
and O
factor B
VIII I
in O
plasma O
were O
obtained O
before O
and O
immediately O
after O
the O
end O
of O
compression O
and O
application O
of O
a O
stocking O
, O
respectively O
. O

Neither O
symptoms O
, O
virions O
, O
nor O
viral O
RNA O
was O
detectable O
in O
plants O
inoculated O
with O
this O
mutant O
or O
a O
mutant O
with O
a O
frameshift O
mutation O
in O
the O
coat B
gene I
. O

We O
speculate O
that O
the O
enhancing O
effect O
of O
glucose O
and O
galactose O
on O
fructose O
absorption O
may O
be O
due O
to O
activation O
of O
the O
fructose B
carrier I
. O

A O
. O
nidulans O
transformants O
secreted O
high O
amounts O
of O
PGI B
and O
PGII B
in O
comparison O
to O
the O
previously O
characterized O
A O
. O
niger O
transformants O
and O
a O
novel O
polygalacturonase B
( O
PGC B
) O
was O
produced O
at O
high O
levels O
by O
A O
. O
nidulans O
transformed O
with O
the O
subcloned O
pgaC B
gene I
. O

Rac2 B
, O
a O
member O
of O
the O
Rho B
family I
of O
GTPases B
, O
is O
highly O
expressed O
in O
myeloid O
cells O
and O
is O
a O
regulator O
of O
the O
NADPH B
- I
oxidase I
complex I
. O

In O
vitro O
kinase O
assays O
on O
isolated O
microvilli O
and O
microvillar O
fractions O
enriched O
in O
the O
putative O
signal O
transduction O
particle O
showed O
a O
high O
specific O
activity O
of O
tyrosine B
kinase I
activity O
compared O
to O
that O
of O
membranes O
from O
EGF B
receptor I
- O
overexpressing O
A431 O
cells O
maximally O
activated O
by O
EGF B
. O

In O
vitro O
kinase O
assays O
on O
isolated O
microvilli O
and O
microvillar O
fractions O
enriched O
in O
the O
putative O
signal O
transduction O
particle O
showed O
a O
high O
specific O
activity O
of O
tyrosine B
kinase I
activity O
compared O
to O
that O
of O
membranes O
from O
EGF B
receptor I
- O
overexpressing O
A431 O
cells O
maximally O
activated O
by O
EGF B
. O

It O
contains O
31 O
exons O
and O
a O
high O
proportion O
of O
class O
0 O
introns O
, O
alternative O
splicing O
of O
which O
results O
in O
significant O
levels O
of O
variant O
transcripts O
that O
maintain O
the O
original O
open O
reading O
frame O
of O
MRP B
mRNA I
. O

These O
findings O
suggest O
that O
NMDA B
receptor I
blockade O
may O
ameliorate O
the O
dyskinetic O
complications O
of O
long O
- O
term O
levodopa O
therapy O
, O
without O
diminishing O
the O
beneficial O
effects O
on O
parkinsonian O
signs O
. O

Scleraxis B
overexpression O
enhanced O
expression O
of O
the O
aggrecan B
gene I
, O
which O
is O
not O
normally O
expressed O
at O
high O
levels O
in O
these O
osteoblastic O
cells O
. O

Finally O
, O
we O
tested O
whether O
activation O
by O
either O
of O
these O
factors O
is O
dependent O
on O
components O
of O
the O
SAGA B
complex I
. O

Overexpression O
of O
eIF4E B
transforms O
cells O
, O
and O
mutations O
in O
eIF4E B
arrest O
cells O
in O
G O
, O
in O
cdc33 B
mutants I
. O

As O
anticipated O
, O
both O
intracellular O
p54 B
- O
SAPKbeta B
activation O
and O
Bcl B
- I
2 I
phosphorylation O
are O
blocked O
by O
co O
- O
transfection O
with O
the O
MAP B
kinase I
specific O
phosphatase O
MKP3 B
/ O
PYST1 B
. O

Relation O
between O
circulating O
immune O
complexes O
and O
serum B
ferritin I
in O
hemosiderosis O
of O
different O
etiologies O

Treatment O
of O
excessive O
bleeding O
after O
cardiopulmonary O
bypass O
was O
based O
on O
an O
algorithm O
using O
point O
- O
of O
- O
care O
testing O
with O
whole O
blood B
prothrombin I
time O
, O
activated O
partial O
thromboplastin B
time O
, O
heparinase B
activated O
clotting O
time O
, O
and O
platelet O
count O
. O

In O
both O
study O
stages O
. O
post O
- O
exposure O
treatment O
consisted O
of O
five O
injections O
of O
vaccine O
[ O
( O
D O
) O
ays O
0 O
, O
3 O
, O
7 O
, O
14 O
, O
28 O
] O
, O
together O
with O
a O
dose O
of O
rabies B
immunoglobulin I
( O
RIG B
) O
of O
equine O
or O
human O
origin O
on O
D0 O
. O

The O
virus O
must O
progress O
past O
the O
immediate O
- O
early O
phase O
and O
express O
an O
early B
gene I
product I
( I
s I
) I
for O
activation O
of O
cyclin B
E I
expression O
. O

Binding O
of O
the O
TorR B
regulator I
to O
cis O
- O
acting O
direct O
repeats O
activates O
tor B
operon I
expression O
. O

Binding O
of O
the O
TorR B
regulator I
to O
cis O
- O
acting O
direct O
repeats O
activates O
tor B
operon I
expression O
. O

This O
is O
a O
consensus O
casein B
kinase I
II I
( O
CKII B
) O
site O
and O
, O
using O
purified O
wild O
- O
type O
and O
mutant O
proteins O
, O
we O
show O
that O
it O
is O
the O
main O
CKII B
site I
in O
the O
body O
of O
the O
N O
- O
terminal O
complex O
- O
forming O
region O
. O

Treatment O
with O
polyinosinic O
- O
polycytidylic O
acid O
to O
induce O
expression O
of O
Cre B
resulted O
in O
complete O
disruption O
of O
the O
Arnt B
gene I
and O
loss O
of O
ARNT B
messenger I
RNA I
( O
mRNA O
) O
expression O
in O
liver O
. O

Sequence O
analysis O
of O
AEBP2 B
cDNA I
revealed O
that O
it O
encodes O
a O
protein O
containing O
three O
Gli B
- O
Kruppel B
( O
Cys2 O
- O
His2 O
) O
- O
type O
zinc O
fingers O
. O

The O
increments O
in O
median O
plasma B
secretin I
concentration O
were O
1 O
. O
6 O
, O
3 O
. O
0 O
, O
and O
6 O
. O
4 O
pmol O
x O
1 O
( O
- O
1 O
) O
after O
secretin B
, O
125 O
, O
250 O
and O
500 O
fmol O
x O
kg O
- O
1 O
, O
and O
the O
corresponding O
15 O
- O
min O
bicarbonate O
output O
283 O
, O
442 O
, O
and O
1435 O
micromol O
, O
respectively O
. O

This O
novel O
TRPC7 B
gene I
could O
be O
a O
candidate O
gene O
for O
genetic O
disorders O
such O
as O
bipolar O
affective O
disorder O
, O
nonsyndromic O
hereditary O
deafness O
, O
Knobloch O
syndrome O
, O
and O
holoprosencephaly O
, O
which O
were O
mapped O
to O
this O
region O
. O

Paradoxically O
, O
loop O
3i O
from O
the O
M1Ach B
- I
muscarinic I
receptor I
also O
maximally O
inhibited O
GnRH B
agonist O
- O
stimulated O
cAMP O
accumulation O
and O
PRL B
release O
by O
40 O
% O
( O
both O
effects O
mediated O
through O
activation O
of O
the O
Gs B
protein I
) O
. O

Analysis O
of O
tobacco O
mRNA O
using O
the O
ACBF B
cDNA I
as O
probe O
showed O
that O
while O
ACBF B
mRNA I
was O
present O
in O
all O
tissues O
examined O
, O
the O
highest O
transcript O
accumulation O
occurred O
in O
stem O
tissues O
. O

Analysis O
of O
tobacco O
mRNA O
using O
the O
ACBF B
cDNA I
as O
probe O
showed O
that O
while O
ACBF B
mRNA I
was O
present O
in O
all O
tissues O
examined O
, O
the O
highest O
transcript O
accumulation O
occurred O
in O
stem O
tissues O
. O

Here O
we O
show O
that O
expression O
of O
KRAB B
domain I
suppresses O
in O
vivo O
the O
activating O
function O
of O
various O
defined O
activating B
transcription I
factors I
, O
and O
we O
demonstrate O
that O
the O
KRAB B
domain I
specifically O
silences O
the O
activity O
of O
promoters O
whose O
initiation O
is O
dependent O
on O
the O
presence O
of O
a O
TATA O
box O
. O

Here O
we O
show O
that O
expression O
of O
KRAB B
domain I
suppresses O
in O
vivo O
the O
activating O
function O
of O
various O
defined O
activating B
transcription I
factors I
, O
and O
we O
demonstrate O
that O
the O
KRAB B
domain I
specifically O
silences O
the O
activity O
of O
promoters O
whose O
initiation O
is O
dependent O
on O
the O
presence O
of O
a O
TATA O
box O
. O

Comparison O
of O
this O
gene O
with O
the O
available O
databases O
reveals O
very O
significant O
homology O
to O
the O
ETS B
factor I
PE B
- I
1 I
and O
probable O
near O
- O
identity O
with O
the O
recently O
cloned O
factor O
ERF B
. O

Similarly O
, O
beta B
adrenoceptors I
blockade O
has O
been O
shown O
to O
be O
of O
value O
in O
achieving O
continence O
in O
a O
small O
group O
of O
patients O
. O

The O
dominant O
inhibitory O
biological O
activity O
of O
the O
N O
terminus O
correlated O
with O
its O
ability O
to O
impair O
EGF B
- O
dependent O
activation O
of O
GTP B
- I
Ras I
and O
of O
MAP B
kinase I
, O
as O
well O
with O
the O
ability O
of O
endogenous O
Sos B
to O
form O
a O
stable O
complex O
with O
activated O
EGF B
receptors I
. O

The O
dominant O
inhibitory O
biological O
activity O
of O
the O
N O
terminus O
correlated O
with O
its O
ability O
to O
impair O
EGF B
- O
dependent O
activation O
of O
GTP B
- I
Ras I
and O
of O
MAP B
kinase I
, O
as O
well O
with O
the O
ability O
of O
endogenous O
Sos B
to O
form O
a O
stable O
complex O
with O
activated O
EGF B
receptors I
. O

Here O
we O
show O
that O
these O
sequences O
are O
essential O
for O
processing O
of O
U18 B
and O
snR38 B
snoRNAs I
and O
that O
they O
compensate O
for O
the O
lack O
of O
a O
canonical O
terminal O
stem O
. O

Three O
putative O
ORFs O
have O
significant O
homology O
with O
known O
proteins O
: O
L0968 B
is O
a O
new O
member O
of O
the O
very O
large O
' B
seripauperins I
' I
family O
, O
comprising O
at O
least O
20 O
yeast O
members O
; O
L1313 B
is O
a O
new O
ABC B
transporter I
highly O
homologous O
to O
the O
yeast O
cadmium O
resistance O
protein O
Ycf1p B
and O
to O
the O
human B
multidrug I
resistance I
protein I
hMRP1 B
; O
the O
C O
- O
terminal O
part O
of O
L1325 B
present O
in O
our O
sequence O
is O
very O
homologous O
to O
the O
fruit O
fly O
abdominal O
segment O
formation O
protein O
Pumilio B
. O

Elevated O
systolic O
blood O
pressure O
and O
high O
postglucose O
serum B
insulin I
levels O
showed O
an O
independent O
, O
significant O
association O
with O
left O
ventricular O
mass O
in O
female O
diabetic O
subjects O
. O

CSEn B
stimulated O
transcription O
of O
a O
variety O
of O
promoters O
, O
including O
the O
hCS B
, O
human B
growth I
hormone I
, O
thymidine B
kinase I
, O
and O
Rous B
sarcoma I
virus I
promoters I
, O
in O
human O
choriocarcinoma O
cell O
lines O
( O
BeWo O
and O
JEG O
- O
3 O
) O
but O
not O
HeLa O
cells O
or O
rat O
somatolactotrophes O
( O
GC O
) O
. O

Effect O
of O
age O
on O
glucose O
, O
reducing O
sugars O
and O
plasma B
insulin I
in O
blood O
of O
milk O
- O
fed O
calves O
. O

During O
seed O
maturation O
, O
the O
transcriptional O
activity O
of O
napin B
genes I
is O
regulated O
by O
developmental O
signals O
involving O
the O
transcriptional B
activator I
ABI3 I
and O
abscisic O
acid O
( O
ABA O
) O
. O

This O
results O
in O
a O
decreased O
secretion O
of O
immunoglobulin B
A I
, O
and O
, O
consequently O
, O
a O
decreased O
resistance O
against O
infections O
. O

With O
this O
study O
, O
a O
total O
of O
13 O
operators O
for O
the O
glp B
regulon I
have O
been O
characterized O
. O

Coexpression O
of O
a O
dominant B
negative I
c I
- I
jun I
antagonized O
the O
ras B
- O
dependent O
stimulation O
of O
the O
92 B
- I
kDa I
gelatinase I
B I
promoter O
- O
driven O
CAT B
reporter I
. O

Engineering O
temperature O
- O
sensitive O
SH3 B
domains I
. O

NGF B
also O
induced O
a O
synthetic O
promoter O
with O
repeated O
Sp1 B
sites I
linked O
to O
a O
core O
promoter O
, O
and O
a O
plasmid O
regulated O
by O
a O
chimeric O
transactivator O
in O
which O
the O
Gal4 B
DNA I
binding I
domain I
is O
fused O
to O
the O
Sp1 B
transactivation I
domain I
, O
indicating O
that O
this O
transactivation O
domain O
is O
regulated O
by O
NGF B
. O

p107 B
induction O
of O
E2F B
DNA O
binding O
was O
observed O
primarily O
in O
S O
phase O
cells O
coincident O
with O
the O
increase O
in O
p107 B
protein I
levels O
. O

Both O
flavoproteins O
are O
active O
as O
AhpC B
reductases I
and O
mediate O
electron O
transfer O
, O
resulting O
in O
the O
NADH O
- O
dependent O
reduction O
of O
hydrogen O
peroxide O
and O
cumene O
hydroperoxide O
. O

Further O
, O
cells O
cotransfected O
with O
a O
UF B
promoter I
- O
luciferase B
( O
- O
1935UF B
- O
Luc B
) O
reporter O
gene O
and O
the O
BTEB B
expression O
vector O
had O
2 O
- O
fold O
higher O
Luc B
activity O
than O
those O
cotransfected O
with O
reporter O
gene O
and O
pcDNA O
- O
3 O
. O

In O
agreement O
with O
this O
, O
archaea O
appear O
to O
lack O
eIF5 B
, O
eIF2B B
and O
the O
lysine O
- O
rich O
binding O
domain O
for O
these O
factors O
in O
their O
eIF2beta B
homolog I
. O

Lastly O
, O
several O
restriction O
length O
polymorphisms O
were O
identified O
and O
mapped O
within O
a O
1 O
kb O
region O
located O
immediately O
upstream O
from O
the O
JH B
cluster I
. O

In O
previous O
studies O
, O
we O
showed O
that O
the O
nuclear O
import O
of O
SREBP B
- I
2 I
occurs O
via O
the O
direct O
interaction O
of O
importin B
beta I
with O
the O
HLH O
- O
Zip O
domain O
. O

In O
the O
normal O
controls O
the O
plasma B
FPA I
level O
( O
mean O
+ O
/ O
- O
SD O
) O
was O
1 O
. O
43 O
+ O
/ O
- O
0 O
. O
46 O
ng O
/ O
ml O
. O

In O
this O
study O
we O
cloned O
the O
cDNA O
of O
AD1 B
Ag I
from O
a O
rat O
basophilic O
leukemia O
2H3 O
cDNA O
library O
. O

We O
have O
shown O
previously O
that O
EGF B
receptor I
activation O
stimulates O
gastrin B
gene O
expression O
through O
a O
GC O
- O
rich O
element O
called O
gERE O
. O

The O
secondary O
end O
points O
included O
creatine B
kinase I
peak O
, O
ventricular O
fibrillation O
/ O
tachycardia O
within O
the O
first O
24 O
hours O
, O
death O
and O
congestive O
heart O
failure O
within O
the O
30 O
- O
day O
follow O
- O
up O
, O
and O
30 O
- O
day O
left O
ventricular O
ejection O
fraction O
. O

This O
demonstrates O
the O
presence O
of O
a O
PKC B
- O
dependent O
pathway O
which O
functions O
independently O
from O
Lck B
in O
MAP B
kinase I
activation O
. O

A O
heterologous O
promoter O
construct O
containing O
three O
repeats O
of O
a O
consensus O
Sp1 B
site I
, O
cloned O
upstream O
of O
a O
single O
copy O
of O
the O
ZII B
( O
CREB B
/ O
AP1 B
) O
element O
from O
the O
BZLF1 B
promoter I
linked O
to O
the O
beta B
- I
globin I
TATA O
box O
, O
exhibited O
phorbol O
ester O
inducibility O
. O

A O
heterologous O
promoter O
construct O
containing O
three O
repeats O
of O
a O
consensus O
Sp1 B
site I
, O
cloned O
upstream O
of O
a O
single O
copy O
of O
the O
ZII B
( O
CREB B
/ O
AP1 B
) O
element O
from O
the O
BZLF1 B
promoter I
linked O
to O
the O
beta B
- I
globin I
TATA O
box O
, O
exhibited O
phorbol O
ester O
inducibility O
. O

Nicotinic B
receptor I
antagonists O
mecamylamine O
( O
0 O
. O
5 O
and O
1 O
mg O
/ O
kg O
) O
and O
hexamethonium O
( O
5 O
and O
10 O
mg O
/ O
kg O
) O
reduced O
the O
response O
induced O
by O
nicotine O
( O
0 O
. O
25 O
mg O
/ O
kg O
) O
. O

We O
also O
show O
that O
psbH B
and O
psbT B
are O
transcribed O
from O
the O
upstream O
psbB B
gene I
promoter I
, O
and O
that O
the O
psbH B
mRNA I
has O
its O
own O
target O
sequence O
for O
Mbb1 B
function O
. O

O5257 B
shows O
homology O
with O
the O
SAS2 B
protein I
and O
another O
hypothetical O
protein O
from O
yeast O
. O

Consistent O
with O
this O
hypothesis O
, O
stimulation O
of O
A B
( I
2A I
) I
- I
R I
or O
PKA B
enhanced O
nuclear B
aPKC I
activity O
. O

The O
hyperpigmentation O
is O
linked O
to O
the O
presence O
of O
numerous O
single O
melanosomes O
and O
polymelanosomes O
in O
keratinocytes O
at O
all O
levels O
of O
the O
epidermis O
, O
and O
in O
dermal O
Factor B
XIIIa I
- O
positive O
dendrocytes O
. O

Methylation O
interference O
analysis O
established O
at O
single O
nucleotide O
resolution O
that O
purified O
recombinant O
Fos B
and O
Jun B
proteins I
bind O
in O
a O
sequence O
- O
specific O
manner O
to O
the O
AP B
- I
1 I
sites I
within O
the O
VDRE O
and O
OC B
box I
. O

Methylation O
interference O
analysis O
established O
at O
single O
nucleotide O
resolution O
that O
purified O
recombinant O
Fos B
and O
Jun B
proteins I
bind O
in O
a O
sequence O
- O
specific O
manner O
to O
the O
AP B
- I
1 I
sites I
within O
the O
VDRE O
and O
OC B
box I
. O

These O
include O
urinalysis O
, O
chest O
X O
- O
P O
, O
ECG O
, O
hematological O
examinations O
( O
RBC O
, O
WBC O
, O
Ht O
, O
Hb B
, O
PLT O
and O
ESR O
) O
and O
biochemical O
tests O
( O
AST B
, O
ALT B
, O
ALP B
, O
gamma B
GTP I
, O
LDH B
, O
CPK B
, O
Chol O
, O
T O
- O
Bil O
, O
TP O
, O
Alb B
, O
TG O
, O
BUN O
, O
Cr O
, O
Glu O
, O
Na O
, O
K O
, O
Ca O
, O
P O
and O
CRP B
) O
. O

The O
pcaR B
regulatory I
locus I
has O
been O
found O
to O
be O
required O
for O
both O
induction O
of O
all O
of O
the O
genes O
within O
the O
pca B
regulon I
( O
pcaBDC B
, O
pcaIJ B
, O
and O
pcaF B
) O
and O
the O
chemotactic O
response O
of O
the O
bacteria O
to O
aromatic O
compounds O
. O

PKCI B
- I
1 I
is O
a O
member O
of O
the O
HIT B
family I
of O
proteins O
, O
shown O
by O
sequence O
identity O
to O
be O
conserved O
in O
a O
broad O
range O
of O
organisms O
including O
mycoplasma O
, O
plants O
, O
and O
humans O
. O

It O
was O
found O
that O
on O
the O
14th O
and O
21st O
day O
after O
cimetidine O
administration O
serum B
gastrin I
levels O
were O
significantly O
elevated O
. O

TFIIIB B
assembles O
autonomously O
on O
the O
upstream O
promoter O
of O
the O
yeast B
U6 I
snRNA I
( O
SNR6 B
) O
gene O
in O
vitro O
, O
through O
the O
interaction O
of O
its O
TBP B
subunit I
with O
a O
consensus O
TATA O
box O
located O
at O
base O
pair O
- O
30 O
. O

Mutational O
analysis O
of O
the O
IME2 B
UAS I
reveals O
two O
critical O
sequence O
elements O
: O
a O
G O
+ O
C O
- O
rich O
sequence O
( O
called O
URS1 O
) O
, O
previously O
identified O
at O
many O
meiotic O
genes O
, O
and O
a O
newly O
described O
element O
, O
the O
T4C O
site O
, O
that O
we O
found O
at O
a O
subset O
of O
meiotic O
genes O
. O

A O
significant O
reduction O
in O
total O
cellular O
p27 B
protein I
levels O
and O
a O
moderate O
reduction O
in O
p27 B
mRNA I
are O
observed O
, O
but O
no O
changes O
in O
Cdk B
regulatory O
kinases O
and O
phosphatases O
occur O
. O

A O
significant O
reduction O
in O
total O
cellular O
p27 B
protein I
levels O
and O
a O
moderate O
reduction O
in O
p27 B
mRNA I
are O
observed O
, O
but O
no O
changes O
in O
Cdk B
regulatory O
kinases O
and O
phosphatases O
occur O
. O

Genetic O
linkage O
mapping O
of O
the O
CYP11A1 B
gene I
encoding O
the O
cholesterol O
side O
- O
chain O
cleavage O
P450scc B
close O
to O
the O
CYP1A1 B
gene I
and O
D15S204 B
in O
the O
chromosome O
15q22 O
. O
33 O
- O
q23 O
region O
. O

Genetic O
linkage O
mapping O
of O
the O
CYP11A1 B
gene I
encoding O
the O
cholesterol O
side O
- O
chain O
cleavage O
P450scc B
close O
to O
the O
CYP1A1 B
gene I
and O
D15S204 B
in O
the O
chromosome O
15q22 O
. O
33 O
- O
q23 O
region O
. O

Genetic O
and O
physiological O
experiments O
suggest O
a O
close O
relationship O
between O
cdc27 B
+ I
and O
the O
cdc2 B
+ I
gene I
, O
a O
key O
regulator O
of O
mitosis O
in O
yeast O
and O
also O
in O
higher O
eukaryotic O
cells O
. O

These O
clones O
contain O
most O
of O
the O
exon O
of O
cyclin B
D2 I
except O
exon O
5 O
. O

This O
action O
could O
be O
antagonized O
by O
aminophylline O
, O
a O
competitive O
antagonist O
on O
P1 B
purinoceptors I
. O

Promoter O
constructs O
containing O
mutations O
in O
the O
PTRE B
sequence I
that O
selectively O
abolished O
the O
binding O
of O
either O
one O
or O
both O
complexes O
exerted O
opposite O
effects O
on O
the O
transcriptional O
activity O
of O
trypsin B
promoters I
in O
A O
. O
gambiae O
and O
Aedes O
aegypti O
cell O
lines O
. O

Promoter O
constructs O
containing O
mutations O
in O
the O
PTRE B
sequence I
that O
selectively O
abolished O
the O
binding O
of O
either O
one O
or O
both O
complexes O
exerted O
opposite O
effects O
on O
the O
transcriptional O
activity O
of O
trypsin B
promoters I
in O
A O
. O
gambiae O
and O
Aedes O
aegypti O
cell O
lines O
. O

The O
Rep78 B
protein I
of O
adeno O
- O
associated O
virus O
( O
AAV O
) O
contains O
amino O
acid O
sequence O
motifs O
common O
to O
rolling B
- I
circle I
replication I
( I
RCR I
) I
initiator I
proteins I
. O

Nuclear O
transcription O
assays O
confirmed O
that O
cys B
- I
3 I
+ I
was O
under O
sulfur O
- O
regulated O
transcriptional O
control O
and O
that O
cys B
- I
3 I
+ I
transcription O
was O
constitutive O
in O
sulfur B
controller I
( O
scon B
) O
- O
negative O
regulator O
mutants O
. O

The O
inhibition O
of O
monoamine B
oxidase I
( O
MAO B
) O
by O
tranylcypromine O
was O
studied O
in O
6 O
healthy O
volunteers O
given O
increasing O
doses O
of O
10 O
, O
15 O
, O
20 O
and O
25 O
mg O
/ O
day O
over O
a O
4 O
- O
week O
period O
. O

Using O
probes O
containing O
C B
/ I
EBP I
- I
binding I
sites I
from O
the O
iNOS B
gene I
revealed O
further O
binding O
of O
different O
complexes O
, O
all O
of O
which O
were O
strongly O
inducible O
by O
cAMP O
and O
to O
a O
lower O
extent O
also O
by O
IL B
- I
1beta I
. O

The O
Pi O
signals O
are O
conveyed O
to O
PHO8 B
by O
binding O
of O
PHO4 B
protein I
, O
a O
positive O
regulatory O
factor O
, O
to O
a O
promoter O
region O
of O
PHO8 B
( O
PHO8p B
) O
under O
the O
influence O
of O
the O
PHO B
regulatory O
circuit O
. O

Desensitization O
of O
the O
growth B
hormone I
- O
induced O
Janus B
kinase I
2 I
( O
Jak B
2 I
) O
/ O
signal B
transducer I
and I
activator I
of I
transcription I
5 I
( O
Stat5 B
) O
- O
signaling O
pathway O
requires O
protein O
synthesis O
and O
phospholipase B
C I
. O

Desensitization O
of O
the O
growth B
hormone I
- O
induced O
Janus B
kinase I
2 I
( O
Jak B
2 I
) O
/ O
signal B
transducer I
and I
activator I
of I
transcription I
5 I
( O
Stat5 B
) O
- O
signaling O
pathway O
requires O
protein O
synthesis O
and O
phospholipase B
C I
. O

Desensitization O
of O
the O
growth B
hormone I
- O
induced O
Janus B
kinase I
2 I
( O
Jak B
2 I
) O
/ O
signal B
transducer I
and I
activator I
of I
transcription I
5 I
( O
Stat5 B
) O
- O
signaling O
pathway O
requires O
protein O
synthesis O
and O
phospholipase B
C I
. O

We O
screened O
an O
A O
. O
thaliana O
cDNA O
library O
, O
whose O
inserts O
are O
under O
the O
control O
of O
the O
galactose O
- O
inducible O
GAL10 B
promoter I
, O
for O
cDNAs O
which O
enabled O
YDH8 O
cells O
to O
grow O
at O
the O
restrictive O
temperature O
. O

One O
of O
the O
major O
transcripts O
encodes O
MEQ B
, O
a O
339 O
- O
amino O
- O
acid O
bZIP B
protein I
which O
is O
homologous O
to O
the O
Jun B
/ O
Fos B
family O
of O
transcription O
factors O
. O

It O
is O
concluded O
that O
the O
new O
class O
of O
competitive O
NMDA B
receptor I
antagonists O
, O
exemplified O
by O
CGP O
37849 O
, O
is O
the O
most O
promising O
candidate O
for O
clinical O
trials O
in O
anxiety O
disorders O
. O

METHODS O
: O
The O
prevalence O
of O
haemagglutination B
inhibiting I
( I
HI I
) I
antibodies I
to O
JE O
virus O
( O
JEV O
) O
, O
West O
Nile O
virus O
( O
WNV O
) O
and O
dengue O
- O
2 O
virus O
( O
DEN O
- O
2 O
) O
was O
detected O
by O
HI O
test O
and O
IgM B
antibody I
capture O
ELISA O
( O
MAC O
ELISA O
) O
was O
performed O
to O
determine O
recent O
infections O
with O
JE O
virus O
. O

Mutations O
in O
nifR1 B
( O
ntrC B
) O
and O
nifR4 B
( O
rpoN B
, O
encoding O
sigma54 B
) O
had O
no O
influence O
on O
xdh B
gene I
expression O
. O

Quantitative O
measurement O
of O
antigamma B
globulin I
factors I
( O
rheumatoid B
factors I
) O
using O
laser O
- O
nephelometry O
in O
comparison O
with O
the O
latex O
agglutination O
test O
and O
the O
Waaler O
- O
Rose O
test O

The O
determination O
of O
antithrombin B
III I
( O
AT B
III I
) O
and O
its O
clinical O
significance O

The O
determination O
of O
antithrombin B
III I
( O
AT B
III I
) O
and O
its O
clinical O
significance O

The O
sensitivity O
of O
central B
dopamine I
receptors I
was O
assessed O
with O
the O
growth B
hormone I
response O
to O
apomorphine O
application O
. O

Oral O
basal O
body O
temperature O
( O
BBT O
) O
recordings O
of O
46 O
women O
that O
conceived O
by O
donor O
insemination O
and O
who O
had O
midcycle O
monitoring O
of O
luteinising B
hormone I
( O
LH B
) O
were O
analysed O
to O
establish O
features O
associated O
with O
an O
optimal O
cycle O
. O

Our O
results O
admit O
that O
a O
ribosome O
scanning O
mechanism O
of O
the O
MP B
gene I
expression O
from O
I O
( O
2 O
) O
sgRNA O
operates O
concurrently O
. O

Specifically O
, O
we O
engineered O
two O
chimeras O
in O
which O
the O
N O
- O
terminal O
lobe O
of O
the O
SH1 B
domain I
of O
c B
- I
Abl I
was O
swapped O
with O
that O
of O
v B
- I
Src I
. O

These O
results O
suggest O
that O
repetitive O
GAA O
sequences O
enhance O
splicing O
by O
binding O
a O
protein O
complex O
containing O
a O
sequence O
- O
specific O
RNA O
binding O
protein O
and O
a O
general O
splicing O
activator O
that O
, O
in O
turn O
, O
recruit O
additional O
SR B
proteins I
. O

Highly O
conserved O
regions O
called O
src B
homology I
2 I
and O
3 O
( O
SH2 B
and O
SH3 B
) O
, O
comprising O
amino O
acid O
residues O
88 O
to O
250 O
, O
are O
believed O
to O
modulate O
the O
protein B
- I
tyrosine I
kinase I
activity O
present O
in O
the O
carboxy O
- O
terminal O
halves O
of O
the O
src B
proteins I
. O

G6620 B
is O
the O
3 O
' O
end O
of O
the O
MOL1 B
gene I
coding O
for O
a O
polypeptide O
similar O
to O
stress O
- O
inducible O
proteins O
from O
Fusarium O
; O
G6630 B
is O
the O
NAT2 B
gene I
which O
encodes O
a O
methionine B
N I
- I
acetyltransferase I
; O
G6635 B
is O
the O
RPL30B B
gene I
coding O
for O
the O
ribosomal B
protein I
L30 I
; O
G6658 B
is O
RSR1 B
encoding O
a O
ras B
- I
related I
protein I
; O
G6667 B
is O
CYS4 B
, O
the O
gene O
for O
cystathionine B
beta I
- I
synthase I

G6620 B
is O
the O
3 O
' O
end O
of O
the O
MOL1 B
gene I
coding O
for O
a O
polypeptide O
similar O
to O
stress O
- O
inducible O
proteins O
from O
Fusarium O
; O
G6630 B
is O
the O
NAT2 B
gene I
which O
encodes O
a O
methionine B
N I
- I
acetyltransferase I
; O
G6635 B
is O
the O
RPL30B B
gene I
coding O
for O
the O
ribosomal B
protein I
L30 I
; O
G6658 B
is O
RSR1 B
encoding O
a O
ras B
- I
related I
protein I
; O
G6667 B
is O
CYS4 B
, O
the O
gene O
for O
cystathionine B
beta I
- I
synthase I

G6620 B
is O
the O
3 O
' O
end O
of O
the O
MOL1 B
gene I
coding O
for O
a O
polypeptide O
similar O
to O
stress O
- O
inducible O
proteins O
from O
Fusarium O
; O
G6630 B
is O
the O
NAT2 B
gene I
which O
encodes O
a O
methionine B
N I
- I
acetyltransferase I
; O
G6635 B
is O
the O
RPL30B B
gene I
coding O
for O
the O
ribosomal B
protein I
L30 I
; O
G6658 B
is O
RSR1 B
encoding O
a O
ras B
- I
related I
protein I
; O
G6667 B
is O
CYS4 B
, O
the O
gene O
for O
cystathionine B
beta I
- I
synthase I

; O
G6670 B
is O
identical O
to O
ORF2 O
located O
close O
to O
CYS4 B
; O
G6673 B
is O
PEM1 B
/ O
CHO2 B
encoding O
a O
phosphatidylethanolamine B
methyltransferase I
; O
G7001 B
is O
the O
NSR1 B
gene I
coding O
for O
a O
nuclear O
signal O
recognition O
protein O
. O

; O
G6670 B
is O
identical O
to O
ORF2 O
located O
close O
to O
CYS4 B
; O
G6673 B
is O
PEM1 B
/ O
CHO2 B
encoding O
a O
phosphatidylethanolamine B
methyltransferase I
; O
G7001 B
is O
the O
NSR1 B
gene I
coding O
for O
a O
nuclear O
signal O
recognition O
protein O
. O

Therefore O
the O
effect O
of O
GAL11 B
on O
PGK B
transcription O
must O
be O
mediated O
at O
the O
PGK B
UAS I
, O
presumably O
as O
part O
of O
the O
activation O
complex O
. O

RNase B
protection O
analysis O
reveals O
a O
10 O
- O
fold O
increase O
in O
the O
expression O
of O
SCD2 B
mRNA I
during O
3T3 O
- O
L1 O
preadipocyte O
differentiation O
. O

To O
probe O
the O
inter O
- O
relationship O
between O
the O
virion O
- O
anchoring O
function O
and O
the O
oligomerization O
function O
, O
we O
constructed O
two O
serotype O
3 O
( O
T3 O
) O
sigma B
1 I
deletion O
mutants O
in O
SV40 O
expression O
vectors O
, O
one O
lacking O
the O
hydrophobic O
tail O
and O
the O
hinge O
, O
and O
the O
other O
lacking O
an O
adjacent O
region O
which O
constituted O
part O
of O
the O
coiled O
- O
coil O
. O

In O
contrast O
, O
overexpression O
of O
the O
DREB2A B
cDNA I
induced O
weak O
expression O
of O
the O
target O
genes O
under O
unstressed O
conditions O
and O
caused O
growth O
retardation O
of O
the O
transgenic O
plants O
. O

Eph B
receptors I
and O
their O
membrane O
- O
associated O
ephrin B
ligands I
regulate O
cell O
- O
cell O
interactions O
during O
development O
. O

Eph B
receptors I
and O
their O
membrane O
- O
associated O
ephrin B
ligands I
regulate O
cell O
- O
cell O
interactions O
during O
development O
. O

We O
discuss O
the O
possibility O
that O
DNA O
- O
protein O
interactions O
at O
homologous O
nucleotide O
sequences O
like O
those O
identified O
in O
PII O
are O
part O
of O
a O
regulatory O
gene O
cascade O
that O
participates O
in O
timing O
fla B
gene I
expression O
in O
the O
C O
. O
crescentus O
cell O
cycle O
. O

Cotransfection O
of O
expression O
plasmids O
encoding O
the O
protein B
kinase I
A I
inhibitor O
, O
or O
an O
inactive O
protein B
kinase I
A I
( O
PKA B
) O
catalytic O
beta O
subunit O
, O
inhibited O
both O
forskolin O
and O
PACAP B
activation O
of O
chromogranin B
A I
transcription O
, O
revealing O
that O
PACAP B
- O
induced O
trans O
- O
activation O
is O
highly O
dependent O
on O
PKA B
. O

The O
cyanobacterial B
phycobilisome I
is O
a O
large O
protein O
complex O
located O
on O
the O
photosynthetic O
membrane O
. O

Sequence O
analysis O
revealed O
100 O
% O
homology O
of O
all O
RA O
- O
derived O
PTEN B
fragments I
to O
those O
from O
normal O
SF O
as O
well O
as O
to O
the O
published O
GenBank O
sequence O
( O
accession O
number O
U93051 B
) O
. O

The O
most O
frequent O
abnormality O
was O
GH B
deficiency O
( O
six O
cases O
) O
, O
followed O
by O
gonadotropin B
( O
four O
cases O
) O
, O
cortisol O
( O
four O
cases O
) O
, O
and O
TSH B
( O
one O
case O
) O
, O
whereas O
four O
patients O
showed O
high O
serum B
PRL I
values O
. O

In O
both O
cell O
types O
, O
insulin B
led O
to O
a O
dose O
- O
dependent O
increase O
in O
the O
association O
of O
tyrosine B
phosphorylated I
IRS I
- I
1 I
with O
the O
SH2 B
domain I
of O
the O
p85 B
regulatory I
subunit I
of O
PI B
- I
3 I
kinase I
, O
and O
also O
increased O
the O
amount O
of O
PI B
kinase I
activity O
detected O
in O
anti B
- I
IRS I
- I
1 I
immunoprecipitates O
. O

In O
both O
cell O
types O
, O
insulin B
led O
to O
a O
dose O
- O
dependent O
increase O
in O
the O
association O
of O
tyrosine B
phosphorylated I
IRS I
- I
1 I
with O
the O
SH2 B
domain I
of O
the O
p85 B
regulatory I
subunit I
of O
PI B
- I
3 I
kinase I
, O
and O
also O
increased O
the O
amount O
of O
PI B
kinase I
activity O
detected O
in O
anti B
- I
IRS I
- I
1 I
immunoprecipitates O
. O

The O
Xenopus B
annexin I
II I
heavy I
chain I
lacks O
the O
highly O
conserved O
tyrosine O
at O
position O
23 O
which O
is O
the O
site O
of O
src B
oncogene I
tyrosine B
kinase I
phosphorylation O
in O
the O
murine O
protein O
. O

The O
Xenopus B
annexin I
II I
heavy I
chain I
lacks O
the O
highly O
conserved O
tyrosine O
at O
position O
23 O
which O
is O
the O
site O
of O
src B
oncogene I
tyrosine B
kinase I
phosphorylation O
in O
the O
murine O
protein O
. O

However O
, O
at O
the O
time O
of O
salvage O
treatment O
, O
the O
mean O
serum B
PSA I
levels O
were O
9 O
. O
1 O
and O
1 O
. O
1 O
ng O
/ O
mL O
for O
the O
salvage O
RP O
and O
salvage O
RT O
groups O
, O
respectively O
( O
P O
= O
0 O
. O
0001 O
) O
. O

Protease O
digestion O
and O
alkaline O
extraction O
of O
microsomes O
containing O
labeled O
mutant O
proteins O
further O
showed O
that O
segment O
3 O
was O
sufficient O
for O
stable O
membrane O
anchoring O
of O
the O
glycoproteins O
, O
indicating O
that O
this O
segment O
may O
specify O
the O
transmembrane O
domain O
of O
the O
gB B
glycoprotein I
. O

Alternative O
immune B
globulin I
preparation O
when O
standard O
immune B
serum I
globulin I
is O
not O
available O
. O

Plasma B
insulin I
responses O
to O
glucose O
in O
femoral O
, O
hepatic O
, O
and O
pancreatic O
veins O
in O
dogs O
. O

Elevated O
potassium O
stimulation O
of O
GAL B
mRNA I
was O
completely O
blocked O
, O
but O
pituitary O
adenylyl B
cyclase I
- I
activating I
polypeptide I
and O
histamine O
stimulations O
were O
only O
partially O
blocked O
, O
by O
cycloheximide O
. O

GBF1 B
and O
GBF2 B
mRNA I
is O
present O
in O
light O
and O
dark O
grown O
leaves O
as O
well O
as O
in O
roots O
. O

A O
transient O
induction O
of O
both O
c B
- I
fos I
and O
c B
- I
jun I
mRNAs I
by O
TPA O
was O
observed O
in O
both O
cell O
populations O
, O
together O
with O
an O
associated O
suppression O
of O
BSP B
mRNA I
in O
the O
fetal O
rat O
calvarial O
cells O
. O

Our O
results O
suggest O
a O
biological O
role O
for O
Elf B
- I
1 I
in O
the O
regulation O
of O
IgH B
gene I
expression O
, O
attribute O
a O
functional O
role O
for O
receptor O
- O
induced O
AP B
- I
1 I
proteins I
in O
B O
lymphocytes O
and O
provide O
evidence O
for O
a O
direct O
link O
between O
IgM B
receptor I
- O
mediated O
signalling O
and O
3 O
' O
enhancer O
activation O
. O

Our O
results O
suggest O
a O
biological O
role O
for O
Elf B
- I
1 I
in O
the O
regulation O
of O
IgH B
gene I
expression O
, O
attribute O
a O
functional O
role O
for O
receptor O
- O
induced O
AP B
- I
1 I
proteins I
in O
B O
lymphocytes O
and O
provide O
evidence O
for O
a O
direct O
link O
between O
IgM B
receptor I
- O
mediated O
signalling O
and O
3 O
' O
enhancer O
activation O
. O

The O
CydDC B
system I
appears O
to O
be O
the O
first O
prokaryotic O
example O
of O
a O
heterodimeric B
ABC I
transport I
system I
in O
which O
each O
polypeptide O
contains O
both O
hydrophobic O
and O
ATP O
- O
binding O
domains O
. O

The O
single O
- O
copy O
U20 B
sequence I
is O
located O
on O
the O
same O
DNA O
strand O
as O
the O
nucleolin B
mRNA I
. O

The O
single O
- O
copy O
U20 B
sequence I
is O
located O
on O
the O
same O
DNA O
strand O
as O
the O
nucleolin B
mRNA I
. O

These O
results O
suggest O
an O
essential O
role O
of O
the O
binding O
of O
HNF B
- I
4 I
and O
/ O
or O
HNF B
- I
4 I
- I
related I
nuclear I
factors I
to O
the O
6 O
beta O
A O
- O
A O
site O
on O
the O
basal O
transcriptional O
activation O
of O
the O
CYP3A2 B
gene I
in O
liver O
cells O
. O

Restriction O
mapping O
showed O
that O
the O
two O
recombinant O
plasmids O
shared O
an O
EcoRI B
fragment I
of O
8 O
. O
9 O
kb O
. O

Profilins B
IIa I
and I
IIb I
are O
also O
present O
in O
humans O
, O
suggesting O
that O
all O
mammals O
have O
three O
profilin B
isoforms I
. O

Using O
the O
yeast O
two O
- O
hybrid O
system O
, O
we O
have O
isolated O
an O
835 O
amino O
acid O
RING O
finger O
( O
C3HC4 O
zinc O
finger O
) O
protein O
, O
TIF1 B
beta I
( O
also O
named O
KAP B
- I
1 I
) O
, O
that O
specifically O
interacts O
with O
the O
KRAB B
domain I
of O
the O
human O
zinc O
finger O
factor O
KOX1 B
/ O
ZNF10 B
. O

Using O
the O
yeast O
two O
- O
hybrid O
system O
, O
we O
have O
isolated O
an O
835 O
amino O
acid O
RING O
finger O
( O
C3HC4 O
zinc O
finger O
) O
protein O
, O
TIF1 B
beta I
( O
also O
named O
KAP B
- I
1 I
) O
, O
that O
specifically O
interacts O
with O
the O
KRAB B
domain I
of O
the O
human O
zinc O
finger O
factor O
KOX1 B
/ O
ZNF10 B
. O

The O
purified O
RAG1 B
protein I
overexpressed O
in O
E O
. O
coli O
exhibited O
the O
expected O
cleavage O
activity O
when O
combined O
with O
RAG2 B
purified O
from O
transfected O
293T O
cells O
. O

Moreover O
, O
we O
show O
that O
GATA B
- I
1 I
and O
Sp1 B
synergize O
from O
a O
distance O
in O
constructs O
designed O
to O
mimic O
the O
architecture O
of O
globin B
locus I
control I
regions I
and O
downstream O
globin B
promoters I
. O

Adhesion O
was O
inhibited O
by O
mAbs O
against O
the O
COOH O
- O
terminus O
and O
central O
cell O
binding O
domains O
of O
fibronectin B
, O
as O
well O
as O
by O
the O
corresponding O
CS1 B
and O
RGD B
peptides I
. O

Consistent O
with O
this O
, O
rh5 B
expression O
in O
R8 B
disappears O
when O
R7 O
cells O
are O
absent O
( O
in O
sevenless B
mutant I
) O
. O

These O
data O
suggest O
that O
the O
secreted O
, O
truncated O
receptor O
encoded O
by O
the O
2 B
. I
6 I
- I
kb I
c I
- I
erbB I
transcript I
can O
bind O
to O
TGF B
alpha I
and O
may O
play O
an O
important O
growth O
- O
regulatory O
function O
in O
vitro O
. O

A O
close O
homologue O
of O
the O
APK2a B
gene I
, O
named O
APK2b B
, O
was O
also O
isolated O
from O
the O
Arabidopsis O
cDNA O
library O
. O

This O
substrate O
was O
cleaved O
efficiently O
in O
trans O
by O
protease B
3C I
derived O
from O
another O
recombinant O
vaccinia O
virus O
expressing O
a O
3C B
precursor I
protein I
. O

In O
particular O
, O
lacZ B
transcripts I
synthesised O
this O
way O
are O
highly O
unstable O
and O
yield O
little O
beta B
- I
galactosidase I
. O

Six O
cDNAs O
represent O
human O
homologs O
of O
genes O
known O
in O
other O
species O
, O
namely O
, O
mouse B
HSPE71 I
, O
Rat B
RhoGAP I
protein I
, O
S B
cerevisiae I
leucyl I
tRNA I
synthetase I
and O
S B
cerevisiae I
chromosome I
II I
ORF I
YBLO44W I
. O

To O
determine O
the O
role O
of O
elevated O
FAK B
expression O
in O
facilitating O
epidermal B
growth I
factor I
( O
EGF B
) O
- O
stimulated O
human O
adenocarcinoma O
( O
A549 O
) O
cell O
motility O
, O
antisense O
oligonucleotides O
were O
used O
to O
reduce O
FAK B
protein I
expression O
> O
75 O
% O
. O

Mutations O
in O
glnB B
, O
nifR1 B
( O
ntrC B
) O
, O
and O
NifR4 B
( O
ntrA B
encoding O
sigma B
54 I
) O
had O
no O
influence O
on O
put B
gene I
expression O
. O

Mutations O
in O
glnB B
, O
nifR1 B
( O
ntrC B
) O
, O
and O
NifR4 B
( O
ntrA B
encoding O
sigma B
54 I
) O
had O
no O
influence O
on O
put B
gene I
expression O
. O

Disruption O
of O
INP53 B
, O
but O
not O
the O
related O
INP51 B
and O
INP52 B
genes I
, O
resulted O
in O
alpha B
- I
factor I
maturation O
defects O
and O
exacerbated O
alpha B
- I
factor I
maturation O
defects O
when O
combined O
with O
chc1 B
- I
521 I
. O

Glutathione B
reductase I
( O
GR B
) O
was O
purified O
from O
the O
cyanobacterium O
Anabaena O
PCC O
7120 O
. O

The O
RTI40 B
gene I
spans O
35 O
kilobase O
pairs O
; O
it O
contains O
6 O
exons O
and O
at O
least O
6 O
rat O
Identifier O
repetitive O
elements O
. O

Furthermore O
, O
deletion O
of O
two O
potential O
Ste11 B
recognition I
sites I
in O
the O
fus1 B
promoter I
region O
abolished O
transcription O
, O
and O
expression O
could O
be O
restored O
when O
we O
inserted O
a O
different O
Ste11 B
site I
from O
the O
mat1 B
- I
P I
promoter I
. O

Furthermore O
, O
deletion O
of O
two O
potential O
Ste11 B
recognition I
sites I
in O
the O
fus1 B
promoter I
region O
abolished O
transcription O
, O
and O
expression O
could O
be O
restored O
when O
we O
inserted O
a O
different O
Ste11 B
site I
from O
the O
mat1 B
- I
P I
promoter I
. O

Using O
reporter O
gene O
constructs O
driven O
by O
the O
CD4 B
promoter I
, O
we O
report O
that O
HHV O
- O
6 O
can O
efficiently O
transactivate O
such O
genetic O
elements O
. O

Previous O
work O
established O
that O
the O
TAL1 B
proteins I
are O
phosphorylated O
exclusively O
on O
serine O
and O
identified O
Ser122 O
as O
a O
substrate O
for O
the O
mitogen B
- I
activated I
protein I
kinase I
ERK B
- I
1 I
. O

When O
cotransfected O
with O
the O
HIV B
LTR I
CAT B
into O
CV O
- O
1 O
cells O
, O
both O
the O
pCD41 B
and O
pGD41 B
clones O
trans O
- O
activated O
the O
HIV B
LTR I
. O

When O
cotransfected O
with O
the O
HIV B
LTR I
CAT B
into O
CV O
- O
1 O
cells O
, O
both O
the O
pCD41 B
and O
pGD41 B
clones O
trans O
- O
activated O
the O
HIV B
LTR I
. O

To O
understand O
this O
dramatic O
effect O
, O
we O
examined O
the O
localization O
of O
SR B
proteins I
and O
found O
that O
SC35 B
was O
shifted O
to O
the O
cytoplasm O
in O
sky1Delta B
yeast O
, O
although O
this O
phenomenon O
was O
not O
obvious O
with O
ASF B
/ O
SF2 B
, O
indicating O
that O
nuclear O
import O
of O
SR B
proteins I
may O
be O
differentially O
regulated O
by O
phosphorylation O
. O

To O
understand O
this O
dramatic O
effect O
, O
we O
examined O
the O
localization O
of O
SR B
proteins I
and O
found O
that O
SC35 B
was O
shifted O
to O
the O
cytoplasm O
in O
sky1Delta B
yeast O
, O
although O
this O
phenomenon O
was O
not O
obvious O
with O
ASF B
/ O
SF2 B
, O
indicating O
that O
nuclear O
import O
of O
SR B
proteins I
may O
be O
differentially O
regulated O
by O
phosphorylation O
. O

Studies O
on O
the O
reaction O
of O
cytochrome B
c I
with O
corticosteroids O
. O

To O
further O
investigate O
the O
role O
of O
PKR B
in O
transcriptional O
signaling O
, O
we O
expressed O
the O
wild B
type I
human I
PKR I
and O
a O
catalytically O
inactive O
dominant O
negative O
PKR B
mutant I
in O
the O
murine O
pre O
- O
B O
lymphoma O
70Z O
/ O
3 O
cells O
. O

Selective O
upper O
abdominal O
sympathectomy O
increased O
basal O
acid O
output O
in O
rats O
but O
was O
without O
effect O
on O
stimulated O
acid O
output O
, O
serum B
gastrin I
concentration O
, O
and O
gastric B
mucosal I
histidine I
decarboxylase I
activity O
. O

Instead O
, O
the O
large O
difference O
in O
ssDNA O
- O
binding O
affinities O
reflects O
the O
loss O
of O
hexamerization O
ability O
by O
uvsY B
, O
suggesting O
that O
a O
form O
of O
intrahexamer O
synergism O
or O
cooperativity O
between O
binding O
sites O
within O
the O
uvsY B
hexamer I
leads O
to O
its O
high O
observed O
affinity O
for O
ssDNA O
. O

The O
PK O
domain O
showed O
pairwise O
in O
vitro O
binding O
interactions O
with O
the O
pseudokinase O
, O
HisRS B
, O
and O
C O
- O
term O
domains O
; O
additionally O
, O
the O
HisRS B
domain I
interacted O
with O
the O
C O
- O
term O
region O
. O

Effect O
of O
bromocriptine O
and O
metoclopramide O
on O
serum B
prolactin I
levels O
in O
patients O
with O
amyotrophic O
lateral O
sclerosis O
. O

Prolongation O
of O
prothrombin B
time O
was O
not O
due O
to O
depletion O
of O
vitamin O
K O
- O
dependent O
coagulation O
factors O
or O
manifest O
fibrinolysis O
, O
but O
due O
to O
the O
presence O
of O
circulating O
fibrinogen B
fibrinmonomer I
- O
FDP O
complexes O
. O

Mutation O
of O
K14 O
in O
H3 B
, O
which O
serves O
as O
the O
major O
target O
of O
recombinant B
Gcn5p I
acetylation O
in O
vitro O
, O
confers O
a O
strong O
, O
synthetic O
growth O
defect O
in O
gcn5 B
cells O
. O

Overexpression O
of O
either O
Sp1 B
or O
phosphorylated B
CREB I
transactivated O
the O
mCgA B
promoter I
dose O
dependently O
, O
while O
coexpression O
of O
both O
transcription O
factors O
resulted O
in O
an O
additive O
mCgA B
promoter I
response O
. O

Overexpression O
of O
either O
Sp1 B
or O
phosphorylated B
CREB I
transactivated O
the O
mCgA B
promoter I
dose O
dependently O
, O
while O
coexpression O
of O
both O
transcription O
factors O
resulted O
in O
an O
additive O
mCgA B
promoter I
response O
. O

Overexpression O
of O
either O
Sp1 B
or O
phosphorylated B
CREB I
transactivated O
the O
mCgA B
promoter I
dose O
dependently O
, O
while O
coexpression O
of O
both O
transcription O
factors O
resulted O
in O
an O
additive O
mCgA B
promoter I
response O
. O

Together O
with O
the O
up O
- O
regulation O
of O
the O
cAMP B
response I
element I
modulator I
protein I
( O
CREM B
) O
mRNA O
and O
protein O
levels O
demonstrated O
previously O
in O
CREB B
mutant I
mice O
, O
we O
suggest O
that O
the O
up O
- O
regulation O
of O
CREB B
beta I
may O
also O
contribute O
to O
compensation O
within O
the O
CREB B
/ O
ATF B
family O
of O
transcription O
factors O
, O
when O
CREB B
delta I
and O
CREB B
alpha I
are O
absent O
. O

Together O
with O
the O
up O
- O
regulation O
of O
the O
cAMP B
response I
element I
modulator I
protein I
( O
CREM B
) O
mRNA O
and O
protein O
levels O
demonstrated O
previously O
in O
CREB B
mutant I
mice O
, O
we O
suggest O
that O
the O
up O
- O
regulation O
of O
CREB B
beta I
may O
also O
contribute O
to O
compensation O
within O
the O
CREB B
/ O
ATF B
family O
of O
transcription O
factors O
, O
when O
CREB B
delta I
and O
CREB B
alpha I
are O
absent O
. O

Together O
with O
the O
up O
- O
regulation O
of O
the O
cAMP B
response I
element I
modulator I
protein I
( O
CREM B
) O
mRNA O
and O
protein O
levels O
demonstrated O
previously O
in O
CREB B
mutant I
mice O
, O
we O
suggest O
that O
the O
up O
- O
regulation O
of O
CREB B
beta I
may O
also O
contribute O
to O
compensation O
within O
the O
CREB B
/ O
ATF B
family O
of O
transcription O
factors O
, O
when O
CREB B
delta I
and O
CREB B
alpha I
are O
absent O
. O

Together O
with O
the O
up O
- O
regulation O
of O
the O
cAMP B
response I
element I
modulator I
protein I
( O
CREM B
) O
mRNA O
and O
protein O
levels O
demonstrated O
previously O
in O
CREB B
mutant I
mice O
, O
we O
suggest O
that O
the O
up O
- O
regulation O
of O
CREB B
beta I
may O
also O
contribute O
to O
compensation O
within O
the O
CREB B
/ O
ATF B
family O
of O
transcription O
factors O
, O
when O
CREB B
delta I
and O
CREB B
alpha I
are O
absent O
. O

Individual O
and O
combined O
effects O
of O
fumonisin B
B1 I
present O
in O
Fusarium O
moniliforme O
culture O
material O
and O
diacetoxyscirpenol O
or O
ochratoxin O
A O
in O
turkey O
poults O
. O

It O
is O
hypothesized O
this O
occurs O
through O
antagonism O
of O
PML B
/ O
RAR B
alpha I
actions O
in O
these O
leukemic O
cells O
. O

13 O
: O
961 O
- O
969 O
, O
1993 O
) O
suggested O
that O
T B
antigen I
could O
mediate O
transcriptional O
activation O
through O
interaction O
with O
the O
TATA B
- I
binding I
protein I
, O
as O
well O
as O
upstream O
bound O
transcription O
factors O
. O

Activation O
of O
the O
cytotactin B
promoter I
by O
the O
homeobox B
- I
containing I
gene I
Evx I
- I
1 I
. O

The O
strategy O
uses O
RNA B
ligase I
to O
add O
DNA O
oligonucleotide O
priming O
sites O
to O
the O
RNA O
for O
subsequent O
reverse O
transcription O
and O
PCR O
( O
RNA B
ligase I
, O
reverse O
transcription O
- O
PCR O
, O
or O
RL O
/ O
RT O
/ O
PCR O
) O
. O

The O
strategy O
uses O
RNA B
ligase I
to O
add O
DNA O
oligonucleotide O
priming O
sites O
to O
the O
RNA O
for O
subsequent O
reverse O
transcription O
and O
PCR O
( O
RNA B
ligase I
, O
reverse O
transcription O
- O
PCR O
, O
or O
RL O
/ O
RT O
/ O
PCR O
) O
. O

We O
analyzed O
the O
effects O
of O
light O
on O
tubulin B
mRNA I
abundance O
in O
Arabidopsis O
seedlings O
using O
RNA O
gel O
blot O
hybridizations O
and O
gene O
- O
specific O
probes O
. O

More O
important O
, O
ligand O
- O
activated O
insulin B
and O
IGF B
- I
I I
receptors I
phosphorylate O
SHC B
proteins I
in O
vitro O
, O
indicating O
that O
SHC B
proteins I
could O
be O
direct O
substrates O
for O
insulin B
and O
IGF B
- I
I I
receptors I
. O

More O
important O
, O
ligand O
- O
activated O
insulin B
and O
IGF B
- I
I I
receptors I
phosphorylate O
SHC B
proteins I
in O
vitro O
, O
indicating O
that O
SHC B
proteins I
could O
be O
direct O
substrates O
for O
insulin B
and O
IGF B
- I
I I
receptors I
. O

This O
chimera O
transduced O
IL B
- I
4 I
- O
specific O
signals O
in O
response O
to O
IL B
- I
2 I
binding O
and O
dramatically O
enhanced O
type O
2 O
responses O
( O
IL B
- I
4 I
, O
IL B
- I
5 I
, O
and O
immunoglobulin B
E I
production O
) O
upon O
in O
vitro O
TCR B
stimulation O
or O
in O
vivo O
antigen O
challenge O
. O

Two O
human B
beta I
- I
1 I
, I
6 I
- I
N I
- I
acetylglucosaminyltransferases I
forming O
the O
core O
2 O
O O
- O
glycan O
branch O
, O
C2GnT O
and O
the O
I B
antigen I
, O
IGnT B
, O
are O
homologous O
to O
each O
other O
in O
three O
regions O
of O
the O
catalytic O
domain O
( O
A O
, O
B O
, O
C O
) O
and O
their O
genes O
reside O
at O
the O
same O
locus O
, O
chromosome O
9 O
, O
band O
q21 O
( O
Bierhuizen O
, O
M O
. O
F O
. O
A O
. O
, O
Mattei O
, O
M O
. O
- O
G O
. O
and O
Fukuda O
, O
M O
. O
, O
Genes O
Dev O
. O
, O
7 O
, O

In O
contrast O
, O
no O
change O
in O
the O
level O
of O
either O
p53 B
or O
activation O
of O
mdm2 B
protein I
by O
p53 B
was O
observed O
in O
hamster O
UV61 O
cells O
after O
UV O
exposure O
. O

Transcriptional O
activation O
of O
the O
proopiomelanocortin B
gene I
by O
cyclic B
AMP I
- I
responsive I
element I
binding I
protein I
. O

The O
NF1 B
family I
members O
and O
HNF4 B
interacted O
with O
overlapping O
sequences O
of O
the O
L O
- O
II O
element O
, O
wherein O
the O
5 O
' O
half O
- O
site O
was O
more O
critical O
for O
NF1 B
binding O
, O
and O
the O
3 O
' O
site O
was O
more O
important O
for O
HNF4 B
binding O
. O

There O
is O
no O
indication O
from O
these O
experiments O
that O
linker B
histones I
bind O
fundamentally O
differently O
to O
5 B
S I
and O
bulk O
nucleosomes O
. O

There O
is O
no O
indication O
from O
these O
experiments O
that O
linker B
histones I
bind O
fundamentally O
differently O
to O
5 B
S I
and O
bulk O
nucleosomes O
. O

Cytochrome B
bd I
biosynthesis O
in O
Escherichia O
coli O
: O
the O
sequences O
of O
the O
cydC B
and O
cydD B
genes I
suggest O
that O
they O
encode O
the O
components O
of O
an O
ABC B
membrane I
transporter I
. O

Cytochrome B
bd I
biosynthesis O
in O
Escherichia O
coli O
: O
the O
sequences O
of O
the O
cydC B
and O
cydD B
genes I
suggest O
that O
they O
encode O
the O
components O
of O
an O
ABC B
membrane I
transporter I
. O

In O
contrast O
, O
inhibition O
of O
MAPK B
activity O
by O
MAPK B
kinase I
inhibitor O
( O
PD O
98059 O
) O
or O
by O
overexpression O
of O
kinase O
- O
deficient O
MAPKs B
activated O
basal O
and O
GnRH B
- I
A I
- O
stimulated O
GnRHR B
- O
Luc B
activity O
. O

Thus O
, O
oxyR B
mutants I
are O
locked O
on O
for O
Ag43 B
expression O
, O
whereas O
dam B
mutants I
are O
locked O
off O
for O
Ag43 B
expression O
. O

Thus O
, O
oxyR B
mutants I
are O
locked O
on O
for O
Ag43 B
expression O
, O
whereas O
dam B
mutants I
are O
locked O
off O
for O
Ag43 B
expression O
. O

A O
rare O
tRNA B
- I
Arg I
( I
CCU I
) I
that O
regulates O
Ty1 B
element I
ribosomal O
frameshifting O
is O
essential O
for O
Ty1 B
retrotransposition O
in O
Saccharomyces O
cerevisiae O
. O

Several O
35 O
- O
mm O
slides O
of O
dystrophin B
- O
, O
laminin B
- O
, O
and O
concanavalin B
A I
( O
ConA B
) O
- O
stained O
muscle O
sections O
were O
used O
to O
calculate O
myofiber O
cross O
- O
sectional O
areas O
and O
to O
compare O
different O
techniques O
and O
settings O
of O
an O
image O
capture O
system O
. O

p185c B
- O
neu B
+ O
, O
EGFr B
+ I
( O
M1 B
) O
, O
and O
p185c B
- O
neu B
- O
kinase O
inactive O
, O
EGFr B
+ I
( O
NEN757 B
) O
expressing O
cells O
undergo O
different O
mitotic O
responses O
to O
EGF B
. O

p185c B
- O
neu B
+ O
, O
EGFr B
+ I
( O
M1 B
) O
, O
and O
p185c B
- O
neu B
- O
kinase O
inactive O
, O
EGFr B
+ I
( O
NEN757 B
) O
expressing O
cells O
undergo O
different O
mitotic O
responses O
to O
EGF B
. O

Ribosome O
association O
of O
GCN2 B
protein I
kinase I
, O
a O
translational O
activator O
of O
the O
GCN4 B
gene I
of O
Saccharomyces O
cerevisiae O
. O

BACKGROUND O
: O
Recent O
iterative O
methods O
for O
sequence O
alignment O
have O
indicated O
that O
the O
380 O
kDa O
motor O
unit O
of O
dynein B
belongs O
to O
the O
AAA B
class I
of O
chaperone B
- I
like I
ATPases I
. O

Transfection O
assays O
using O
the O
first O
600 O
bp O
of O
the O
upstream O
nucleotide O
sequences O
indicated O
that O
a O
region O
from O
- O
75 O
to O
- O
120 O
was O
necessary O
for O
the O
ALDH2 B
gene I
expression O
, O
and O
especially O
NF B
- I
Y I
/ O
CP1 B
binding O
site O
from O
- O
92 O
to O
- O
96 O
( O
CCAAT O
box O
) O
is O
important O
in O
the O
expression O
of O
the O
gene O
. O

Blood B
coagulation I
Factor I
X I
and O
its O
activated O
form O
Factor B
Xa I
play O
an O
essential O
role O
in O
the O
midphase O
of O
the O
clotting O
cascade O
. O

Intramolecular O
interaction O
is O
believed O
to O
result O
in O
the O
formation O
of O
MxA B
monomers I
, O
whereas O
intermolecular O
interaction O
may O
induce O
the O
formation O
of O
large B
MxA I
oligomers I
. O

The O
psbA B
gene I
encodes O
the O
D1 B
protein I
of O
photosystem B
II I
, O
which O
is O
synthesized O
at O
very O
high O
rates O
in O
the O
light O
in O
order O
to O
replace O
photodamaged O
protein O
. O

The O
psbA B
gene I
encodes O
the O
D1 B
protein I
of O
photosystem B
II I
, O
which O
is O
synthesized O
at O
very O
high O
rates O
in O
the O
light O
in O
order O
to O
replace O
photodamaged O
protein O
. O

The O
psbA B
gene I
encodes O
the O
D1 B
protein I
of O
photosystem B
II I
, O
which O
is O
synthesized O
at O
very O
high O
rates O
in O
the O
light O
in O
order O
to O
replace O
photodamaged O
protein O
. O

Specifically O
, O
we O
demonstrate O
that O
this O
25 O
- O
base O
pair O
region O
mediates O
the O
up O
- O
regulatory O
effect O
of O
TGF B
- I
beta I
on O
COL1A2 B
promoter I
activity O
and O
allows O
antagonistic O
activity O
of O
TNF B
- I
alpha I
on O
the O
TGF B
- I
beta I
effect O
. O

Translation O
of O
mok B
is O
tightly O
regulated O
by O
Sok B
RNA I
, O
and O
Sok B
RNA I
thus O
regulates O
hok B
translation O
indirectly O
through O
mok B
. O

Translation O
of O
mok B
is O
tightly O
regulated O
by O
Sok B
RNA I
, O
and O
Sok B
RNA I
thus O
regulates O
hok B
translation O
indirectly O
through O
mok B
. O

In O
this O
study O
, O
transcriptional O
fusions O
were O
constructed O
between O
the O
xcpP B
and O
xcpR B
genes I
and O
the O
lacZ B
reporter I
. O

In O
this O
study O
, O
transcriptional O
fusions O
were O
constructed O
between O
the O
xcpP B
and O
xcpR B
genes I
and O
the O
lacZ B
reporter I
. O

To O
explore O
the O
mechanism O
of O
insulin B
receptor I
phosphorylation O
we O
have O
used O
NIH3T3 O
cells O
transfected O
with O
two O
receptor O
constructs O
: O
one O
encoding O
a O
chimeric O
receptor O
composed O
of O
the O
extracellular O
domain O
of O
the O
human B
EGF I
receptor I
and O
the O
cytosolic O
domain O
of O
the O
human B
insulin I
receptor I
beta I
- I
subunit I
, O
and O
a O
second O
construct O
encoding O
a O
kinase O
- O
defiecient O
human B
insulin I
receptor I
. O

It O
is O
pathogenetically O
proved O
to O
use O
antithrombin B
III I
concentrate O
preparations O
with O
anti O
- O
and O
dysaggregatory O
properties O
, O
fibronectin B
preparations O
, O
trasylol O
or O
its O
analogs O
during O
complex O
preoperative O
preparation O
of O
patients O
. O

We O
have O
used O
the O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
reporter O
gene O
system O
to O
study O
the O
effect O
of O
T B
on O
the O
long O
terminal O
repeats O
( O
LTRs O
) O
of O
a O
large O
family O
of O
human O
endogenous O
retrovirus O
- O
like O
sequences O
, O
RTVL O
- O
H O
. O

Finally O
, O
the O
conservation O
of O
the O
two O
residues O
most O
sensitive O
to O
mutations O
( O
Y949 O
and O
Y953 O
) O
in O
TM11 O
, O
and O
in O
the O
homologous O
TM5 O
, O
of O
all O
mammalian B
P I
- I
gps I
and O
also O
in O
other O
ABC B
transporters I
, O
suggests O
that O
these O
residues O
and O
domains O
may O
play O
an O
important O
role O
in O
structural O
as O
well O
as O
mechanistic O
aspects O
common O
to O
this O
family O
of O
proteins O
. O

Based O
on O
the O
requirement O
for O
CREM B
/ O
ICER B
and O
Rad6B B
proteins I
in O
spermatogenesis O
, O
we O
determined O
expression O
of O
Cdc34 B
, O
Rad6B B
, O
CREM B
/ O
ICER B
isoforms O
, O
and O
the O
Skp1 B
- O
Cullin B
- O
F O
- O
box O
ubiquitin B
protein O
ligase O
subunits O
Cul B
- I
1 I
and O
Cul B
- I
2 I
, O
which O
are O
associated O
with O
Cdc34 B
activity O
during O
murine O
testicular O
development O
. O

Transcription B
factor I
IIIC I
( O
TFIIIC B
) O
is O
required O
for O
the O
assembly O
of O
a O
preinitiation O
complex O
on O
5S B
RNA I
, O
tRNA O
, O
and O
adenovirus B
VA I
RNA O
genes O
and O
contains O
two O
separable O
components O
, O
TFIIIC1 B
and O
TFIIIC2 B
. O

Transcription B
factor I
IIIC I
( O
TFIIIC B
) O
is O
required O
for O
the O
assembly O
of O
a O
preinitiation O
complex O
on O
5S B
RNA I
, O
tRNA O
, O
and O
adenovirus B
VA I
RNA O
genes O
and O
contains O
two O
separable O
components O
, O
TFIIIC1 B
and O
TFIIIC2 B
. O

Furthermore O
, O
we O
show O
that O
Nck B
- I
2 I
is O
capable O
of O
recognizing O
several O
key O
components O
of O
growth B
factor I
receptor I
kinase I
- O
signaling O
pathways O
including O
EGF B
receptors I
, O
PDGF B
receptor I
- I
beta I
, O
and O
IRS B
- I
1 I
. O

p54 B
belongs O
to O
the O
subfamily O
of O
HNF3 B
beta I
proteins I
, O
while O
p47 B
/ I
48 I
binding O
activity O
includes O
HNF3 B
gamma I
. O

Southern O
hybridization O
of O
genomic O
DNA O
from O
WT O
and O
Lp B
/ O
Lp B
embryos O
failed O
to O
identify O
specific O
rearrangements O
at O
or O
near O
the O
Nhlh1 B
locus I
, O
and O
Northern O
RNA O
blotting O
and O
RT O
- O
PCR O
evaluation O
of O
Nhlh1 B
mRNA I
expression O
indicated O
that O
both O
the O
levels O
and O
types O
of O
Nhlh1 B
mRNAs I
produced O
in O
WT O
and O
Lp B
/ O
Lp B
embryos O
were O
indistinguishable O
. O

Southern O
hybridization O
of O
genomic O
DNA O
from O
WT O
and O
Lp B
/ O
Lp B
embryos O
failed O
to O
identify O
specific O
rearrangements O
at O
or O
near O
the O
Nhlh1 B
locus I
, O
and O
Northern O
RNA O
blotting O
and O
RT O
- O
PCR O
evaluation O
of O
Nhlh1 B
mRNA I
expression O
indicated O
that O
both O
the O
levels O
and O
types O
of O
Nhlh1 B
mRNAs I
produced O
in O
WT O
and O
Lp B
/ O
Lp B
embryos O
were O
indistinguishable O
. O

Southern O
hybridization O
of O
genomic O
DNA O
from O
WT O
and O
Lp B
/ O
Lp B
embryos O
failed O
to O
identify O
specific O
rearrangements O
at O
or O
near O
the O
Nhlh1 B
locus I
, O
and O
Northern O
RNA O
blotting O
and O
RT O
- O
PCR O
evaluation O
of O
Nhlh1 B
mRNA I
expression O
indicated O
that O
both O
the O
levels O
and O
types O
of O
Nhlh1 B
mRNAs I
produced O
in O
WT O
and O
Lp B
/ O
Lp B
embryos O
were O
indistinguishable O
. O

This O
is O
the O
first O
report O
that O
the O
PH B
domain I
of O
an O
IRS B
protein I
can O
function O
in O
a O
dominant O
negative O
manner O
to O
inhibit O
insulin B
signaling O
. O

This O
is O
the O
first O
report O
that O
the O
PH B
domain I
of O
an O
IRS B
protein I
can O
function O
in O
a O
dominant O
negative O
manner O
to O
inhibit O
insulin B
signaling O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged O
V B
kappa I
- O
C B
kappa I
gene O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged O
V B
kappa I
- O
C B
kappa I
gene O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged O
V B
kappa I
- O
C B
kappa I
gene O
. O

C O
. O
glabrata O
cells O
containing O
the O
CBF1 B
gene I
under O
the O
influence O
of O
a O
shutdown O
promoter O
( O
tetO O
- O
ScHOP O
) O
arrested O
their O
growth O
after O
5 O
h O
of O
cultivation O
in O
the O
presence O
of O
the O
reactive O
drug O
doxycycline O
. O

In O
addition O
, O
there O
was O
an O
increase O
in O
the O
amount O
of O
p120 B
Ras I
- O
specific O
GTPase B
- I
activating I
protein I
( O
GAP B
) O
and O
GAP B
- O
associated O
p190 O
. O

By O
sequencing O
of O
exonuclease B
III I
deletion O
clones O
an O
open O
reading O
frame O
of O
405 O
nucleotides O
was O
found O
coding O
for O
a O
protein O
of O
135 O
amino O
acids O
with O
a O
molecular O
mass O
of O
15 O
kDa O
. O

The O
pepI B
gene I
was O
overexpressed O
in O
Escherichia O
coli O
. O

SH3A B
competes O
with O
the O
SH3 B
domains I
of O
Grb2 B
in O
binding O
to O
mSos1 B
, O
and O
the O
intersectin B
- O
mSos1 B
complex O
can O
be O
separated O
from O
Grb2 B
by O
sucrose O
gradient O
centrifugation O
. O

The O
sequences O
of O
two O
previously O
known O
tail B
genes I
, O
R B
and O
S B
, O
of O
the O
temperate O
bacteriophage O
P2 O
and O
the O
sequence O
of O
an O
additional O
open O
reading O
frame O
( O
orf O
- O
30 O
) O
located O
between O
S B
and O
V B
, O
were O
determined O
. O

GH B
signals O
by O
interacting O
with O
GH B
receptor I
( O
GHR B
) O
. O

Plasma B
prolactin I
concentrations O
during O
incubation O
, O
25 O
. O
8 O
+ O
/ O
- O
2 O
. O
3 O
ng O
/ O
ml O
, O
decreased O
to O
baseline O
levels O
, O
10 O
. O
8 O
+ O
/ O
- O
1 O
. O
9 O
ng O
/ O
ml O
, O
within O
24 O
hr O
after O
nestbox O
removal O
. O

Brome B
mosaic I
virus I
polymerase I
- O
like O
protein B
2a I
is O
directed O
to O
the O
endoplasmic O
reticulum O
by O
helicase B
- O
like O
viral B
protein I
1a I
. O

Diagnostic O
importance O
of O
determining O
leucine B
aminotransferase I
activity O
in O
acute O
pancreatitis O

The O
Mer1 B
protein I
contains O
the O
KH O
motif O
found O
in O
some O
RNA O
- O
binding O
proteins O
, O
and O
RNA O
gel O
mobility O
shift O
assays O
demonstrate O
that O
Mer1 B
binds O
specifically O
to O
MER2 B
RNA I
. O

The O
Mer1 B
protein I
contains O
the O
KH O
motif O
found O
in O
some O
RNA O
- O
binding O
proteins O
, O
and O
RNA O
gel O
mobility O
shift O
assays O
demonstrate O
that O
Mer1 B
binds O
specifically O
to O
MER2 B
RNA I
. O

In O
NIH O
3T3 O
fibroblasts O
the O
high O
affinity O
IL B
- I
2R I
bearing O
a O
deletion O
of O
a O
region O
rich O
in O
acidic O
amino O
acids O
( O
the O
" O
acidic O
" O
region O
) O
in O
the O
IL B
- I
2R I
beta I
- I
chain I
failed O
to O
induce O
the O
tyrosine O
phosphorylation O
of O
MAP B
kinase I
as O
well O
as O
the O
expression O
of O
the O
all O
three O
nuclear O
proto O
- O
oncogenes O
. O

The O
avian O
carcinoma O
virus O
MH2 O
contains O
a O
hybrid O
gene O
delta B
gag I
- O
mht B
with O
a O
contiguous O
open O
reading O
frame O
of O
2682 O
base O
pairs O
as O
well O
as O
v B
- I
myc I
and O
avian O
helper O
virus O
- O
related O
sequences O
. O
delta B
gag I
is O
a O
partial O
retroviral B
core I
protein I
gene I
while O
v B
- I
mht I
and O
v B
- I
myc I
are O
cell O
- O
drived O
sequences O
. O

The O
avian O
carcinoma O
virus O
MH2 O
contains O
a O
hybrid O
gene O
delta B
gag I
- O
mht B
with O
a O
contiguous O
open O
reading O
frame O
of O
2682 O
base O
pairs O
as O
well O
as O
v B
- I
myc I
and O
avian O
helper O
virus O
- O
related O
sequences O
. O
delta B
gag I
is O
a O
partial O
retroviral B
core I
protein I
gene I
while O
v B
- I
mht I
and O
v B
- I
myc I
are O
cell O
- O
drived O
sequences O
. O

These O
findings O
also O
demonstrate O
that O
unless O
excluded O
by O
other O
factors O
, O
the O
C B
proteins I
are O
likely O
to O
be O
located O
along O
the O
length O
of O
nascent O
transcripts O
. O

In O
contrast O
to O
the O
restricted O
tissue O
expression O
of O
gonadotropin B
and O
TSH B
receptors I
in O
gonads O
and O
thyroid O
, O
respectively O
, O
LGR4 B
is O
expressed O
in O
diverse O
tissues O
including O
ovary O
, O
testis O
, O
adrenal O
, O
placenta O
, O
thymus O
, O
spinal O
cord O
, O
and O
thyroid O
, O
whereas O
LGR5 B
is O
found O
in O
muscle O
, O
placenta O
, O
spinal O
cord O
, O
and O
brain O
. O

In O
contrast O
to O
the O
effect O
on O
DNA O
replication O
, O
the O
L13V O
substitution O
in O
large B
T I
antigen I
did O
not O
prevent O
complex O
formation O
with O
Hsc70 B
and O
the O
Rb B
protein I
. O

Indeed O
, O
DEX O
also O
enhanced O
the O
RA O
- O
dependent O
increase O
in O
RARbeta B
mRNA I
in O
a O
cycloheximide O
- O
sensitive O
manner O
. O

Avian B
EMILIN I
was O
extracted O
from O
19 O
- O
day O
- O
old O
embryonic O
chick O
aortas O
and O
associated O
blood O
vessels O
and O
purified O
by O
ion O
- O
exchange O
chromatography O
and O
gel O
filtration O
. O

CYP51P1 B
is O
96 O
. O
5 O
% O
identical O
to O
the O
human B
CYP51 I
coding O
sequence O
and O
is O
not O
interrupted O
with O
introns O
but O
has O
six O
in O
- O
frame O
stop O
codons O
resulting O
from O
point O
mutations O
. O

Three O
RasV12 B
mutants I
( O
S35 B
, O
G37 B
, O
and O
C40 B
) O
which O
differ O
by O
their O
ability O
to O
bind O
to O
Ras B
effectors I
( O
Raf B
, O
Ral B
- I
GEFs I
, O
and O
the O
p110 B
subunit I
of I
PI I
3 I
- I
kinase I
, O
respectively O
) O
were O
able O
to O
induce O
sustained O
NR O
cell O
proliferation O
, O
although O
none O
of O
these O
mutants O
was O
reported O
to O
transform O
NIH O
3T3 O
cells O
. O

Three O
RasV12 B
mutants I
( O
S35 B
, O
G37 B
, O
and O
C40 B
) O
which O
differ O
by O
their O
ability O
to O
bind O
to O
Ras B
effectors I
( O
Raf B
, O
Ral B
- I
GEFs I
, O
and O
the O
p110 B
subunit I
of I
PI I
3 I
- I
kinase I
, O
respectively O
) O
were O
able O
to O
induce O
sustained O
NR O
cell O
proliferation O
, O
although O
none O
of O
these O
mutants O
was O
reported O
to O
transform O
NIH O
3T3 O
cells O
. O

A O
significant O
difference O
in O
the O
distribution O
of O
antibodies O
to O
thyroglobulin B
and O
thyroid B
peroxidase I
was O
found O
in O
subgroup O
2 O
. O

These O
results O
induce O
that O
the O
putative O
TATA O
box O
and O
initiator O
are O
not O
involved O
in O
the O
promoter O
activity O
, O
and O
that O
the O
vitronectin B
promoter I
lacks O
the O
TATA O
box O
, O
initiator O
and O
GC O
box O
. O

Using O
the O
interaction O
- O
trap O
assay O
to O
identify O
candidate O
proteins O
that O
bind O
the O
cytoplasmic O
region O
of O
the O
LAR B
transmembrane I
protein I
tyrosine I
phosphatase I
( O
PT B
- I
Pase I
) O
, O
we O
isolated O
a O
cDNA O
encoding O
a O
2861 O
- O
amino O
acid O
protein O
termed O
Trio B
that O
contains O
three O
enzyme O
domains O
: O
two O
functional O
GEF B
domains I
and O
a O
protein B
serine I
/ I
threonine I
kinase I
( O
PSK B
) O
domain O
. O

We O
have O
isolated O
two O
H19 B
cDNAs I
( O
AP B
and O
ES B
) O
that O
contain O
this O
ORF4 O
and O
correspond O
to O
incomplete O
copies O
of O
the O
unique O
2 B
. I
3 I
kb I
H19 I
RNA I
. O

Earlier O
reports O
have O
localized O
mutations O
which O
affect O
the O
processing O
and O
transport O
of O
herpes O
simplex O
virus O
1 O
glycoproteins O
to O
a O
region O
located O
between O
the O
genes O
specifying O
glycoprotein B
B I
and O
the O
major O
viral O
DNA O
- O
binding O
protein O
( O
beta B
8 I
) O
. O

Earlier O
reports O
have O
localized O
mutations O
which O
affect O
the O
processing O
and O
transport O
of O
herpes O
simplex O
virus O
1 O
glycoproteins O
to O
a O
region O
located O
between O
the O
genes O
specifying O
glycoprotein B
B I
and O
the O
major O
viral O
DNA O
- O
binding O
protein O
( O
beta B
8 I
) O
. O

p56 B
( O
lck B
) O
utilizes O
Shc B
and O
Grb2 B
adaptors I
to O
mediate O
activation O
of O
p21 B
( O
ras B
) O
in O
the O
thymoblast O
lines O
by O
promoting O
tyrosine O
phosphorylation O
of O
the O
Shc B
protein I
and O
constitutive O
interaction O
between O
Shc B
and O
Grb2 B
. O

p56 B
( O
lck B
) O
utilizes O
Shc B
and O
Grb2 B
adaptors I
to O
mediate O
activation O
of O
p21 B
( O
ras B
) O
in O
the O
thymoblast O
lines O
by O
promoting O
tyrosine O
phosphorylation O
of O
the O
Shc B
protein I
and O
constitutive O
interaction O
between O
Shc B
and O
Grb2 B
. O

Based O
on O
the O
results O
of O
this O
analysis O
, O
we O
also O
predict O
that O
the O
budding B
yeast I
arsenate I
resistance I
protein I
Acr2 B
and O
the O
ORF B
Ygr203w I
encode O
protein O
phosphatases O
with O
catalytic O
properties O
similar O
to O
that O
of O
the O
Cdc25 B
family I
. O

Based O
on O
the O
results O
of O
this O
analysis O
, O
we O
also O
predict O
that O
the O
budding B
yeast I
arsenate I
resistance I
protein I
Acr2 B
and O
the O
ORF B
Ygr203w I
encode O
protein O
phosphatases O
with O
catalytic O
properties O
similar O
to O
that O
of O
the O
Cdc25 B
family I
. O

The O
PHO5 B
gene I
is O
activated O
by O
the O
Pho4p B
transcription I
factor I
, O
which O
itself O
is O
negatively O
regulated O
through O
phosphorylation O
by O
the O
products O
of O
PHO80 B
and O
PHO85 B
. O

Analysis O
of O
the O
DNA O
sequence O
upstream O
of O
the O
narQ B
gene I
, O
which O
encodes O
the O
second O
nitrate O
- O
responsive O
sensor O
- O
transmitter O
protein O
in O
Escherichia O
coli O
, O
revealed O
an O
open O
reading O
frame O
( O
ORF O
) O
whose O
product O
shows O
a O
high O
degree O
of O
similarity O
to O
a O
number O
of O
iron B
- I
sulfur I
proteins I
as O
well O
as O
to O
the O
beta O
subunit O
of O
glutamate B
synthase I
( O
gltD B
) O
of O
E O
. O
coli O
. O

Analysis O
of O
the O
DNA O
sequence O
upstream O
of O
the O
narQ B
gene I
, O
which O
encodes O
the O
second O
nitrate O
- O
responsive O
sensor O
- O
transmitter O
protein O
in O
Escherichia O
coli O
, O
revealed O
an O
open O
reading O
frame O
( O
ORF O
) O
whose O
product O
shows O
a O
high O
degree O
of O
similarity O
to O
a O
number O
of O
iron B
- I
sulfur I
proteins I
as O
well O
as O
to O
the O
beta O
subunit O
of O
glutamate B
synthase I
( O
gltD B
) O
of O
E O
. O
coli O
. O

The O
5 O
' O
half O
of O
the O
EWS B
gene I
has O
recently O
been O
described O
to O
be O
fused O
to O
the O
3 O
' O
regions O
of O
genes O
encoding O
the O
DNA O
- O
binding O
domain O
of O
several O
transcriptional O
regulators O
, O
including O
ATF1 B
, O
FLI B
- I
1 I
, O
and O
ERG B
, O
in O
several O
human O
tumors O
. O

When O
translated O
in O
- O
frame O
with O
PKC B
zeta I
, O
a O
stop O
codon O
is O
located O
28 O
amino O
acids O
towards O
the O
N O
- O
terminus O
of O
the O
divergence O
point O
and O
the O
intervening O
sequence O
lacks O
an O
expected O
initiating O
methionine O
. O
psi B
PKC I
zeta I
is O
non O
- O
functional O
in O
terms O
of O
protein O
synthesis O
since O
Western O
blotting O
with O
an O
antibody O
directed O
against O
the O
C O
- O
terminus O
of O
PKC B
zeta I
failed O
to O
reveal O
a O
protein O
smaller O
than O
PKC B
zeta I
, O
and O
synthetic O
psi B
PKC I
zeta I
RNA I
failed O
to O
support O
protein O
synthesis O
in O
a O
translation O
system O
in O
vitro O
. O

When O
translated O
in O
- O
frame O
with O
PKC B
zeta I
, O
a O
stop O
codon O
is O
located O
28 O
amino O
acids O
towards O
the O
N O
- O
terminus O
of O
the O
divergence O
point O
and O
the O
intervening O
sequence O
lacks O
an O
expected O
initiating O
methionine O
. O
psi B
PKC I
zeta I
is O
non O
- O
functional O
in O
terms O
of O
protein O
synthesis O
since O
Western O
blotting O
with O
an O
antibody O
directed O
against O
the O
C O
- O
terminus O
of O
PKC B
zeta I
failed O
to O
reveal O
a O
protein O
smaller O
than O
PKC B
zeta I
, O
and O
synthetic O
psi B
PKC I
zeta I
RNA I
failed O
to O
support O
protein O
synthesis O
in O
a O
translation O
system O
in O
vitro O
. O

When O
translated O
in O
- O
frame O
with O
PKC B
zeta I
, O
a O
stop O
codon O
is O
located O
28 O
amino O
acids O
towards O
the O
N O
- O
terminus O
of O
the O
divergence O
point O
and O
the O
intervening O
sequence O
lacks O
an O
expected O
initiating O
methionine O
. O
psi B
PKC I
zeta I
is O
non O
- O
functional O
in O
terms O
of O
protein O
synthesis O
since O
Western O
blotting O
with O
an O
antibody O
directed O
against O
the O
C O
- O
terminus O
of O
PKC B
zeta I
failed O
to O
reveal O
a O
protein O
smaller O
than O
PKC B
zeta I
, O
and O
synthetic O
psi B
PKC I
zeta I
RNA I
failed O
to O
support O
protein O
synthesis O
in O
a O
translation O
system O
in O
vitro O
. O

A O
novel O
serine B
kinase I
activated O
by O
rac1 B
/ O
CDC42Hs B
- O
dependent O
autophosphorylation O
is O
related O
to O
PAK65 B
and O
STE20 B
. O

Overexpression O
of O
SNURF B
in O
cultured O
mammalian O
cells O
enhanced O
not O
only O
androgen O
, O
glucocorticoid O
, O
and O
progesterone B
receptor I
- O
dependent O
transactivation O
but O
also O
basal O
transcription O
from O
steroid O
- O
regulated O
promoters O
. O

The O
human O
protein O
binds O
most O
strongly O
to O
the O
SH3 B
domain I
from O
the O
abl B
proto I
- I
oncogene I
. O

Foamy O
viruses O
( O
FVs O
) O
express O
the O
Gag B
protein I
as O
a O
precursor O
with O
a O
molecular O
mass O
of O
74 O
kDa O
( O
pr74 B
) O
from O
which O
a O
70 O
- O
kDa O
protein O
( O
p70 B
) O
is O
cleaved O
by O
the O
viral O
protease O
. O

The O
occurrence O
of O
the O
different O
types O
of O
TCRB B
rearrangement O
patterns O
has O
implications O
for O
PCR O
- O
based O
clonality O
assessment O
and O
for O
PCR O
- O
based O
detection O
of O
minimal O
residual O
disease O
via O
TCRB B
gene I
analysis O
. O

No O
patient O
demonstrated O
a O
decrease O
in O
bone O
marrow O
fibrosis O
as O
determined O
by O
serial O
procollagen B
( O
PC B
III I
) O
serum O
level O
analysis O
. O

Ectopic O
expression O
of O
cyclin B
D1 I
in O
progestin O
- O
inhibited O
cells O
led O
to O
the O
reappearance O
of O
the O
120 O
- O
kDa O
active O
form O
of O
cyclin B
E I
- O
Cdk2 B
preceding O
the O
resumption O
of O
cell O
cycle O
progression O
. O

Ectopic O
expression O
of O
cyclin B
D1 I
in O
progestin O
- O
inhibited O
cells O
led O
to O
the O
reappearance O
of O
the O
120 O
- O
kDa O
active O
form O
of O
cyclin B
E I
- O
Cdk2 B
preceding O
the O
resumption O
of O
cell O
cycle O
progression O
. O

Unlike O
these O
contaminant O
- O
responsive O
T O
cells O
, O
those O
that O
are O
truly O
specific O
for O
natural O
AChR B
epitopes I
appear O
less O
heterogeneous O
and O
therefore O
more O
suitable O
targets O
for O
selective O
immunotherapy O
. O

Spodoptera O
frugiperda O
( O
Sf9 O
) O
cells O
have O
proved O
a O
suitable O
cell O
system O
in O
which O
to O
study O
this O
association O
and O
to O
produce O
recombinant B
CR3 I
, O
and O
we O
show O
here O
that O
another O
lepidopteran O
cell O
line O
, O
Trichoplusia O
niTN O
- O
5B1 O
- O
4 O
( O
High O
- O
Five O
) O
cells O
, O
allows O
the O
recovery O
of O
large O
amounts O
of O
functional B
recombinant I
CR3 I
. O

In O
one O
trial O
, O
116 O
subjects O
with O
transfusion O
- O
related O
chronic O
hepatitis O
C O
were O
treated O
with O
lymphoblastoid B
interferon I
( O
5 O
MU O
/ O
m2 O
three O
times O
a O
week O
for O
2 O
mo O
, O
then O
3 O
MU O
/ O
m2 O
three O
times O
a O
week O
for O
4 O
or O
10 O
mo O
) O
. O

Therefore O
, O
we O
have O
reevaluated O
the O
age O
- O
related O
changes O
in O
serum B
leptin I
levels O
and O
their O
relationship O
with O
adiposity O
and O
androgen O
levels O
in O
a O
large O
group O
of O
community O
dwelling O
men O
. O

Expression O
of O
the O
E2 B
protein I
resulted O
in O
rapid O
repression O
of O
HPV B
E6 I
and O
E7 B
expression O
, O
followed O
approximately O
12 O
h O
later O
by O
profound O
inhibition O
of O
cellular O
DNA O
synthesis O
. O

Expression O
of O
the O
E2 B
protein I
resulted O
in O
rapid O
repression O
of O
HPV B
E6 I
and O
E7 B
expression O
, O
followed O
approximately O
12 O
h O
later O
by O
profound O
inhibition O
of O
cellular O
DNA O
synthesis O
. O

Plasma B
renin I
activity O
in O
end O
- O
stage O
kidney O
disease O
. O

Immunoblotting O
with O
antiphosphotyrosine O
antibody O
showed O
that O
many O
yeast O
proteins O
, O
including O
the O
p34CDC28 B
kinase I
, O
became O
phosphorylated O
at O
tyrosine O
in O
cells O
expressing O
v B
- I
src I
. O

In O
cells O
co O
- O
expressing O
high O
levels O
of O
the O
p38 B
( O
MAPK B
) O
kinase O
( O
MKK3 B
) O
together O
with O
the O
p38 B
( O
MAPK B
) O
, O
a O
significant O
inhibition O
of O
mitogen O
- O
induced O
cyclin B
D1 I
expression O
was O
observed O
. O

The O
RHO1 B
gene I
encodes O
a O
homolog O
of O
the O
mammalian O
RhoA B
small I
GTP I
- I
binding I
protein I
in O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

As O
regards O
the O
short O
stature O
, O
they O
have O
proved O
that O
the O
syndrome O
is O
related O
to O
low O
levels O
of O
somatomedin B
C I
( O
SmC B
) O
. O

HBO O
had O
marked O
effects O
on O
these O
enzymes O
: O
lung B
SOD I
increased O
( O
guinea O
pigs O
47 O
% O
, O
rats O
88 O
% O
) O
and O
CAT B
and O
GSHPx B
activities O
decreased O
( O
33 O
% O
) O
in O
brain O
and O
lung O
. O

Although O
indomethacin O
is O
useful O
for O
examining O
the O
role O
of O
cyclooxygenase B
products I
in O
asthmatic O
responses O
, O
it O
should O
not O
be O
considered O
in O
the O
treatment O
of O
asthma O
. O

Both O
v B
- I
Myb I
and O
c B
- I
Myb I
bind O
specifically O
to O
delta B
E3 I
. O

Further O
, O
we O
find O
that O
the O
BMI1 B
protein I
can O
also O
interact O
with O
itself O
. O

Dominant O
- O
negative O
upf1 B
mutations O
were O
isolated O
following O
in O
vitro O
mutagenesis O
of O
a O
plasmid O
containing O
the O
UPF1 B
gene I
. O

We O
previously O
identified O
a O
highly O
conserved O
L O
- O
X O
- O
X O
- O
L O
- O
F O
sequence O
near O
the O
C O
terminus O
of O
the O
p6 B
domain I
of O
the O
Gag B
precursor I
as O
the O
major O
virion O
association O
motif O
for O
HIV B
- I
1 I
Vpr I
. O

We O
previously O
identified O
a O
highly O
conserved O
L O
- O
X O
- O
X O
- O
L O
- O
F O
sequence O
near O
the O
C O
terminus O
of O
the O
p6 B
domain I
of O
the O
Gag B
precursor I
as O
the O
major O
virion O
association O
motif O
for O
HIV B
- I
1 I
Vpr I
. O

This O
50 O
- O
kDa O
protein O
contains O
two O
SH2 B
domains I
and O
an O
inter B
- I
SH2 I
domain I
of O
p85alpha B
, O
but O
the O
SH3 B
and O
bcr B
homology I
domains I
of O
p85alpha B
were O
replaced O
by O
a O
unique O
6 O
- O
amino O
acid O
sequence O
. O

We O
have O
determined O
the O
complete O
cDNA O
sequence O
of O
rat B
plectin I
from O
a O
number O
of O
well O
- O
characterized O
overlapping O
lambda O
gt11 O
clones O
. O

These O
observations O
demonstrate O
that O
KSR B
is O
capable O
of O
uncoupling O
the O
MAP B
kinase I
activation O
from O
its O
target O
phosphorylation O
, O
and O
thus O
provide O
a O
novel O
mechanism O
for O
modulating O
the O
Ras B
- O
MAP B
kinase I
signaling O
pathway O
. O

These O
observations O
demonstrate O
that O
KSR B
is O
capable O
of O
uncoupling O
the O
MAP B
kinase I
activation O
from O
its O
target O
phosphorylation O
, O
and O
thus O
provide O
a O
novel O
mechanism O
for O
modulating O
the O
Ras B
- O
MAP B
kinase I
signaling O
pathway O
. O

A O
higher O
percentage O
of O
children O
with O
cerebral O
malaria O
( O
40 O
per O
cent O
) O
than O
with O
non O
- O
cerebral O
malaria O
( O
29 O
per O
cent O
) O
or O
controls O
( O
20 O
per O
cent O
) O
also O
had O
either O
serum B
ferritin I
< O
100 O
micrograms O
/ O
l O
and O
inflammation O
or O
sTfR B
> O
7 O
. O
3 O
mg O
/ O
l O
or O
both O
. O

During O
the O
burst O
period O
( O
approximately O
5 O
- O
10 O
min O
) O
, O
local O
blood O
H2O2 O
concentrations O
and O
xanthine B
oxidase I
activities O
were O
highly O
correlated O
( O
r O
= O
0 O
. O
999 O
) O
. O

UV O
cross O
- O
linking O
and O
Southwestern O
analysis O
suggested O
that O
KTP1 B
is O
a O
DNA O
- O
binding O
protein O
clearly O
distinct O
from O
AP2 B
, O
and O
this O
protein O
may O
be O
responsible O
for O
the O
basal O
keratinocyte O
- O
specific O
expression O
of O
the O
BPAG1 B
gene I
. O

It O
competes O
with O
the O
calcium O
ion O
which O
brings O
about O
inhibition O
of O
myosine B
kinase I
, O
and O
therefore O
a O
drop O
in O
phosphorylated O
myosine O
. O

Injection O
of O
horseradish B
peroxidase I
( O
HRP B
) O
into O
the O
cerebellar O
flocculus O
of O
the O
rat O
was O
employed O
to O
identify O
neurons O
in O
the O
abducens O
nucleus O
that O
project O
to O
the O
flocculus O
. O

To O
assay O
for O
sequences O
that O
could O
potentially O
regulate O
Xenopus B
proenkephalin I
expression O
, O
we O
transfected O
constructs O
that O
contained O
upstream O
genomic O
sequences O
linked O
to O
the O
CAT B
reporter I
gene I
into O
various O
eukaryotic O
cell O
lines O
. O

UVB O
- O
induced O
association O
of O
tumor B
necrosis I
factor I
( I
TNF I
) I
receptor I
1 I
/ O
TNF B
receptor I
- I
associated I
factor I
- I
2 I
mediates O
activation O
of O
Rel B
proteins I
. O

Experimental O
studies O
and O
clinical O
application O
of O
plasma B
ACTH I
radioimmunoassay O
kit O
without O
extraction O
process O

Our O
data O
define O
Ile O
( O
16 O
) O
, O
Val O
( O
18 O
) O
, O
Val O
( O
31 O
) O
, O
and O
Ile O
( O
33 O
) O
as O
crucial O
for O
protein B
S I
binding O
, O
with O
secondary O
effects O
from O
Leu O
( O
38 O
) O
and O
Val O
( O
39 O
) O
. O

Nitroglycerin O
( O
glyceryl O
trinitrate O
) O
as O
a O
monoamine B
oxidase I
inhibitor O
. O

Gastrin B
stimulates O
transcription O
of O
the O
human B
histidine I
decarboxylase I
( O
HDC B
) O
gene O
through O
binding O
to O
the O
G B
- I
protein I
- O
coupled O
cholecystokinin B
- I
B I
/ O
gastrin B
receptor I
. O

Reduced O
concentrations O
of O
antithrombin B
III I
, O
plasminogen B
, O
( O
free O
) O
protein B
S I
, O
and O
protein B
C I
were O
found O
in O
some O
patients O
but O
were O
not O
associated O
with O
either O
thrombosis O
or O
lupus O
anticoagulant O
. O

Reduced O
concentrations O
of O
antithrombin B
III I
, O
plasminogen B
, O
( O
free O
) O
protein B
S I
, O
and O
protein B
C I
were O
found O
in O
some O
patients O
but O
were O
not O
associated O
with O
either O
thrombosis O
or O
lupus O
anticoagulant O
. O

Reduced O
concentrations O
of O
antithrombin B
III I
, O
plasminogen B
, O
( O
free O
) O
protein B
S I
, O
and O
protein B
C I
were O
found O
in O
some O
patients O
but O
were O
not O
associated O
with O
either O
thrombosis O
or O
lupus O
anticoagulant O
. O

These O
transcripts O
directed O
the O
synthesis O
of O
three O
proteins O
: O
the O
virus B
trans I
- I
activator I
protein I
( O
EIAV B
Tat I
) O
encoded O
by O
ORF O
S1 O
, O
a O
protein O
of O
unknown O
function O
encoded O
by O
ORF O
S2 O
, O
and O
the O
virus O
envelope B
glycoprotein I
. O

These O
transcripts O
directed O
the O
synthesis O
of O
three O
proteins O
: O
the O
virus B
trans I
- I
activator I
protein I
( O
EIAV B
Tat I
) O
encoded O
by O
ORF O
S1 O
, O
a O
protein O
of O
unknown O
function O
encoded O
by O
ORF O
S2 O
, O
and O
the O
virus O
envelope B
glycoprotein I
. O

The O
unusual O
properties O
of O
TRAC B
activity O
and O
its O
relationship O
, O
if O
any O
, O
with O
the O
enigmatic O
Ku B
protein I
, O
are O
discussed O
. O

We O
have O
isolated O
and O
determined O
the O
complete O
nucleotide O
sequence O
of O
another O
operon O
, O
cpeCD B
, O
that O
encodes O
the O
linker O
proteins O
associated O
with O
phycoerythrin B
hexamers I
in O
the O
phycobilisome B
. O

When O
expressed O
in O
thymidine B
kinase I
- O
deficient O
L O
cells O
or O
3T3 O
cells O
, O
C B
/ I
EBPalpha I
is O
detected O
in O
a O
protein O
complex O
which O
binds O
to O
the O
E2F B
binding I
sites I
found O
in O
the O
promoters O
of O
the O
genes O
for O
E2F B
- I
1 I
and O
dihydrofolate B
reductase I
( O
DHFR B
) O
. O

When O
expressed O
in O
thymidine B
kinase I
- O
deficient O
L O
cells O
or O
3T3 O
cells O
, O
C B
/ I
EBPalpha I
is O
detected O
in O
a O
protein O
complex O
which O
binds O
to O
the O
E2F B
binding I
sites I
found O
in O
the O
promoters O
of O
the O
genes O
for O
E2F B
- I
1 I
and O
dihydrofolate B
reductase I
( O
DHFR B
) O
. O

Role O
of O
double B
- I
stranded I
RNA I
- I
dependent I
protein I
kinase I
in O
mediating O
hypersensitivity O
of O
Fanconi O
anemia O
complementation O
group O
C O
cells O
to O
interferon B
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
, O
and O
double O
- O
stranded O
RNA O
. O

Our O
results O
suggest O
a O
dose O
- O
dependent O
activity O
of O
lysine B
vasopressin I
on O
the O
EEG O
, O
which O
might O
be O
similar O
to O
that O
observed O
in O
animal O
and O
man O
after O
administration O
of O
nicotine O
. O

Guanylyl B
cyclase I
C I
, O
the O
apparent O
guanylin B
receptor I
, O
was O
found O
in O
abundant O
amounts O
in O
the O
intestine O
by O
Northern O
analysis O
, O
and O
by O
the O
polymerase O
chain O
reaction O
or O
cDNA O
cloning O
it O
was O
also O
found O
in O
adrenal O
gland O
, O
airway O
epithelial O
cells O
, O
brain O
, O
and O
olfactory O
and O
tracheal O
mucosa O
. O

Reaction O
of O
aromatic O
/ O
heterocyclic O
sulfonamides O
possessing O
free O
amino O
, O
imino O
or O
hydrazino O
moieties O
with O
7 O
- O
chloro O
- O
4 O
- O
chloromethylcoumarin O
afforded O
a O
series O
of O
N O
- O
[ O
( O
7 O
- O
chloro O
- O
4 O
- O
coumarinyl O
) O
- O
methyl O
] O
- O
derivatives O
which O
showed O
effective O
inhibition O
of O
three O
carbonic B
anhydrase I
( O
CA B
) O
isozymes O
. O

Uncertainty O
exists O
about O
the O
function O
of O
these O
potential O
isoforms O
of O
the O
Cbfa1 B
gene I
. O

Human B
CD38 I
, O
a O
leukocyte O
receptor O
and O
ectoenzyme O
, O
is O
a O
member O
of O
a O
novel O
eukaryotic O
gene O
family O
of O
nicotinamide B
adenine I
dinucleotide I
+ I
- I
converting I
enzymes I
: O
extensive O
structural O
homology O
with O
the O
genes O
for O
murine B
bone I
marrow I
stromal I
cell I
antigen I
1 I
and O
aplysian B
ADP I
- I
ribosyl I
cyclase I
. O

When O
O O
- O
2A O
/ O
c B
- I
myc I
cells O
underwent O
terminal O
differentiation O
APprog B
complexes I
were O
lost O
and O
conventional O
AP B
- I
1 I
DNA O
- O
binding O
activity O
became O
evident O
, O
particularly O
in O
astrocytes O
. O

From O
the O
deduced O
amino O
acid O
sequence O
, O
a O
molecular O
weight O
of O
38 O
, O
549 O
was O
calculated O
for O
the O
ADH B
subunit I
. O

The O
two O
SH3 B
domains I
are O
separated O
by O
a O
54 O
amino O
acid O
linker O
region O
, O
whose O
length O
is O
highly O
conserved O
in O
xenopus O
, O
chicken O
, O
and O
mamalian B
Crk I
II I
proteins I
. O

A O
40 O
- O
fold O
stimulation O
of O
chloramphenicol B
acetyltransferase I
activity O
mediated O
by O
four O
tandem O
repeats O
of O
the O
SNE B
could O
be O
induced O
within O
2 O
h O
( O
and O
up O
to O
250 O
- O
fold O
within O
6 O
h O
) O
after O
addition O
of O
TPA O
in O
DNA O
- O
transfected O
U O
- O
937 O
cells O
, O
indicating O
that O
the O
stimulation O
appeared O
likely O
to O
be O
a O
true O
protein B
kinase I
C I
- O
mediated O
signal O
transduction O
event O
rather O
than O
a O
differentiation O
response O
. O

A O
mouse O
brain O
cDNA O
library O
in O
lambdagt11 O
was O
screened O
for O
this O
association O
, O
and O
two O
positive O
clones O
encoding O
tyrosine B
phosphatase I
SH B
- I
PTP2 I
were O
isolated O
. O

To O
elucidate O
the O
molecular O
mechanism O
by O
which O
the O
Ras B
signaling O
pathway O
activates O
a O
cell O
- O
type O
- O
specific O
gene O
, O
we O
have O
used O
the O
pituitary B
- I
specific I
rat I
prolactin I
( O
rPRL B
) O
promoter O
as O
a O
target O
of O
oncogenic B
Ras I
and O
Raf B
in O
GH4 O
rat O
pituitary O
cells O
. O

HGF B
treatment O
increased O
cyclin B
A I
, O
cyclin B
G1 I
and O
nuclear O
transcriptional O
factor O
( O
NFkappaB B
) O
protein O
expression O
. O

HGF B
treatment O
increased O
cyclin B
A I
, O
cyclin B
G1 I
and O
nuclear O
transcriptional O
factor O
( O
NFkappaB B
) O
protein O
expression O
. O

The O
yjr041c B
delta I
haploid O
cells O
gave O
rise O
to O
microcolonies O
comprising O
about O
20 O
to O
50 O
cells O
. O

Two O
mutants O
, O
mapping O
at O
the O
HindIII B
site I
( O
between O
the O
consensus O
sequences O
) O
of O
the O
pSC101 B
tetA I
promoter I
, O
were O
studied O
: O
MA2 O
corresponds O
to O
a O
4 O
bp O
deletion O
between O
positions O
- O
12 O
and O
- O
15 O
; O
B30 O
bears O
a O
44 O
bp O
insertion O
C O
( O
TA O
) O
21 O
G O
at O
the O
HindIII B
site I
. O

Two O
mutants O
, O
mapping O
at O
the O
HindIII B
site I
( O
between O
the O
consensus O
sequences O
) O
of O
the O
pSC101 B
tetA I
promoter I
, O
were O
studied O
: O
MA2 O
corresponds O
to O
a O
4 O
bp O
deletion O
between O
positions O
- O
12 O
and O
- O
15 O
; O
B30 O
bears O
a O
44 O
bp O
insertion O
C O
( O
TA O
) O
21 O
G O
at O
the O
HindIII B
site I
. O

The O
Valpha B
and O
Vbeta B
domains I
have O
the O
canonical O
features O
of O
known O
teleost B
and I
mammalian I
TCR I
V I
domains I
, O
including O
conserved O
residues O
in O
the O
beginning O
of O
FR2 B
and O
at O
the O
end O
of O
FR3 B
. O

The O
H5 B
mutants I
were O
: O
DH5 B
( O
all O
amino O
acids O
in O
D O
configuration O
) O
and O
H5F B
( O
where O
all O
His O
are O
replaced O
by O
Phe O
at O
positions O
3 O
, O
7 O
, O
8 O
, O
15 O
, O
18 O
, O
19 O
, O
21 O
) O
. O

When O
targeted O
to O
the O
GAL1 B
promoter I
by O
fusing O
with O
the O
Gal4p B
DNA I
- I
binding I
domain I
, O
Sko1p B
acts O
as O
an O
Ssn6 B
/ O
Tup1p B
- O
dependent O
repressor O
regulated O
by O
osmotic O
stress O
. O

We O
used O
an O
immobilized O
template O
- O
based O
assay O
to O
examine O
transcription O
termination O
by O
VA1 B
, O
7SL B
, O
and O
Alu B
class I
III I
templates O
and O
the O
role O
of O
transcript O
release O
in O
the O
pol B
III I
terminator O
- O
dependent O
inhibition O
of O
processing O
of O
B1 B
- O
Alu B
transcripts O
. O

Although O
IL B
- I
6 I
can O
activate O
ERK B
- I
1 I
in O
HepG2 O
cells O
, O
STAT3 B
transactivation O
and O
Ser O
( O
727 O
) O
phosphorylation O
were O
not O
reduced O
by O
using O
the O
MAP B
kinase I
/ O
ERK B
kinase I
( O
MEK B
) O
inhibitor O
PD98059 O
or O
by O
overexpression O
of O
dominant O
- O
negative O
Raf B
. O

Although O
IL B
- I
6 I
can O
activate O
ERK B
- I
1 I
in O
HepG2 O
cells O
, O
STAT3 B
transactivation O
and O
Ser O
( O
727 O
) O
phosphorylation O
were O
not O
reduced O
by O
using O
the O
MAP B
kinase I
/ O
ERK B
kinase I
( O
MEK B
) O
inhibitor O
PD98059 O
or O
by O
overexpression O
of O
dominant O
- O
negative O
Raf B
. O

Nuclear O
runoff O
assays O
show O
that O
complementation O
by O
HPV16 B
E7 I
restores O
the O
ability O
of O
the O
E1A B
mutants I
to O
stimulate O
early B
gene I
expression O
at O
the O
level O
of O
transcription O
. O

Nuclear O
runoff O
assays O
show O
that O
complementation O
by O
HPV16 B
E7 I
restores O
the O
ability O
of O
the O
E1A B
mutants I
to O
stimulate O
early B
gene I
expression O
at O
the O
level O
of O
transcription O
. O

Nuclear O
runoff O
assays O
show O
that O
complementation O
by O
HPV16 B
E7 I
restores O
the O
ability O
of O
the O
E1A B
mutants I
to O
stimulate O
early B
gene I
expression O
at O
the O
level O
of O
transcription O
. O

We O
conclude O
that O
a O
0 O
. O
25 O
mg O
dose O
of O
triazolam O
does O
not O
effectively O
counteract O
a O
posture O
- O
induced O
sleep O
disturbance O
, O
but O
induces O
changes O
in O
the O
EEG O
spectra O
which O
are O
typical O
for O
benzodiazepine B
receptor I
agonists O
. O

In O
addition O
, O
we O
mapped O
a O
putative O
hnRNP B
A1 I
binding I
site I
in O
U5 B
RNA I
and O
demonstrated O
that O
p40CRS B
( O
hnRNP B
A1 I
) O
binding O
to O
that O
site O
correlates O
with O
CRS B
function O
. O

In O
addition O
, O
we O
mapped O
a O
putative O
hnRNP B
A1 I
binding I
site I
in O
U5 B
RNA I
and O
demonstrated O
that O
p40CRS B
( O
hnRNP B
A1 I
) O
binding O
to O
that O
site O
correlates O
with O
CRS B
function O
. O

Sequence O
comparisons O
reveal O
that O
the O
P B
. I
woesei I
GTP I
- I
binding I
protein I
is O
strikingly O
related O
in O
sequence O
to O
eubacterial B
FtsZ I
and O
is O
marginally O
more O
similar O
to O
eukaryotic B
tubulins I
than O
are O
bacterial B
FtsZ I
proteins I
. O

Sequence O
comparisons O
reveal O
that O
the O
P B
. I
woesei I
GTP I
- I
binding I
protein I
is O
strikingly O
related O
in O
sequence O
to O
eubacterial B
FtsZ I
and O
is O
marginally O
more O
similar O
to O
eukaryotic B
tubulins I
than O
are O
bacterial B
FtsZ I
proteins I
. O

However O
, O
this O
posttranslational O
modification O
of O
the O
gar2 B
protein I
does O
not O
appear O
to O
be O
essential O
for O
normal O
production O
of O
18S B
rRNA I
. O

However O
, O
this O
posttranslational O
modification O
of O
the O
gar2 B
protein I
does O
not O
appear O
to O
be O
essential O
for O
normal O
production O
of O
18S B
rRNA I
. O

When O
yeast O
cells O
reach O
a O
critical O
size O
in O
late O
G1 O
they O
simultaneously O
start O
budding O
, O
initiate O
DNA O
synthesis O
, O
and O
activate O
transcription O
of O
a O
set O
of O
genes O
that O
includes O
G1 B
cyclins I
CLN1 B
, O
CLN2 B
, O
and O
many O
DNA O
synthesis O
genes O
. O

4 O
) O
Mutation O
of O
the O
three O
extracellular O
cysteine O
residues O
of O
GFKAR B
beta I
indicated O
that O
the O
two O
conserved O
cysteine O
residues O
( O
C305 O
and O
C385 O
) O
, O
located O
between O
two O
transmembrane O
segments O
, O
form O
a O
solvent O
- O
accessible O
disulfide O
bond O
. O

In O
this O
work O
, O
we O
have O
used O
Xenopus O
oocyte O
maturation O
as O
a O
read O
- O
out O
for O
examining O
the O
ability O
of O
the O
neu B
tyrosine B
kinase I
( O
p185neu B
) O
to O
participate O
with O
the O
epidermal B
growth I
factor I
( I
EGF I
) I
receptor I
in O
a O
common O
signal O
transduction O
pathway O
. O

In O
contrast O
, O
MAPK B
activation O
stimulated O
by O
the O
Gq B
- O
coupled O
alpha O
1B O
AR O
or O
M1 B
muscarinic B
cholinergic I
receptor I
is O
unaffected O
by O
expression O
of O
beta B
ARKct I
or O
RasN17 B
expression O
or O
by O
PTK B
inhibitors O
, O
but O
is O
blocked O
by O
expression O
of O
N B
delta I
Raf I
or O
by O
PKC B
depletion O
. O

Transcriptional O
analysis O
indicates O
that O
human B
TBP I
functions O
poorly O
at O
promoters O
recognized O
by O
RNA B
polymerases I
I I
and I
III I
and O
at O
RNA B
Pol I
II I
promoters I
lacking O
a O
conventional O
TATA O
element O
. O

The O
steady O
- O
state O
levels O
of O
Cdk2 B
, O
Cdk4 B
and O
Cyclin B
A I
proteins I
were O
unaffected O
by O
HPR O
, O
while O
those O
of O
Cyclin B
D1 I
were O
significantly O
reduced O
in O
all O
three O
cell O
lines O
. O

Mapping O
the O
5 O
' O
and O
3 O
' O
termini O
of O
TED B
RNAs I
indicated O
that O
the O
LTRs O
have O
a O
retroviral O
U3 O
- O
R O
- O
U5 O
structural O
organization O
that O
is O
capable O
of O
directing O
the O
synthesis O
of O
transcripts O
that O
represent O
potential O
substrates O
for O
reverse O
transcription O
and O
intermediates O
in O
transposition O
. O

These O
proteins O
were O
detected O
by O
an O
antibody O
which O
recognizes O
the O
N O
- O
terminus O
of O
SRK3 B
and O
, O
in O
an O
F2 O
progeny O
segregating O
for O
the O
S3 B
haplotype I
, O
were O
only O
expressed O
in O
plants O
possessing O
the O
S3 B
haplotype I
. O

These O
proteins O
were O
detected O
by O
an O
antibody O
which O
recognizes O
the O
N O
- O
terminus O
of O
SRK3 B
and O
, O
in O
an O
F2 O
progeny O
segregating O
for O
the O
S3 B
haplotype I
, O
were O
only O
expressed O
in O
plants O
possessing O
the O
S3 B
haplotype I
. O

Three O
experiments O
using O
20 O
microM O
2 O
- O
( O
hydroxyamino O
) O
- O
1 O
- O
methyl O
- O
6 O
- O
phenylimidazo O
[ O
4 O
, O
5 O
- O
b O
] O
pyridine O
( O
N O
- O
OH O
- O
PhIP O
) O
were O
performed O
to O
induce O
mutations O
in O
the O
dihydrofolate B
reductase I
( O
DHFR B
) O
gene O
of O
a O
hemizygous O
Chinese O
hamster O
ovary O
( O
CHO O
) O
cell O
line O
( O
UA21 O
) O
. O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct B
- I
1 I
and O
probably O
Sp1 B
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
kappa I
B I
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 B
response I
element I
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
AT I
and O
AP B
- I
1 I
, O
that O
can O
be O
activated O

Our O
results O
separate O
these O
factors O
into O
four O
regulatory O
classes O
: O
( O
i O
) O
constitutive O
factors O
, O
such O
as O
Oct B
- I
1 I
and O
probably O
Sp1 B
, O
that O
are O
expressed O
in O
thymocytes O
at O
all O
stages O
; O
( O
ii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
kappa I
B I
and O
complexes O
binding O
to O
the O
region O
of O
a O
CD28 B
response I
element I
, O
that O
can O
be O
activated O
in O
all O
thymocytes O
, O
including O
those O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
that O
can O
undergo O
selection O
; O
( O
iii O
) O
inducible O
factors O
, O
such O
as O
NF B
- I
AT I
and O
AP B
- I
1 I
, O
that O
can O
be O
activated O

in O
mature O
( O
CD4 B
+ I
CD8 B
- I
TcRhigh B
) O
and O
immature O
( O
CD4 B
- I
CD8 B
- I
TcR B
- I
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB B
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

in O
mature O
( O
CD4 B
+ I
CD8 B
- I
TcRhigh B
) O
and O
immature O
( O
CD4 B
- I
CD8 B
- I
TcR B
- I
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB B
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

in O
mature O
( O
CD4 B
+ I
CD8 B
- I
TcRhigh B
) O
and O
immature O
( O
CD4 B
- I
CD8 B
- I
TcR B
- I
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB B
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

in O
mature O
( O
CD4 B
+ I
CD8 B
- I
TcRhigh B
) O
and O
immature O
( O
CD4 B
- I
CD8 B
- I
TcR B
- I
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB B
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

in O
mature O
( O
CD4 B
+ I
CD8 B
- I
TcRhigh B
) O
and O
immature O
( O
CD4 B
- I
CD8 B
- I
TcR B
- I
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB B
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

in O
mature O
( O
CD4 B
+ I
CD8 B
- I
TcRhigh B
) O
and O
immature O
( O
CD4 B
- I
CD8 B
- I
TcR B
- I
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB B
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

in O
mature O
( O
CD4 B
+ I
CD8 B
- I
TcRhigh B
) O
and O
immature O
( O
CD4 B
- I
CD8 B
- I
TcR B
- I
) O
thymocytes O
alike O
but O
not O
in O
the O
transitional O
stages O
when O
the O
cells O
( O
CD4 B
+ I
CD8 B
+ I
TcRlow B
) O
are O
subject O
to O
selection O
; O
and O
( O
iv O
) O
a O
factor O
containing O
CREB B
, O
which O
can O
be O
activated O
in O
thymocytes O
of O
all O
developmental O
stages O
by O
culture O
but O
does O
not O
require O
specific O
induction O
. O

Of O
these O
four O
PP2C B
genes I
, O
the O
expression O
of O
the O
PP2Cbeta B
gene I
has O
been O
reported O
to O
be O
tissue O
- O
specific O
and O
development O
- O
dependent O
. O

Of O
these O
four O
PP2C B
genes I
, O
the O
expression O
of O
the O
PP2Cbeta B
gene I
has O
been O
reported O
to O
be O
tissue O
- O
specific O
and O
development O
- O
dependent O
. O

Moreover O
, O
antibody O
binding O
to O
the O
same O
two O
determinants O
was O
also O
inhibited O
when O
ZAP B
- I
70 I
or O
the O
SH2 B
domains I
bound O
to O
the O
zeta O
chain O
or O
to O
a O
2pY B
- I
ITAM I
. O

The O
immunoreactive O
antithrombin B
III I
increased O
significantly O
while O
the O
increase O
in O
antithrombin B
III I
activity O
was O
insignificant O
in O
20 O
male O
Caucasian O
Danes O
upon O
3 O
weeks O
supplementation O
of O
the O
diet O
with O
10 O
ml O
daily O
of O
a O
cod O
liver O
oil O
concentrate O
. O

The O
immunoreactive O
antithrombin B
III I
increased O
significantly O
while O
the O
increase O
in O
antithrombin B
III I
activity O
was O
insignificant O
in O
20 O
male O
Caucasian O
Danes O
upon O
3 O
weeks O
supplementation O
of O
the O
diet O
with O
10 O
ml O
daily O
of O
a O
cod O
liver O
oil O
concentrate O
. O

The O
transcriptional B
transactivator I
( O
Tas B
) O
of O
simian O
foamy O
virus O
type O
1 O
strongly O
augments O
gene O
expression O
directed O
by O
both O
the O
promoter O
in O
the O
viral O
long O
terminal O
repeat O
and O
the O
newly O
discovered O
internal O
promoter O
located O
within O
the O
env B
gene I
. O

The O
transcriptional B
transactivator I
( O
Tas B
) O
of O
simian O
foamy O
virus O
type O
1 O
strongly O
augments O
gene O
expression O
directed O
by O
both O
the O
promoter O
in O
the O
viral O
long O
terminal O
repeat O
and O
the O
newly O
discovered O
internal O
promoter O
located O
within O
the O
env B
gene I
. O

Deletion O
of O
this O
consensus O
element O
from O
the O
spo6 B
promoter I
abolished O
the O
transcription O
of O
spo6 B
+ I
and O
resulted O
in O
a O
sporulation O
deficiency O
. O

Deletion O
of O
this O
consensus O
element O
from O
the O
spo6 B
promoter I
abolished O
the O
transcription O
of O
spo6 B
+ I
and O
resulted O
in O
a O
sporulation O
deficiency O
. O

We O
were O
able O
to O
demonstrate O
a O
significant O
statistical O
interaction O
effect O
between O
gender O
and O
globulin B
protein I
concentration O
on O
Vu O
( O
p O
= O
0 O
. O
022 O
) O
. O

The O
RPC31 B
gene I
encoding O
the O
C31 B
subunit I
of I
Saccharomyces I
cerevisiae I
RNA I
polymerase I
C I
( I
III I
) I
has O
been O
isolated O
, O
starting O
from O
a O
C O
- O
terminal O
fragment O
cloned O
on O
a O
lambda O
gt11 O
library O
. O

Further O
studies O
aim O
at O
characterizing O
the O
trans O
- O
acting O
factors O
that O
mediate O
the O
spatial O
and O
temporal O
expression O
of O
Hox B
genes I
in O
the O
developing O
embryo O
. O

Serum B
C3 I
was O
measured O
in O
1 O
, O
282 O
school O
children O
with O
abnormal O
urinary O
findings O
between O
1980 O
and O
1997 O
. O

Computer O
analysis O
revealed O
that O
the O
human B
protein I
P1 I
sequence I
corresponding O
to O
amino O
acid O
residues O
within O
the O
N O
- O
terminal O
RNA O
binding O
domain O
displays O
high O
homology O
( O
greater O
than O
54 O
% O
identity O
; O
61 O
to O
94 O
% O
similarity O
) O
with O
two O
animal O
virus O
proteins O
which O
possess O
RNA O
binding O
activity O
( O
vaccinia B
virus I
E3L I
; O
rotavirus B
VP2 I
) O
and O
two O
proteins O
of O
unknown O
function O
( O
murine B
TIK I
; O
rotavirus B
NS34 I
) O
, O
but O
which O
are O
likely O
RNA O
binding O
proteins O
. O

Computer O
analysis O
revealed O
that O
the O
human B
protein I
P1 I
sequence I
corresponding O
to O
amino O
acid O
residues O
within O
the O
N O
- O
terminal O
RNA O
binding O
domain O
displays O
high O
homology O
( O
greater O
than O
54 O
% O
identity O
; O
61 O
to O
94 O
% O
similarity O
) O
with O
two O
animal O
virus O
proteins O
which O
possess O
RNA O
binding O
activity O
( O
vaccinia B
virus I
E3L I
; O
rotavirus B
VP2 I
) O
and O
two O
proteins O
of O
unknown O
function O
( O
murine B
TIK I
; O
rotavirus B
NS34 I
) O
, O
but O
which O
are O
likely O
RNA O
binding O
proteins O
. O

Computer O
analysis O
revealed O
that O
the O
human B
protein I
P1 I
sequence I
corresponding O
to O
amino O
acid O
residues O
within O
the O
N O
- O
terminal O
RNA O
binding O
domain O
displays O
high O
homology O
( O
greater O
than O
54 O
% O
identity O
; O
61 O
to O
94 O
% O
similarity O
) O
with O
two O
animal O
virus O
proteins O
which O
possess O
RNA O
binding O
activity O
( O
vaccinia B
virus I
E3L I
; O
rotavirus B
VP2 I
) O
and O
two O
proteins O
of O
unknown O
function O
( O
murine B
TIK I
; O
rotavirus B
NS34 I
) O
, O
but O
which O
are O
likely O
RNA O
binding O
proteins O
. O

Finally O
, O
transfection O
of O
Grb10 B
genes I
with O
specific O
mutations O
in O
their O
SH2 B
domains I
induces O
apoptosis O
in O
HTC O
- O
IR O
and O
COS O
- O
7 O
cells O
. O

Finally O
, O
transfection O
of O
Grb10 B
genes I
with O
specific O
mutations O
in O
their O
SH2 B
domains I
induces O
apoptosis O
in O
HTC O
- O
IR O
and O
COS O
- O
7 O
cells O
. O

We O
have O
demonstrated O
that O
a O
putative O
HOX B
cofactor I
, O
PBX1A B
, O
participates O
in O
cooperative O
DNA O
binding O
with O
HOXA B
- I
1 I
and O
the O
Deformed B
group O
protein O
HOXD B
- I
4 I
. O

The O
CHL B
1 I
( O
CTF B
1 I
) O
gene O
product O
of O
Saccharomyces O
cerevisiae O
is O
important O
for O
chromosome O
transmission O
and O
normal O
cell O
cycle O
progression O
in O
G2 O
/ O
M O
. O

The O
CHL B
1 I
( O
CTF B
1 I
) O
gene O
product O
of O
Saccharomyces O
cerevisiae O
is O
important O
for O
chromosome O
transmission O
and O
normal O
cell O
cycle O
progression O
in O
G2 O
/ O
M O
. O

Sequence O
analysis O
revealed O
that O
Hv B
- I
p68 I
belongs O
to O
the O
large O
family O
of O
FAD B
- I
dependent I
glucose I
methanol I
choline I
oxidoreductases I
and O
that O
it O
shares O
significant O
sequence O
identity O
( O
> O
67 O
% O
) O
with O
the O
alcohol B
oxidases I
of O
the O
methylotrophic O
yeasts O
. O

In O
the O
HIV B
LTR I
, O
this O
region O
has O
been O
demonstrated O
to O
have O
both O
positive O
and O
negative O
regulatory O
effects O
on O
HIV O
gene O
expression O
. O

Small B
t I
also O
inhibited O
the O
dephosphorylation O
of O
cAMP B
- I
dependent I
protein I
kinase I
( O
PKA B
) O
- O
phosphorylated O
CREB B
in O
rat O
liver O
nuclear O
extracts O
. O

Despite O
their O
high O
degree O
of O
sequence O
similarity O
, O
all O
five O
RFC B
genes I
are O
essential O
for O
cell O
proliferation O
in O
S O
. O
cerevisiae O
. O

Moreover O
, O
we O
show O
that O
ectopic O
expression O
of O
the O
E2A B
protein I
E12 B
in O
this O
macrophage O
line O
results O
in O
the O
induction O
of O
many O
B O
lineage O
genes O
, O
including O
EBF B
, O
IL7Ralpha B
, O
lambda5 B
, O
and O
Rag B
- I
1 I
, O
and O
the O
ability O
to O
induce O
kappa B
light I
chain I
in O
response O
to O
mitogen O
. O

PRP20 B
is O
related O
, O
both O
in O
structure O
and O
function O
, O
to O
the O
RCC1 B
gene I
of O
mammals O
and O
the O
PIM1 B
gene I
of O
Schizosaccharomyces O
pombe O
, O
both O
of O
which O
appear O
to O
regulate O
entry O
into O
mitosis O
and O
chromosome O
condensation O
. O

PRP20 B
is O
related O
, O
both O
in O
structure O
and O
function O
, O
to O
the O
RCC1 B
gene I
of O
mammals O
and O
the O
PIM1 B
gene I
of O
Schizosaccharomyces O
pombe O
, O
both O
of O
which O
appear O
to O
regulate O
entry O
into O
mitosis O
and O
chromosome O
condensation O
. O

A O
selective O
transcriptional O
induction O
system O
for O
mammalian O
cells O
based O
on O
Gal4 B
- O
estrogen B
receptor I
fusion O
proteins O
. O

Through O
interactions O
with O
the O
pre O
- O
mRNA O
and O
the O
CTD O
domain O
of O
the O
Polymerase B
II I
, O
SR B
proteins I
have O
been O
shown O
to O
regulate O
alternative O
splicing O
. O

Through O
interactions O
with O
the O
pre O
- O
mRNA O
and O
the O
CTD O
domain O
of O
the O
Polymerase B
II I
, O
SR B
proteins I
have O
been O
shown O
to O
regulate O
alternative O
splicing O
. O

Rabbit B
KCC1 I
( O
rbKCC1 B
) O
and O
rat B
KCC1 I
( O
rtKCC1 B
) O
were O
cloned O
by O
screening O
rabbit O
kidney O
and O
rat O
brain O
cDNA O
libraries O
using O
homologous O
cDNA O
probes O
. O

Rabbit B
KCC1 I
( O
rbKCC1 B
) O
and O
rat B
KCC1 I
( O
rtKCC1 B
) O
were O
cloned O
by O
screening O
rabbit O
kidney O
and O
rat O
brain O
cDNA O
libraries O
using O
homologous O
cDNA O
probes O
. O

A O
protein O
which O
promotes O
DNA O
strand O
transfer O
between O
linear O
double O
- O
stranded O
M13mp19 O
DNA O
and O
single O
- O
stranded O
viral O
M13mp19 O
DNA O
has O
been O
isolated O
from O
recA B
- I
E O
. O
coli O
. O

IgE B
antibody I
to O
twelve O
common O
food O
and O
inhalant O
allergens O
was O
measured O
by O
enzyme O
- O
linked O
immunosorbent O
assay O
( O
ELISA O
) O
in O
the O
sera O
of O
thirteen O
atopic O
patients O
with O
one O
or O
more O
allergic O
disorders O
( O
asthma O
occurring O
in O
eleven O
; O
rhinitis O
in O
ten O
; O
eczema O
in O
six O
; O
urticaria O
in O
four O
; O
mouth O
and O
gastro O
- O
intestinal O
symptoms O
in O
six O
) O
, O
of O
twelve O
non O
- O
atopic O
patients O
with O
various O
clinical O
symptoms O
( O
asthma O
in O
four O
; O
rhinitis O
in O
four O
; O
eczema O
in O
one O
; O
urticaria O
in O

Internalization O
of O
prolactin B
receptor I
and O
prolactin B
in O
transfected O
cells O
does O
not O
involve O
nuclear O
translocation O
. O

Using O
mammalian O
expression O
vectors O
( O
pRSV O
- O
neo O
and O
pSV2 O
- O
neo O
) O
, O
antisense O
constructs O
for O
perforin B
and O
granzyme B
B I
were O
independently O
electroporated O
into O
YT O
- O
INDY O
, O
a O
human O
non O
- O
MHC B
- O
restricted O
, O
IL B
- I
2 I
- O
independent O
, O
cytotoxic O
lymphocyte O
. O

The O
biological O
activity O
of O
these O
mutants O
was O
tested O
by O
determining O
their O
capacity O
to O
( O
i O
) O
reconstitute O
RNA B
polymerase I
activity O
in O
vivo O
by O
cotransfection O
with O
proteins O
NP B
, O
PB1 B
, O
and O
PA B
and O
a O
virion O
- O
like O
RNA O
encoding O
the O
cat B
gene O
into O
vaccinia O
virus O
T7 O
- O
infected O
COS O
- O
1 O
cells O
and O
( O
ii O
) O
complete O
with O
the O
wild B
- I
type I
PB2 I
activity O
. O

To O
investigate O
the O
role O
of O
this O
domain O
in O
the O
incorporation O
of O
the O
SIV B
Env I
into O
virions O
, O
we O
generated O
a O
series O
of O
SIV B
Env I
mutants I
carrying O
small O
in O
- O
frame O
deletions O
within O
the O
cytoplasmic O
domain O
. O

Sorting O
information O
to O
the O
chloroplastic O
inner O
envelope O
is O
contained O
in O
an O
NH2 O
- O
proximal O
part O
of O
mature B
IEP110 I
( O
110N B
) O
. O

Iomazenil O
- O
SPECT O
revealed O
a O
highly O
significant O
increase O
in O
the O
benzodiazepine B
receptor I
uptake O
in O
all O
studied O
cortical O
regions O
except O
temporal O
cortices O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

We O
established O
that O
, O
in O
unstimulated O
lymphocytes O
, O
the O
Src B
homology I
2 I
( O
SH2 B
) O
and O
SH3 B
domain I
- I
containing I
protein I
Grb2 B
and O
the O
p85 B
subunit O
of O
phosphatidylinositol B
3 I
- I
kinase I
, O
associate O
constitutively O
with O
Cbl B
via O
their O
SH3 B
domains I
. O

Increased O
gliadin B
antibody I
levels O
were O
found O
more O
frequently O
in O
patients O
with O
subtotal O
villous O
atrophy O
( O
9 O
out O
of O
17 O
patients O
, O
or O
53 O
% O
; O
p O
less O
than O
0 O
. O
05 O
) O
than O
in O
patients O
with O
partial O
villous O
atrophy O
( O
2 O
out O
of O
13 O
patients O
, O
or O
15 O
% O
) O
or O
normal O
villous O
appearance O
( O
2 O
out O
of O
10 O
patients O
, O
or O
20 O
% O
) O
. O

Expression O
of O
the O
Hox B
genes I
egl B
- I
5 I
and O
mab B
- I
5 I
is O
reduced O
in O
lin B
- I
49 I
and O
lin B
- I
59 I
mutants I
, O
suggesting O
lin B
- I
49 I
and O
lin B
- I
59 I
regulate O
HOM B
- I
C I
gene I
expression O
in O
C O
. O
elegans O
as O
the O
trx B
- I
G I
genes I
do O
in O
Drosophila O
. O

Two O
genes O
( O
ptsI B
and O
ptsA B
) O
that O
encode O
homologues O
of O
the O
energy O
coupling O
Enzyme B
I I
of O
the O
phosphoenolpyruvate B
- I
dependent I
sugar I
- I
transporting I
phosphotransferase I
system O
( O
PTS O
) O
have O
previously O
been O
identified O
on O
the O
Escherichia O
coli O
chromosome O
. O

The O
activated O
glucocorticoid B
receptor I
forms O
a O
complex O
with O
Stat5 B
and O
enhances O
Stat5 B
- O
mediated O
transcriptional O
induction O
. O

For O
example O
, O
the O
presence O
of O
two O
related O
genes O
, O
b B
and O
b B
' I
, O
in O
the O
cyanobacterium O
suggests O
that O
its O
ATP B
synthase I
is O
a O
complex O
of O
nine O
polypeptides O
, O
and O
that O
it O
may O
have O
single O
copies O
of O
related O
b B
and O
b B
' I
proteins I
rather O
than O
two O
copies O
of O
identical O
b B
subunits I
as O
found O
in O
the O
E O
. O
coli O
enzyme O
. O
4 O
+ O
off O

For O
example O
, O
the O
presence O
of O
two O
related O
genes O
, O
b B
and O
b B
' I
, O
in O
the O
cyanobacterium O
suggests O
that O
its O
ATP B
synthase I
is O
a O
complex O
of O
nine O
polypeptides O
, O
and O
that O
it O
may O
have O
single O
copies O
of O
related O
b B
and O
b B
' I
proteins I
rather O
than O
two O
copies O
of O
identical O
b B
subunits I
as O
found O
in O
the O
E O
. O
coli O
enzyme O
. O
4 O
+ O
off O

For O
example O
, O
the O
presence O
of O
two O
related O
genes O
, O
b B
and O
b B
' I
, O
in O
the O
cyanobacterium O
suggests O
that O
its O
ATP B
synthase I
is O
a O
complex O
of O
nine O
polypeptides O
, O
and O
that O
it O
may O
have O
single O
copies O
of O
related O
b B
and O
b B
' I
proteins I
rather O
than O
two O
copies O
of O
identical O
b B
subunits I
as O
found O
in O
the O
E O
. O
coli O
enzyme O
. O
4 O
+ O
off O

Antiserum O
raised O
against O
rat B
liver I
S6 I
kinase I
specifically O
immunoprecipitates O
the O
purified O
32P O
- O
labeled O
H4 O
hepatoma O
insulin O
- O
stimulated O
S6 B
kinase I
. O

CRKL B
, O
an O
SH2 B
- O
SH3 B
- O
SH3 B
adapter O
protein O
, O
is O
one O
of O
the O
major O
tyrosine B
phosphoproteins I
detected O
in O
primary O
leukemic O
neutrophils O
from O
patients O
with O
CML O
. O

BACKGROUND O
: O
Murine B
Nramp I
is O
a O
candidate O
for O
the O
macrophage O
resistance O
gene O
Ity B
/ O
Lsh B
/ O
Bcg B
. O

The O
other O
end O
of O
this O
cluster O
contained O
the O
human B
type I
I I
cytokeratin I
K20 B
and O
K12 B
gene I
loci O
. O

However O
, O
in O
transient O
transfection O
assays O
, O
a O
truncation O
of O
as O
little O
as O
15 O
Nurr1 B
COOH O
- O
terminal O
amino O
acids O
diminished O
transcriptional O
activation O
of O
B1A B
- O
thymidine B
kinase I
- O
chloramphenicol B
acetyltransferase I
reporter O
. O

However O
, O
in O
transient O
transfection O
assays O
, O
a O
truncation O
of O
as O
little O
as O
15 O
Nurr1 B
COOH O
- O
terminal O
amino O
acids O
diminished O
transcriptional O
activation O
of O
B1A B
- O
thymidine B
kinase I
- O
chloramphenicol B
acetyltransferase I
reporter O
. O

Electron O
microscopic O
visualization O
of O
the O
general O
population O
of O
active O
genes O
in O
flies O
overexpressing O
hnRNP B
proteins I
also O
indicated O
that O
the O
great O
majority O
of O
genes O
seemed O
normal O
in O
terms O
of O
cotranscriptional O
RNA O
processing O
events O
, O
although O
there O
were O
a O
few O
abnormalities O
consistent O
with O
rare O
exon O
- O
skipping O
events O
. O

In O
the O
univariate O
models O
of O
either O
fixed O
or O
time O
dependent O
covariates O
, O
many O
variables O
were O
significantly O
associated O
with O
risk O
of O
progression O
to O
AIDS O
( O
T4 O
cell O
count O
, O
T4 O
/ O
T8 O
ratio O
, O
blastogenic O
responses O
to O
phytohemagglutinin B
, O
concanavalin B
A I
, O
and O
pokeweed B
mitogen I
, O
serum B
IgA I
, O
appearance O
of O
p24 B
antigen I
, O
and O
the O
development O
of O
oral O
hairy O
leukoplakia O
, O
thrush O
, O
or O
herpes O
zoster O
) O
. O

In O
the O
univariate O
models O
of O
either O
fixed O
or O
time O
dependent O
covariates O
, O
many O
variables O
were O
significantly O
associated O
with O
risk O
of O
progression O
to O
AIDS O
( O
T4 O
cell O
count O
, O
T4 O
/ O
T8 O
ratio O
, O
blastogenic O
responses O
to O
phytohemagglutinin B
, O
concanavalin B
A I
, O
and O
pokeweed B
mitogen I
, O
serum B
IgA I
, O
appearance O
of O
p24 B
antigen I
, O
and O
the O
development O
of O
oral O
hairy O
leukoplakia O
, O
thrush O
, O
or O
herpes O
zoster O
) O
. O

In O
the O
univariate O
models O
of O
either O
fixed O
or O
time O
dependent O
covariates O
, O
many O
variables O
were O
significantly O
associated O
with O
risk O
of O
progression O
to O
AIDS O
( O
T4 O
cell O
count O
, O
T4 O
/ O
T8 O
ratio O
, O
blastogenic O
responses O
to O
phytohemagglutinin B
, O
concanavalin B
A I
, O
and O
pokeweed B
mitogen I
, O
serum B
IgA I
, O
appearance O
of O
p24 B
antigen I
, O
and O
the O
development O
of O
oral O
hairy O
leukoplakia O
, O
thrush O
, O
or O
herpes O
zoster O
) O
. O

In O
the O
univariate O
models O
of O
either O
fixed O
or O
time O
dependent O
covariates O
, O
many O
variables O
were O
significantly O
associated O
with O
risk O
of O
progression O
to O
AIDS O
( O
T4 O
cell O
count O
, O
T4 O
/ O
T8 O
ratio O
, O
blastogenic O
responses O
to O
phytohemagglutinin B
, O
concanavalin B
A I
, O
and O
pokeweed B
mitogen I
, O
serum B
IgA I
, O
appearance O
of O
p24 B
antigen I
, O
and O
the O
development O
of O
oral O
hairy O
leukoplakia O
, O
thrush O
, O
or O
herpes O
zoster O
) O
. O

Adenovirus O
- O
mediated O
gene O
transfer O
of O
MMAC1 B
/ O
PTEN B
to O
glioblastoma O
cells O
inhibits O
S O
phase O
entry O
by O
the O
recruitment O
of O
p27Kip1 B
into O
cyclin B
E I
/ O
CDK2 B
complexes O
. O

These O
cells O
also O
showed O
an O
increase O
in O
cyclin B
A I
and O
cyclin B
A I
- I
and I
E I
- I
associated I
kinase I
activities O
characteristic O
of O
S O
phase O
induction O
. O

Both O
genes B
ARO3 I
and O
ARO4 B
are O
strongly O
regulated O
under O
the O
general O
control O
regulatory O
system O
. O

Importantly O
, O
a O
single O
base O
change O
in O
the O
fifth O
position O
of O
the O
c B
- I
fos I
sequence I
( O
GGTCTnnnAGACC O
to O
GGTCA O
/ O
GnnnAGACC O
) O
produced O
an O
element O
that O
bound O
the O
estrogen B
receptor I
and O
conferred O
estrogen O
- O
dependent O
transcriptional O
activation O
of O
a O
reporter O
gene O
. O

The O
IB2 B
gene I
( O
HGMW O
- O
approved O
symbol O
MAPK8IP2 B
) O
maps O
to O
human O
chromosome O
22q13 O
and O
contains O
10 O
coding O
exons O
. O

Transcription O
start O
sites O
of O
sal B
and O
salR B
genes I
were O
determined O
to O
lie O
30 O
- O
and O
24 O
- O
bp O
upstream O
of O
the O
respective O
initiation O
codons O
and O
separated O
from O
each O
other O
by O
78 O
nucleotides O
. O

When O
linked O
to O
the O
herpes O
simplex O
thymidine B
kinase I
minimal O
promoter O
, O
this O
fragment O
acts O
as O
an O
enhancing O
element O
in O
Rcho O
but O
not O
GC O
cells O
. O

VBP B
and O
a1 B
/ I
EBP I
could O
mediate O
the O
high O
rates O
of O
ALV O
and O
RSV B
LTR I
- O
enhanced O
transcription O
in O
bursal O
lymphoma O
cells O
and O
many O
other O
cell O
types O
. O

Developmental O
slot O
blots O
demonstrate O
that O
mRNAs O
corresponding O
to O
the O
three O
LHM B
cDNAs I
are O
transcribed O
from O
prophase O
of O
meiosis O
I O
to O
the O
uninucleate O
microspore O
stage O
, O
while O
Northern O
analysis O
reveals O
these O
tapetally O
expressed O
cDNAs O
to O
correspond O
with O
transcripts O
of O
some O
500 O
bp O
. O

In O
this O
study O
, O
we O
sought O
to O
determine O
the O
specific O
effect O
of O
HIV B
protease I
inhibitors O
on O
patient O
weight O
. O

The O
ATF B
/ O
CRE O
site O
is O
also O
essential O
for O
CD4 B
promoter I
activation O
by O
forskolin O
, O
an O
activator O
of O
adenylate B
cyclase I
. O

The O
ATF B
/ O
CRE O
site O
is O
also O
essential O
for O
CD4 B
promoter I
activation O
by O
forskolin O
, O
an O
activator O
of O
adenylate B
cyclase I
. O

After O
dialysis O
online O
, O
lactate O
was O
converted O
by O
means O
of O
lactate B
oxidase I
immobilized O
to O
porous O
glass O
, O
and O
the O
depletion O
of O
oxygen O
was O
registered O
by O
means O
of O
a O
Clark O
electrode O
. O

Despite O
this O
loss O
, O
YEpFAS1 B
is O
still O
able O
to O
complement O
a O
fas1 B
mutation O
at O
the O
enoyl B
reductase I
domain O
. O

Hepatitis B
B I
immune I
globulins I
and O
HIV B
antibodies I
. O

This O
gene O
is O
divided O
into O
six O
exons O
spanning O
about O
3kb O
, O
and O
encodes O
a O
175 O
amino O
acid O
protein O
with O
40 O
- O
52 O
% O
identity O
with O
the O
other O
five O
mouse B
Reg I
( O
regenerating B
gene I
product I
) O
proteins O
. O

The O
p63 B
sequence I
also O
features O
an O
acidic O
domain O
characteristic O
of O
transcriptional O
activation O
factors O
, O
as O
well O
as O
sequence O
blocks O
displaying O
limited O
similarity O
to O
positionally O
equivalent O
regions O
in O
sigma B
factors I
from O
eubacteria O
related O
to O
mitochondria O
. O

The O
p63 B
sequence I
also O
features O
an O
acidic O
domain O
characteristic O
of O
transcriptional O
activation O
factors O
, O
as O
well O
as O
sequence O
blocks O
displaying O
limited O
similarity O
to O
positionally O
equivalent O
regions O
in O
sigma B
factors I
from O
eubacteria O
related O
to O
mitochondria O
. O

In O
contrast O
, O
a O
similar O
fusion O
protein O
( O
hGH B
- O
LDLR B
- O
DAF17 B
, O
abbreviated O
HLD B
) O
containing O
a O
fragment O
of O
the O
serine O
/ O
threonine O
- O
rich O
domain O
of O
the O
LDL B
receptor I
( O
LDLR B
) O
in O
place O
of O
the O
DAF B
- I
derived I
serine I
/ I
threonine I
- I
rich I
sequences I
, O
does O
not O
become O
GPI O
anchored O
. O

Thus O
, O
the O
pathway O
to O
Fc B
epsilonRI I
- O
mediated O
MEK B
/ O
ERK B
and O
ERK B
activation O
can O
apparently O
bypass O
Ras B
and O
Raf B
- I
1 I
. O

This O
mechanism O
seems O
to O
be O
involved O
in O
VIP B
- O
induced O
PRL B
gene I
regulation O
. O

The O
strongly O
DNA O
binding O
p50 B
subunit I
showed O
only O
very O
weak O
, O
if O
any O
, O
induction O
of O
gene O
expression O
. O

Here O
we O
show O
that O
inhibition O
occurs O
with O
a O
NS1 B
- O
Rev B
chimera O
in O
which O
the O
78 O
amino O
- O
terminal O
amino O
acids O
of O
the O
NS1A B
protein I
comprising O
its O
entire O
RNA O
- O
binding O
domain O
is O
deleted O
, O
thereby O
establishing O
that O
this O
carboxyl O
portion O
of O
the O
NS1A B
protein I
can O
function O
as O
an O
independent O
effector O
domain O
. O

Here O
we O
show O
that O
inhibition O
occurs O
with O
a O
NS1 B
- O
Rev B
chimera O
in O
which O
the O
78 O
amino O
- O
terminal O
amino O
acids O
of O
the O
NS1A B
protein I
comprising O
its O
entire O
RNA O
- O
binding O
domain O
is O
deleted O
, O
thereby O
establishing O
that O
this O
carboxyl O
portion O
of O
the O
NS1A B
protein I
can O
function O
as O
an O
independent O
effector O
domain O
. O

The O
non B
- I
major I
histocompatibility I
complex I
( O
MHC B
) O
- O
encoded O
CD1 B
family I
has O
recently O
emerged O
as O
a O
new O
antigen O
- O
presenting O
system O
that O
is O
distinct O
from O
either O
MHC B
class I
I I
or I
class I
II I
molecules I
. O

The O
predicted O
amino O
acid O
sequence O
of O
Pst1p B
possessed O
high O
sequence O
homology O
with O
the O
Sin3 B
family I
of O
proteins O
, O
known O
for O
their O
interaction O
with O
histone B
deacetylases I
. O

The O
predicted O
amino O
acid O
sequence O
of O
Pst1p B
possessed O
high O
sequence O
homology O
with O
the O
Sin3 B
family I
of O
proteins O
, O
known O
for O
their O
interaction O
with O
histone B
deacetylases I
. O

In O
this O
study O
, O
we O
verified O
that O
PI B
3 I
- I
kinase I
associates O
with O
the O
CD4 B
: O
p56lck B
complex I
as O
judged O
by O
the O
presence O
of O
PI O
3 O
- O
phosphate O
generated O
from O
anti B
- I
CD4 I
immunoprecipitates O
and O
detected O
by O
high O
- O
pressure O
liquid O
chromatographic O
analysis O
. O

In O
this O
study O
, O
a O
site O
of O
PDGF B
- O
induced O
tyrosine O
phosphorylation O
was O
mapped O
to O
Tyr O
138 O
in O
the O
SH3 B
domain I
; O
Tyr O
138 O
is O
exposed O
on O
the O
SH3 B
peptide I
binding I
surface I
. O

We O
also O
identified O
a O
DNA O
fragment O
, O
10 O
. O
7 O
kbp O
upstream O
from O
the O
first O
coding O
exon O
of O
human B
aFGF I
, O
whose O
sequence O
is O
conserved O
in O
both O
the O
primate O
and O
rodent O
genomes O
. O

We O
have O
analyzed O
herein O
the O
roles O
that O
four O
different O
PIAS B
proteins I
( O
ARIP3 B
/ O
PIASx B
alpha I
, O
Miz1 B
/ O
PIASx B
beta I
, O
GBP B
/ O
PIAS1 B
, O
and O
PIAS3 B
) O
play O
in O
the O
regulation O
of O
steroid B
receptor I
- O
or O
STAT B
- O
mediated O
transcriptional O
activation O
. O

We O
have O
analyzed O
herein O
the O
roles O
that O
four O
different O
PIAS B
proteins I
( O
ARIP3 B
/ O
PIASx B
alpha I
, O
Miz1 B
/ O
PIASx B
beta I
, O
GBP B
/ O
PIAS1 B
, O
and O
PIAS3 B
) O
play O
in O
the O
regulation O
of O
steroid B
receptor I
- O
or O
STAT B
- O
mediated O
transcriptional O
activation O
. O

We O
have O
analyzed O
herein O
the O
roles O
that O
four O
different O
PIAS B
proteins I
( O
ARIP3 B
/ O
PIASx B
alpha I
, O
Miz1 B
/ O
PIASx B
beta I
, O
GBP B
/ O
PIAS1 B
, O
and O
PIAS3 B
) O
play O
in O
the O
regulation O
of O
steroid B
receptor I
- O
or O
STAT B
- O
mediated O
transcriptional O
activation O
. O

We O
have O
analyzed O
herein O
the O
roles O
that O
four O
different O
PIAS B
proteins I
( O
ARIP3 B
/ O
PIASx B
alpha I
, O
Miz1 B
/ O
PIASx B
beta I
, O
GBP B
/ O
PIAS1 B
, O
and O
PIAS3 B
) O
play O
in O
the O
regulation O
of O
steroid B
receptor I
- O
or O
STAT B
- O
mediated O
transcriptional O
activation O
. O

A O
phase O
II O
clinical O
trial O
on O
MDS O
was O
conducted O
in O
a O
cooperative O
study O
with O
orally O
administrable O
ara O
- O
C O
analogue O
, O
PLAC O
, O
which O
is O
resistant O
to O
cytidine B
deaminase I
and O
had O
shown O
an O
anti O
- O
tumor O
activity O
on O
various O
experimental O
tumors O
by O
oral O
route O
. O

Previously O
, O
we O
had O
shown O
that O
interleukin B
8 I
( O
IL B
- I
8 I
) O
is O
constitutively O
expressed O
in O
HTLV O
- O
I O
- O
infected O
cells O
and O
in O
cells O
transiently O
expressing O
Tax B
. O

To O
address O
this O
question O
with O
respect O
to O
skeletal O
muscle O
, O
we O
have O
examined O
the O
effects O
of O
the O
Providence O
mutation O
in O
cultured O
muscle O
cells O
, O
after O
adoptive O
gene O
transfer O
to O
adult O
mice O
, O
and O
in O
two O
infants O
homozygous O
for O
spectrin B
Providence I
. O

B B
and O
C1 B
fusions I
with O
yeast B
GAL4 I
DNA I
- I
binding I
and I
transcriptional I
activation I
domains I
were O
also O
found O
to O
interact O
when O
synthesized O
and O
assayed O
in O
yeast O
. O

We O
propose O
that O
optimal O
transcription O
of O
the O
gD B
gene I
depends O
on O
the O
interaction O
of O
ICP4 B
with O
multiple O
binding O
sites O
across O
the O
gene O
and O
cellular O
factors O
that O
recognize O
specific O
sequence O
elements O
in O
the O
promoter O
. O

A O
360 O
- O
bp O
DNA O
fragment O
located O
over O
500 O
bp O
upstream O
from O
the O
cfl B
transcriptional O
start O
site O
was O
used O
in O
DNase B
I I
protection O
assays O
to O
define O
the O
specific O
bases O
bound O
by O
CorR B
. O

CONCLUSIONS O
- O
- O
Postlumbar O
puncture O
headache O
may O
be O
mediated O
by O
the O
release O
of O
substance B
P I
triggered O
by O
lumbar O
puncture O
, O
in O
patients O
predisposed O
to O
headache O
by O
a O
hypersensitivity O
to O
substance B
P I
. O

CONCLUSIONS O
- O
- O
Postlumbar O
puncture O
headache O
may O
be O
mediated O
by O
the O
release O
of O
substance B
P I
triggered O
by O
lumbar O
puncture O
, O
in O
patients O
predisposed O
to O
headache O
by O
a O
hypersensitivity O
to O
substance B
P I
. O

A O
mutated B
ABF1 I
site I
that O
displays O
a O
very O
low O
affinity O
for O
ABF1 B
does O
not O
functionally O
replace O
the O
ILV1 B
REB1 B
site I
. O

By O
screening O
a O
human O
testis O
cDNA O
library O
with O
a O
probe O
containing O
the O
mouse B
PEA3 I
ETS B
domain O
, O
we O
isolated O
a O
2 O
. O
2 O
kb O
clone O
containing O
a O
510 O
AA O
open O
reading O
frame O
. O

Changes O
in O
testicular O
testosterone O
and O
acid O
and O
alkaline B
phosphatase I
activity O
in O
testis O
and O
accessory O
sex O
organs O
after O
induction O
of O
varicocele O
in O
Noble O
rats O
. O

These O
data O
suggest O
that O
weight O
gain O
or O
increased O
caloric O
intake O
, O
in O
contrast O
to O
its O
large O
effect O
on O
peripheral O
thyroid O
function O
, O
has O
relatively O
little O
effect O
on O
CNS B
TRH I
activity O
. O

The O
requirement O
for O
an O
essential O
interaction O
between O
NPH B
I I
and O
H4L B
provides O
an O
explanation O
for O
the O
observed O
restriction O
of O
transcription O
termination O
to O
early O
viral O
genes O
. O

The O
relation O
between O
the O
changes O
of O
bone O
density O
and O
the O
level O
of O
blood O
calcium O
, O
blood O
phosphorus O
and O
alkaline B
phosphatase I
( O
AKP B
) O
as O
well O
as O
the O
metabolism O
of O
vitamin O
D O
was O
studied O
. O

These O
results O
demonstrate O
the O
extensive O
homology O
in O
sequence O
among O
light O
chains O
of O
IgM B
kappa I
autoantibodies I
and O
indicate O
that O
a O
particular O
V B
kappa I
germ I
line I
gene I
, O
kappa B
IIIb I
, O
is O
expressed O
as O
a O
phylogenetic O
response O
to O
certain O
self O
antigens O
or O
as O
part O
of O
a O
selection O
process O
by O
which O
these O
autoimmune O
responses O
are O
regulated O
. O

Comparison O
of O
the O
sequences O
of O
the O
alpha B
- I
like I
DNA I
polymerases I
including O
E B
. I
coli I
DNA I
polymerase I
II I
showed O
that O
there O
were O
nine O
highly O
conserved O
regions O
, O
and O
we O
constructed O
an O
unrooted O
phylogenetic O
tree O
of O
the O
DNA B
polymerases I
based O
on O
the O
differences O
in O
these O
conserved O
regions O
. O

Before O
and O
6 O
and O
12 O
months O
after O
H O
. O
pylori O
eradication O
the O
patients O
were O
evaluated O
for O
fasting O
gastrinemia O
and O
pepsinogen B
I I
, O
basal O
and O
peak O
acid O
output O
, O
and O
detailed O
histological O
assessment O
including O
the O
ECL O
cell O
proliferative O
patterns O
. O

Defective O
concanavalin B
A I
- O
induced O
suppression O
in O
bancroftian O
filariasis O
. O

This O
result O
, O
together O
with O
the O
fact O
that O
unrearranged B
V I
kappa I
genes I
are O
transcriptionally O
silent O
, O
suggests O
that O
structural O
features O
of O
both O
the O
V B
kappa I
and O
C B
kappa I
loci I
contribute O
to O
the O
overall O
transcriptional O
efficiency O
of O
a O
rearranged B
V I
kappa I
- I
C I
kappa I
gene I
. O

NSD1 B
contains O
a O
SET B
domain I
and O
multiple O
PHD O
fingers O
. O

Inhibition O
of O
endogenous B
Cdk2 I
by O
dominant B
negative I
Cdk2 I
attenuated O
phosphorylation O
of O
Thr447 O
, O
Thr490 O
and O
Thr497 O
, O
but O
had O
no O
effect O
upon O
Ser581 O
modification O
. O

Symptoms O
, O
skin O
- O
prick O
tests O
( O
SPT O
) O
with O
environmental O
allergens O
and O
Pt O
salt O
, O
total O
serum B
IgE I
, O
lung O
function O
, O
and O
bronchial O
hyperresponsiveness O
were O
assessed O
by O
standard O
procedures O
. O

However O
, O
studies O
using O
the O
A20 B
promoter I
demonstrated O
that O
LMP1 B
transcriptionally O
activates O
the O
A20 B
gene I
through O
cis O
- O
acting O
kappa B
B I
sites I
. O

However O
, O
studies O
using O
the O
A20 B
promoter I
demonstrated O
that O
LMP1 B
transcriptionally O
activates O
the O
A20 B
gene I
through O
cis O
- O
acting O
kappa B
B I
sites I
. O

We O
conclude O
that O
GRF1 B
and O
GRF2 B
can O
form O
homo O
- O
and O
hetero O
- O
oligomers O
via O
their O
DH B
domains I
, O
that O
mutational O
inactivation O
of O
oligomer O
formation O
by O
GRF1 B
is O
associated O
with O
impaired O
biological O
and O
signaling O
activities O
, O
and O
that O
in O
293T O
cells O
GRF1 B
mediates O
at O
least O
two O
pathways O
for O
Raf B
activation O
: O
one O
a O
constitutive O
signal O
that O
is O
mainly O
Ras B
- O
dependent O
, O
and O
one O
an O
ionomycin O
- O
induced O
signal O
that O
cooperates O
with O
the O
constitutive O
signal O
without O
further O
augmenting O
the O
level O
of O
GTP B
- I
Ras I

Influenza O
virus O
- O
induced O
NF B
- I
kappaB I
- I
dependent I
gene I
expression O
is O
mediated O
by O
overexpression O
of O
viral O
proteins O
and O
involves O
oxidative O
radicals O
and O
activation O
of O
IkappaB B
kinase I
. O

These O
morphological O
changes O
are O
associated O
with O
a O
marked O
induction O
of O
P450arom B
gene I
expression O
. O

Like O
other O
known O
GCD B
genes I
, O
GCD14 B
and O
GCD15 B
are O
therefore O
probably O
required O
for O
general O
translation O
initiation O
in O
addition O
to O
their O
roles O
in O
GCN4 B
- O
specific O
translational O
control O
. O

No O
effect O
of O
4 O
beta O
- O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
was O
observed O
on O
the O
expression O
of O
hnRNP B
H I
. O

The O
activity O
of O
plasminogen B
activator I
has O
been O
measured O
in O
tissue O
sections O
with O
the O
aid O
of O
a O
modified O
Todd O
technique O
. O

Thus O
, O
the O
mutants O
are O
deficient O
in O
production O
of O
the O
O B
- I
antigen I
polymerase I
and O
were O
termed O
rfc B
mutants I
. O

The O
D443N B
substitution I
is O
an O
activating O
mutation O
that O
increases O
the O
activity O
of O
SCAP B
and O
renders O
it O
resistant O
to O
inhibition O
by O
25 O
- O
hydroxycholesterol O
. O

Central O
( O
heart O
rate O
, O
VE O
, O
VO2 O
) O
or O
local O
( O
muscle O
and O
blood O
lactate O
, O
adenosine O
triphosphate O
, O
creatine B
phosphokinase I
, O
glycogen O
) O
cues O
highlighted O
in O
these O
studies O
demonstrate O
both O
the O
complexity O
of O
effort O
perception O
, O
and O
the O
need O
for O
better O
understanding O
of O
the O
physiological O
components O
upon O
which O
it O
is O
based O
. O

The O
human B
p18 I
gene I
spans O
at O
least O
7 O
. O
5 O
kb O
and O
is O
composed O
of O
three O
exons O
, O
two O
of O
which O
encode O
the O
p18 B
protein I
. O

Serum O
creatinine B
kinase I
activity O
was O
7 O
, O
800 O
- O
17 O
, O
500 O
U O
/ O
l O
, O
making O
acute O
muscle O
damage O
likely O
, O
probably O
rhabdomyolysis O
. O

The O
nucleotide O
sequence O
of O
a O
PCR O
- O
amplified O
SMT3A B
genomic O
DNA O
fragment O
was O
found O
to O
be O
identical O
to O
that O
of O
SMT3A B
cDNA I
, O
indicating O
the O
absence O
of O
intron O
( O
s O
) O
in O
its O
protein O
coding O
region O
. O

Mutant O
p53 B
DNA I
clones O
from O
human O
colon O
carcinomas O
cooperate O
with O
ras B
in O
transforming O
primary O
rat O
cells O
: O
a O
comparison O
of O
the O
" O
hot O
spot O
" O
mutant O
phenotypes O
. O

The O
SEC27 B
gene I
was O
cloned O
, O
and O
the O
sequence O
predicts O
a O
99 O
. O
4 O
- O
kDa O
protein O
with O
45 O
% O
sequence O
identity O
to O
mammalian O
beta B
' I
- I
COP I
. O

Characterization O
and O
targeted O
disruption O
of O
murine B
Nup50 I
, O
a O
p27 B
( O
Kip1 B
) O
- O
interacting O
component O
of O
the O
nuclear O
pore O
complex O
. O

Therefore O
, O
the O
Ogg1 B
protein I
is O
a O
eukaryotic O
DNA B
glycosylase I
/ O
AP B
lyase I
. O

Therefore O
, O
the O
Ogg1 B
protein I
is O
a O
eukaryotic O
DNA B
glycosylase I
/ O
AP B
lyase I
. O

Therefore O
, O
the O
Ogg1 B
protein I
is O
a O
eukaryotic O
DNA B
glycosylase I
/ O
AP B
lyase I
. O

For O
Thermus O
strain O
ZO5 B
dihydroorotase I
( O
DHOase B
; O
encoded O
by O
pyrC B
) O
, O
the O
highest O
similarity O
scores O
( O
about O
40 O
% O
identity O
) O
were O
obtained O
with O
DHOases B
from O
B O
. O
caldolyticus O
and O
Bacillus O
subtilis O
. O

We O
recently O
described O
the O
isolation O
and O
characterization O
of O
nontoxic O
PAP B
mutants I
, O
NT123 O
- O
2 O
, O
which O
has O
a O
point O
mutation O
( O
E176V O
) O
in O
the O
active O
site O
that O
abolishes O
enzymatic O
activity O
, O
and O
NT124 O
- O
3 O
, O
which O
has O
a O
nonsense O
mutation O
that O
results O
in O
deletion O
of O
the O
C O
- O
terminal O
25 O
aa O
( O
W237Stop O
) O
. O

The O
genes O
expressed O
during O
the O
embryonic O
( O
zeta B
) O
or O
fetal O
and O
adult O
stage O
( O
alpha B
2 I
and O
alpha B
1 I
) O
can O
be O
modified O
by O
point O
mutations O
which O
affect O
either O
the O
processing O
- O
translation O
of O
mRNA O
or O
make O
the O
polypeptide O
chains O
extremely O
unstable O
. O

The O
genes O
expressed O
during O
the O
embryonic O
( O
zeta B
) O
or O
fetal O
and O
adult O
stage O
( O
alpha B
2 I
and O
alpha B
1 I
) O
can O
be O
modified O
by O
point O
mutations O
which O
affect O
either O
the O
processing O
- O
translation O
of O
mRNA O
or O
make O
the O
polypeptide O
chains O
extremely O
unstable O
. O

Many O
human O
malignant O
cells O
lack O
methylthioadenosine B
phosphorylase I
( O
MTAP B
) O
enzyme O
activity O
. O

The O
pattern O
of O
net B
RNA I
expression O
in O
adult O
mouse O
tissues O
is O
different O
. O

Reduction O
of O
p53 B
protein I
was O
detected O
after O
1 O
day O
of O
OM B
treatment O
and O
reached O
maximal O
suppression O
of O
10 O
- O
20 O
% O
of O
control O
after O
3 O
days O
in O
H3922 O
and O
40 O
% O
of O
control O
after O
4 O
days O
in O
MCF O
- O
7 O
cells O
. O

Association O
of O
Syk B
protein B
tyrosine I
kinase I
( O
PTK B
) O
with O
LMP2A B
occurs O
at O
the O
two O
tyrosines O
of O
the O
LMP2A B
immunoreceptor I
tyrosine O
- O
based O
activation O
motif O
, O
and O
it O
is O
hypothesized O
that O
Lyn B
PTK B
associates O
with O
the O
YEEA O
amino O
acid O
motif O
at O
LMP2A B
tyrosine O
112 O
( O
Y112 O
) O
. O

An O
additional O
stimulation O
of O
D1 B
receptors I
by O
giving O
SKF38393 O
30 O
min O
later O
produced O
an O
almost O
continuous O
pattern O
of O
jaw O
openings O
but O
less O
closure O
movements O
from O
the O
rest O
position O
, O
and O
the O
openings O
were O
accompanied O
by O
frequent O
tongue O
protrusions O
. O

Human B
CR2 I
has O
a O
restricted O
cellular O
distribution O
, O
being O
expressed O
on O
B O
lymphocytes O
, O
dendritic O
cells O
of O
the O
spleen O
, O
pharyngeal O
epithelial O
cells O
, O
and O
at O
low O
levels O
on O
some O
T O
lymphocytes O
. O

ADR1 B
in O
extracts O
made O
from O
glucose O
- O
repressed O
and O
- O
derepressed O
cells O
bound O
UAS1 O
DNA O
with O
similar O
affinities O
despite O
having O
greatly O
different O
abilities O
to O
activate O
ADH2 B
gene I
expression O
in O
vivo O
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil B
DNA I
glycosylase I
, O
AP B
endonuclease I
, O
DNA B
polymerase I
beta I
, O
and O
an O
NAD B
+ I
- I
dependent I
DNA I
ligase I
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane B
pyrimidine I
dimer I
photolyase I
) O
, O
a O
LINE B
- I
type I
reverse I
transcriptase I
, O
and O
a O
mutT B
homologue I
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil B
DNA I
glycosylase I
, O
AP B
endonuclease I
, O
DNA B
polymerase I
beta I
, O
and O
an O
NAD B
+ I
- I
dependent I
DNA I
ligase I
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane B
pyrimidine I
dimer I
photolyase I
) O
, O
a O
LINE B
- I
type I
reverse I
transcriptase I
, O
and O
a O
mutT B
homologue I
. O

A O
V1 B
mutant I
generated O
in O
vivo O
with O
11 O
of O
the O
14 O
N O
- O
terminal O
amino O
acids O
altered O
, O
was O
viable O
and O
produced O
symptoms O
typical O
of O
a O
wild O
- O
type O
infection O
. O

Located O
between O
the O
3 O
' O
trans O
- O
spliced O
leader O
acceptor O
site O
and O
the O
translational O
initiation O
codon O
of O
the O
GP63 B
gene I
is O
an O
area O
of O
conserved O
hexanucleotide O
direct O
repeats O
( O
CTCGCC O
) O
which O
vary O
in O
number O
according O
to O
species O
. O

We O
have O
previously O
demonstrated O
that O
pyrene O
in O
diesel O
- O
exhaust O
particles O
( O
DEP O
) O
has O
an O
adjuvant O
activity O
on O
immunoglobulin B
E I
( O
IgE B
) O
antibody O
production O
in O
mice O
immunized O
with O
Japanese O
cedar O
pollen O
allergen O
( O
JCPA O
) O
or O
ovalbumin B
( O
OA B
) O
intraperitoneally O
. O

We O
conclude O
that O
transcription O
of O
both O
SCD1 B
and O
SCD2 B
genes I
is O
responsive O
to O
cellular O
sterol O
levels O
and O
to O
the O
levels O
of O
nuclear O
SREBP B
/ O
ADD1 B
and O
that O
transcriptional O
induction O
requires O
three O
spatially O
conserved O
cis O
elements O
, O
that O
bind O
SREBP B
and O
NF B
- I
Y I
. O

In O
contrast O
, O
the O
sequences O
essential O
for O
the O
transcription O
of O
EFT1 B
were O
localized O
to O
the O
region O
between O
the O
start O
ATG O
and O
the O
stop O
codon O
of O
the O
VPS17 B
gene I
that O
terminates O
267 O
nt O
upstream O
on O
the O
same O
strand O
. O

Exposure O
of O
raft O
cultures O
to O
activators O
of O
protein B
kinase I
C I
, O
such O
as O
phorbol O
esters O
, O
results O
in O
the O
further O
induction O
of O
late B
gene I
expression O
as O
well O
as O
virion O
assembly O
. O

Hydroxyl O
radical O
footprinting O
of O
DNA O
complexes O
of O
the O
ets B
domain I
of O
PU B
. I
1 I
and O
its O
comparison O
to O
the O
crystal O
structure O
. O

The O
classic O
sterol O
regulatory O
cis O
element O
( O
sre O
- O
1 O
) O
in O
the O
LDL B
receptor I
promoter O
mediates O
sterol B
regulatory I
element I
binding I
protein I
( O
SREBP B
) O
- O
binding O
and O
the O
effects O
of O
insulin B
and O
platelet B
derived I
growth I
factor I
( O
PDGF B
) O
. O

Fusion O
of O
mouse B
CD8 I
+ I
class B
I I
MHC I
- O
restricted O
T O
cells O
with O
the O
BW5147 O
thymoma O
invariably O
yields O
CD8 B
- I
hybridomas O
in O
which O
RNA O
transcribed O
from O
the O
CD8 B
alpha I
( O
Lyt B
- I
2 I
) O
gene O
is O
undetectable O
. O

Fusion O
of O
mouse B
CD8 I
+ I
class B
I I
MHC I
- O
restricted O
T O
cells O
with O
the O
BW5147 O
thymoma O
invariably O
yields O
CD8 B
- I
hybridomas O
in O
which O
RNA O
transcribed O
from O
the O
CD8 B
alpha I
( O
Lyt B
- I
2 I
) O
gene O
is O
undetectable O
. O

For O
the O
P B
transcript I
from O
phage O
with O
the O
G O
( O
- O
) O
orientation O
, O
full O
termination O
activity O
required O
both O
the O
region O
containing O
the O
stem O
- O
loop O
structure O
and O
upstream O
sequences O
. O

These O
results O
suggest O
that O
the O
Reg1 B
- O
Glc7 B
phosphatase O
is O
a O
cytoplasmic O
component O
of O
the O
machinery O
responsible O
for O
returning O
Snf1 B
kinase I
activity O
to O
its O
basal O
level O
and O
reestablishing O
glucose O
repression O
. O

The O
IFNAR B
chain I
interacts O
with O
both O
IFN B
- I
alpha I
2 I
and O
IFN B
- I
beta I
, O
as O
demonstrated O
by O
cross O
- O
linking O
. O

We O
report O
the O
cloning O
of O
the O
ade1 B
gene I
on O
a O
4 B
. I
4 I
kb I
Sau3A I
insert I
in O
the O
yeast O
shuttle O
vector O
pWH5 O
. O

These O
three O
phases O
of O
cyclin B
E I
association O
with O
chromatin O
may O
facilitate O
the O
diverse O
activities O
of O
cyclin B
E I
- O
- O
Cdk2 B
in O
initiating O
replication O
, O
blocking O
rereplication O
, O
and O
allowing O
resetting O
of O
origins O
after O
mitosis O
. O

These O
three O
phases O
of O
cyclin B
E I
association O
with O
chromatin O
may O
facilitate O
the O
diverse O
activities O
of O
cyclin B
E I
- O
- O
Cdk2 B
in O
initiating O
replication O
, O
blocking O
rereplication O
, O
and O
allowing O
resetting O
of O
origins O
after O
mitosis O
. O

Plasma B
LH I
and O
progesterone O
levels O
after O
single O
or O
multiple O
injections O
of O
synthetic O
LH B
- O
RH B
in O
anoestrous O
ewes O
and O
comparison O
with O
levels O
during O
the O
oestrous O
cycle O
. O

Repeated O
interferon B
- I
beta I
( O
IFN B
- I
beta I
) O
silencer O
B O
motifs O
and O
a O
lysozyme B
silencer I
1 I
motif I
have O
been O
found O
in O
the O
CD95 B
gene I
at O
approximately O
- O
1 O
, O
600 O
and O
- O
1 O
, O
100 O
, O
respectively O
. O

Action O
against O
Vibrio O
cholerae O
O1 O
Tox B
+ I
of O
chemical O
products O
used O
in O
the O
lemon O
production O
. O

Tax B
and O
the O
active O
Tax B
mutants I
were O
able O
to O
abrogate O
the O
G1 O
arrest O
and O
apoptosis O
induced O
by O
p53 B
, O
and O
this O
effect O
does O
not O
correlate O
with O
an O
altered O
localization O
of O
nuclear B
p53 I
or O
with O
the O
disruption O
of O
p53 B
- I
DNA I
complexes I
. O

Tax B
and O
the O
active O
Tax B
mutants I
were O
able O
to O
abrogate O
the O
G1 O
arrest O
and O
apoptosis O
induced O
by O
p53 B
, O
and O
this O
effect O
does O
not O
correlate O
with O
an O
altered O
localization O
of O
nuclear B
p53 I
or O
with O
the O
disruption O
of O
p53 B
- I
DNA I
complexes I
. O

A O
4 O
. O
0 O
- O
kb O
Nlk B
message I
is O
also O
present O
during O
embryogenesis O
, O
detectable O
at O
day O
E10 O
. O

The O
mouse B
tapasin I
gene I
was O
mapped O
about O
70 O
kilobases O
from O
H2 B
- I
K I
at O
the O
centromeric O
end O
of O
the O
mouse B
MHC I
. O

Due O
to O
significant O
homology O
to O
the O
C O
- O
terminus O
of O
the O
Mutator B
transposase I
this O
alternative O
gene O
product O
was O
named O
Trap B
( O
transposon B
- I
associated I
protein I
) O
. O

Using O
gel O
retardation O
analysis O
, O
four O
binding O
sites O
for O
Rap1p B
have O
been O
identified O
within O
the O
promoter O
of O
the O
RAP1 B
gene I
. O

In O
human O
myxoid O
liposarcoma O
, O
a O
chromosomal O
rearrangement O
leads O
to O
fusion O
of O
the O
growth O
- O
arresting O
and O
DNA O
- O
damage O
- O
inducible O
transcription O
factor O
CHOP B
( O
GADD153 B
) O
to O
a O
peptide O
fragment O
encoded O
by O
the O
TLS B
gene I
. O

We O
previously O
described O
the O
upregulation O
of O
the O
MT2 B
antigen I
during O
urodele O
limb O
regeneration O
and O
characterized O
the O
MT2 B
antigen I
as O
a O
310 O
- O
to O
325 O
- O
kDa O
chondroitin O
- O
sulfated O
glycoprotein O
with O
a O
core O
protein O
of O
285 O
- O
300 O
kDa O
. O

We O
previously O
described O
the O
upregulation O
of O
the O
MT2 B
antigen I
during O
urodele O
limb O
regeneration O
and O
characterized O
the O
MT2 B
antigen I
as O
a O
310 O
- O
to O
325 O
- O
kDa O
chondroitin O
- O
sulfated O
glycoprotein O
with O
a O
core O
protein O
of O
285 O
- O
300 O
kDa O
. O

Plasma B
renin I
activity O
in O
essential O
arterial O
hypertension O
. O

The O
proteins O
encoded O
by O
these O
genes O
, O
called O
GF14 B
proteins I
, O
participate O
in O
protein O
/ O
DNA O
complexes O
and O
show O
more O
than O
60 O
% O
identity O
with O
a O
highly O
conserved O
, O
widely O
distributed O
protein O
family O
, O
collectively O
referred O
to O
as O
14 B
- I
3 I
- I
3 I
proteins O
. O

PtdIns B
( I
4 I
, I
5 I
) I
P2 I
synthesis O
, O
on O
the O
other O
hand O
, O
is O
only O
moderately O
affected O
even O
in O
fab1Delta B
mutants I
. O

A O
simple O
procedure O
for O
accurate O
quantitation O
of O
factor B
VIII I
inhibitors O
. O

Low O
serum B
C3 I
values O
were O
observed O
in O
all O
11 O
children O
at O
some O
stage O
of O
their O
illness O
. O

The O
predicted O
amino O
acid O
sequence O
contained O
all O
consensus O
regions O
for O
S B
- I
adenosyl I
methionine I
methyltransferases I
and O
presented O
26 O
% O
identity O
with O
Saccharomyces B
cerevisiae I
DHHB I
- I
methyltransferase I
and O
38 O
% O
identity O
with O
the O
rat O
protein O
, O
as O
well O
as O
with O
a O
bacterial O
( O
Escherichia O
coli O
and O
Salmonella O
typhimurium O
) O
methyltransferase B
encoded O
by O
the O
UBIG B
gene I
. O

The O
introduction O
of O
FWD1 B
into O
cells O
significantly O
promotes O
ubiquitination O
and O
degradation O
of O
IkappaBalpha B
in O
concert O
with O
IkappaB B
kinases I
, O
resulting O
in O
nuclear O
translocation O
of O
NF B
- I
kappaB I
. O

Two O
plasmids O
, O
one O
containing O
the O
amino O
terminus O
of O
P O
fused O
to O
the O
DNA O
- O
binding O
domain O
of O
the O
yeast O
transactivator O
, O
GAL4 B
, O
and O
the O
other O
containing O
the O
amino O
terminus O
of O
NP B
fused O
to O
the O
herpesvirus O
transactivator O
, O
VP16 B
, O
were O
transfected O
in O
COS O
- O
1 O
cells O
along O
with O
a O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
reporter O
plasmid O
containing O
GAL4 B
DNA O
- O
binding O
sites O
. O

Biochemical O
experiments O
and O
genome O
sequencing O
have O
shown O
that O
, O
despite O
the O
prokaryotic O
cell O
and O
genome O
organization O
, O
basal O
transcriptional O
elements O
of O
members O
of O
the O
domain O
Archaea O
( O
i O
. O
e O
. O
, O
TATA O
box O
- O
like O
sequences O
, O
RNA B
polymerase I
, O
and O
transcription O
factors O
TBP B
, O
TFIIB B
, O
and O
TFIIS B
) O
are O
of O
the O
eukaryotic O
type O
. O

We O
report O
on O
a O
case O
of O
a O
43 O
- O
old O
- O
male O
with O
a O
bronchogenic O
cyst O
in O
the O
distal O
esophagus O
, O
which O
was O
misdiagnosed O
as O
a O
malignant O
esophageal O
tumor O
based O
on O
preoperative O
imaging O
and O
high O
levels O
of O
the O
tumor O
markers O
CA B
19 I
- I
9 I
and O
CA B
125 I
. O

These O
operons O
encode O
subunits O
of O
photosystems B
I I
( O
psa B
) O
and O
II O
( O
psb B
) O
, O
the O
cytochrome B
bGf I
complex I
( O
pet B
) O
, O
the O
plastid O
NAD B
( I
P I
) I
H I
dehydrogenase I
( O
ndh B
) O
, O
and O
the O
unidentified O
open O
reading O
frame O
ycf9 B
. O

The O
level O
of O
expression O
of O
the O
PDE B
protein I
was O
monitored O
by O
immunoblot O
analysis O
using O
two O
specific O
cAMP B
- I
PDE I
polyclonal I
antibodies I
and O
by O
measuring O
the O
PDE B
activity O
. O

Since O
UmuD B
protein I
is O
proteolytically O
processed O
to O
an O
active O
form O
( O
UmuD B
* I
) O
in O
a O
RecA B
* O
- O
dependent O
fashion O
, O
and O
MucA B
shares O
extensive O
amino O
acid O
homology O
with O
UmuD B
, O
we O
examined O
whether O
MucA B
is O
similarly O
processed O
in O
the O
cell O
, O
using O
antiserum O
against O
a O
LacZ B
' I
- O
' B
MucA I
fusion O
protein O
. O

Since O
UmuD B
protein I
is O
proteolytically O
processed O
to O
an O
active O
form O
( O
UmuD B
* I
) O
in O
a O
RecA B
* O
- O
dependent O
fashion O
, O
and O
MucA B
shares O
extensive O
amino O
acid O
homology O
with O
UmuD B
, O
we O
examined O
whether O
MucA B
is O
similarly O
processed O
in O
the O
cell O
, O
using O
antiserum O
against O
a O
LacZ B
' I
- O
' B
MucA I
fusion O
protein O
. O

Since O
UmuD B
protein I
is O
proteolytically O
processed O
to O
an O
active O
form O
( O
UmuD B
* I
) O
in O
a O
RecA B
* O
- O
dependent O
fashion O
, O
and O
MucA B
shares O
extensive O
amino O
acid O
homology O
with O
UmuD B
, O
we O
examined O
whether O
MucA B
is O
similarly O
processed O
in O
the O
cell O
, O
using O
antiserum O
against O
a O
LacZ B
' I
- O
' B
MucA I
fusion O
protein O
. O

Since O
UmuD B
protein I
is O
proteolytically O
processed O
to O
an O
active O
form O
( O
UmuD B
* I
) O
in O
a O
RecA B
* O
- O
dependent O
fashion O
, O
and O
MucA B
shares O
extensive O
amino O
acid O
homology O
with O
UmuD B
, O
we O
examined O
whether O
MucA B
is O
similarly O
processed O
in O
the O
cell O
, O
using O
antiserum O
against O
a O
LacZ B
' I
- O
' B
MucA I
fusion O
protein O
. O

We O
have O
determined O
the O
molecular O
organization O
and O
transcription O
start O
points O
( O
tsp O
) O
for O
the O
murine O
gene O
( O
TK B
) O
encoding O
thymidine B
kinase I
. O

Mutation O
of O
the O
HNF3 B
element I
significantly O
reduced O
promoter O
activity O
in O
HepG2 O
cells O
, O
whereas O
this O
element O
in O
isolation O
conferred O
HNF3beta B
responsiveness O
to O
a O
heterologous O
promoter O
. O

We O
have O
utilized O
transient O
transfections O
, O
mutation O
analysis O
, O
electromobility O
gel O
- O
shifts O
, O
and O
immunoblot O
analysis O
to O
test O
the O
hypothesis O
that O
expression O
of O
the O
CTalpha B
gene I
is O
controlled O
in O
part O
by O
the O
binding O
of O
three O
trans O
- O
acting O
nuclear O
factors O
, O
Sp1 B
, O
Sp2 B
, O
and O
Sp3 B
. O

Antinuclear O
antibodies O
, O
rheumatoid B
factor I
and O
C B
- I
reactive I
protein I
in O
serum O
of O
normal O
women O
using O
oral O
contraceptives O
. O

Adenovirus O
infection O
of O
hepatoma O
cells O
inhibited O
transcription O
of O
the O
phosphoenolpyruvate B
carboxykinase I
( O
GTP O
) O
( O
EC B
4 I
. I
1 I
. I
1 I
. I
32 I
) O
( O
PEPCK B
) O
gene O
and O
virtually O
eliminated O
transcription O
of O
a O
chimeric O
gene O
which O
contained O
the O
PEPCK B
promoter I
linked O
to O
the O
structural O
gene O
for O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
. O

Adenovirus O
infection O
of O
hepatoma O
cells O
inhibited O
transcription O
of O
the O
phosphoenolpyruvate B
carboxykinase I
( O
GTP O
) O
( O
EC B
4 I
. I
1 I
. I
1 I
. I
32 I
) O
( O
PEPCK B
) O
gene O
and O
virtually O
eliminated O
transcription O
of O
a O
chimeric O
gene O
which O
contained O
the O
PEPCK B
promoter I
linked O
to O
the O
structural O
gene O
for O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
. O

Adenovirus O
infection O
of O
hepatoma O
cells O
inhibited O
transcription O
of O
the O
phosphoenolpyruvate B
carboxykinase I
( O
GTP O
) O
( O
EC B
4 I
. I
1 I
. I
1 I
. I
32 I
) O
( O
PEPCK B
) O
gene O
and O
virtually O
eliminated O
transcription O
of O
a O
chimeric O
gene O
which O
contained O
the O
PEPCK B
promoter I
linked O
to O
the O
structural O
gene O
for O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
. O

Choline B
acetyltransferase I
immunohistochemistry O
combined O
with O
the O
retrograde O
transport O
of O
horseradish B
peroxidase I
showed O
that O
the O
reticular O
and O
mediodorsal O
thalamic O
nuclei O
of O
the O
cat O
receive O
an O
important O
input O
from O
cholinergic O
and O
non O
- O
cholinergic O
neurons O
of O
substantia O
innominata O
and O
adjacent O
structures O
in O
the O
basal O
forebrain O
. O

Choline B
acetyltransferase I
immunohistochemistry O
combined O
with O
the O
retrograde O
transport O
of O
horseradish B
peroxidase I
showed O
that O
the O
reticular O
and O
mediodorsal O
thalamic O
nuclei O
of O
the O
cat O
receive O
an O
important O
input O
from O
cholinergic O
and O
non O
- O
cholinergic O
neurons O
of O
substantia O
innominata O
and O
adjacent O
structures O
in O
the O
basal O
forebrain O
. O

( O
i O
) O
The O
chimeric O
gene O
consisting O
of O
the O
coding O
and O
5 O
' O
nontranslated O
leader O
regions O
of O
the O
TK B
gene I
fused O
to O
portions O
of O
the O
domain O
of O
alpha B
gene I
0 I
extending O
largely O
upstream O
from O
the O
site O
of O
initiation O
of O
transcription O
of O
alpha B
gene I
0 I
was O
regulated O
in O
the O
same O
fashion O
as O
the O
alpha B
4 I
- I
and I
alpha I
27 I
- I
TK I
chimeras O
. O

Thus O
, O
an O
unmodified O
threonine O
at O
position O
169 O
in O
Cdc28 B
is O
important O
for O
interaction O
with O
G1 B
cyclins I
. O

From O
a O
chromosomal O
cosmid O
library O
of O
Streptomyces O
argillaceus O
, O
a O
Mtm B
producer O
, O
a O
clone O
( O
cosAR7 O
) O
was O
isolated O
by O
homology O
to O
the O
actI B
/ I
III I
region I
of O
S O
. O
coelicolor O
and O
the O
strDEM B
genes I
of O
S O
. O
griseus O
. O

We O
report O
the O
complete O
nucleotide O
sequence O
of O
the O
camC B
gene I
along O
with O
155 O
base O
pairs O
of O
5 O
' O
and O
175 O
base O
pairs O
of O
3 O
' O
flanking O
sequence O
. O

gp170 B
is O
generated O
by O
an O
alternatively O
spliced O
Env B
mRNA I
using O
a O
splice O
donor O
and O
splice O
acceptor O
pair O
localized O
within O
the O
env B
open I
reading I
frame I
( I
ORF I
) I
, O
which O
is O
normally O
used O
to O
generate O
Bell B
and O
Bet B
transcripts I
derived O
from O
the O
internal O
promoter O
within O
the O
env B
ORF I
. O

gp170 B
is O
generated O
by O
an O
alternatively O
spliced O
Env B
mRNA I
using O
a O
splice O
donor O
and O
splice O
acceptor O
pair O
localized O
within O
the O
env B
open I
reading I
frame I
( I
ORF I
) I
, O
which O
is O
normally O
used O
to O
generate O
Bell B
and O
Bet B
transcripts I
derived O
from O
the O
internal O
promoter O
within O
the O
env B
ORF I
. O

gp170 B
is O
generated O
by O
an O
alternatively O
spliced O
Env B
mRNA I
using O
a O
splice O
donor O
and O
splice O
acceptor O
pair O
localized O
within O
the O
env B
open I
reading I
frame I
( I
ORF I
) I
, O
which O
is O
normally O
used O
to O
generate O
Bell B
and O
Bet B
transcripts I
derived O
from O
the O
internal O
promoter O
within O
the O
env B
ORF I
. O

gp170 B
is O
expressed O
at O
a O
level O
30 O
to O
50 O
% O
of O
the O
Env B
precursor I
gp130 B
. O

Our O
results O
are O
consistent O
with O
TCOF1 B
mutations I
leading O
to O
the O
Treacher O
Collins O
syndrome O
phenotype O
. O

Residues O
that O
affect O
PLCbeta B
and O
adenylyl B
cyclase I
II I
activity O
are O
found O
on O
opposite O
sides O
of O
the O
central O
tunnel O
, O
suggesting O
that O
PLC B
and O
adenylyl B
cyclase I
, O
like O
the O
alpha O
subunit O
, O
make O
many O
contacts O
on O
the O
top O
surface O
. O

Vertebrate O
U6 B
small I
nuclear I
RNA I
( O
snRNA O
) O
loci O
exemplify O
a O
novel O
class O
of O
polymerase B
III I
- O
transcribed O
genes O
that O
lack O
an O
intragenic O
control O
region O
( O
ICR O
) O
. O

Elements O
of O
the O
hAT B
transposon I
family I
, O
such O
as O
the O
maize B
activator I
( O
Ac B
) O
, O
have O
been O
discovered O
in O
a O
large O
number O
of O
eukaryotic O
species O
. O

The O
tro B
operon I
is O
flanked O
by O
a O
Holliday B
structure I
DNA I
helicase I
homolog O
( O
upstream O
) O
and O
two O
ORFs O
representing O
a O
purine B
nucleoside I
phosphorylase I
homolog O
and O
tpp15 B
, O
a O
previously O
characterized O
gene O
encoding O
a O
membrane O
lipoprotein O
( O
downstream O
) O
. O

No O
cleavage O
of O
gp B
130 I
was O
observed O
in O
analogous O
pulse O
- O
chase O
radiolabelling O
of O
Ad O
- O
gB B
- O
infected O
human O
fibroblasts O
, O
even O
though O
these O
cells O
are O
permissive O
for O
HCMV O
replication O
and O
can O
process O
the O
native B
gB I
molecule I
. O

A O
phylogenetic O
comparison O
of O
32 O
species O
showed O
minor O
differences O
in O
the O
apoB B
mRNA I
sequence I
, O
and O
the O
apoB B
mRNA I
from O
31 O
species O
was O
robustly O
edited O
in O
vitro O
. O

These O
include O
the O
genes O
, O
undefined B
1 I
( O
UD1 B
) O
, O
UD2 B
, O
and O
UD3 B
, O
each O
coding O
for O
proteins O
of O
unknown O
function O
, O
the O
ken B
gene I
encoding O
a O
new O
Kruppel B
- I
like I
putative I
transcription I
factor I
, O
the O
fly O
homologues O
of O
the O
mammalian B
mitochondrial I
trifunctional I
enzyme I
( O
thiolase B
) O
, O
and O
the O
TAR B
DNA I
- I
binding I
protein I
- I
43 I
( O
TBPH B
) O
, O
the O
first O
nonvertebrate O
member O
of O
the O
transmembrane B
4 I
superfamily I
( O
TM4SF B
) O
gene O
, O
a O
new O
homeodomain B
gene I
, O
and O
a O
gene O
coding O
for O

These O
include O
the O
genes O
, O
undefined B
1 I
( O
UD1 B
) O
, O
UD2 B
, O
and O
UD3 B
, O
each O
coding O
for O
proteins O
of O
unknown O
function O
, O
the O
ken B
gene I
encoding O
a O
new O
Kruppel B
- I
like I
putative I
transcription I
factor I
, O
the O
fly O
homologues O
of O
the O
mammalian B
mitochondrial I
trifunctional I
enzyme I
( O
thiolase B
) O
, O
and O
the O
TAR B
DNA I
- I
binding I
protein I
- I
43 I
( O
TBPH B
) O
, O
the O
first O
nonvertebrate O
member O
of O
the O
transmembrane B
4 I
superfamily I
( O
TM4SF B
) O
gene O
, O
a O
new O
homeodomain B
gene I
, O
and O
a O
gene O
coding O
for O

These O
include O
the O
genes O
, O
undefined B
1 I
( O
UD1 B
) O
, O
UD2 B
, O
and O
UD3 B
, O
each O
coding O
for O
proteins O
of O
unknown O
function O
, O
the O
ken B
gene I
encoding O
a O
new O
Kruppel B
- I
like I
putative I
transcription I
factor I
, O
the O
fly O
homologues O
of O
the O
mammalian B
mitochondrial I
trifunctional I
enzyme I
( O
thiolase B
) O
, O
and O
the O
TAR B
DNA I
- I
binding I
protein I
- I
43 I
( O
TBPH B
) O
, O
the O
first O
nonvertebrate O
member O
of O
the O
transmembrane B
4 I
superfamily I
( O
TM4SF B
) O
gene O
, O
a O
new O
homeodomain B
gene I
, O
and O
a O
gene O
coding O
for O

The O
host O
range O
( O
HR O
) O
of O
poliovirus O
is O
thought O
to O
be O
primarily O
determined O
by O
a O
cell O
surface O
molecule O
that O
functions O
as O
poliovirus B
receptor I
( O
PVR B
) O
, O
since O
it O
has O
been O
shown O
that O
transgenic O
mice O
are O
made O
poliovirus O
sensitive O
by O
introducing O
the O
human B
PVR I
gene I
into O
the O
genome O
. O

The O
control O
of O
human B
aromatase I
expression O
is O
complex O
in O
that O
several O
promoters O
drive O
aromatase B
expression O
in O
a O
tissue O
- O
specific O
manner O
. O

Evidence O
for O
involvement O
of O
proteins O
HU B
and O
RpoS B
in O
transcription O
of O
the O
osmoresponsive O
proU B
operon I
in O
Escherichia O
coli O
. O

These O
data O
demonstrate O
that O
oleosin B
gene I
transcription O
is O
regulated O
in O
a O
tissue O
- O
specific O
and O
temporally O
regulated O
manner O
and O
clearly O
indicate O
that O
oleosin B
protein I
expression O
is O
co O
- O
ordinated O
primarily O
at O
the O
transcriptional O
level O
. O

These O
data O
demonstrate O
that O
oleosin B
gene I
transcription O
is O
regulated O
in O
a O
tissue O
- O
specific O
and O
temporally O
regulated O
manner O
and O
clearly O
indicate O
that O
oleosin B
protein I
expression O
is O
co O
- O
ordinated O
primarily O
at O
the O
transcriptional O
level O
. O

Together O
, O
these O
results O
implicate O
Fal1p B
in O
the O
18S B
rRNA I
maturation O
pathway O
rather O
than O
in O
translation O
initiation O
. O

Despite O
this O
dependency O
, O
however O
, O
a O
B B
. I
japonicum I
fixK I
mutant I
did O
not O
have O
the O
phenotypic O
characteristics O
of O
B B
. I
japonicum I
fixL I
and O
fixJ B
mutants I
: O
the O
fixK B
mutant I
was O
neither O
Fix O
- O
in O
symbiosis O
with O
soybean O
plants O
nor O
defective O
in O
anaerobic O
respiration O
with O
nitrate O
as O
the O
terminal O
electron O
acceptor O
. O

Despite O
this O
dependency O
, O
however O
, O
a O
B B
. I
japonicum I
fixK I
mutant I
did O
not O
have O
the O
phenotypic O
characteristics O
of O
B B
. I
japonicum I
fixL I
and O
fixJ B
mutants I
: O
the O
fixK B
mutant I
was O
neither O
Fix O
- O
in O
symbiosis O
with O
soybean O
plants O
nor O
defective O
in O
anaerobic O
respiration O
with O
nitrate O
as O
the O
terminal O
electron O
acceptor O
. O

Human B
PDNP3 I
is O
expressed O
in O
glioma O
cells O
, O
prostate O
, O
and O
uterus O
, O
but O
not O
in O
the O
alimentary O
tract O
. O

Screening O
of O
a O
human O
foetal O
brain O
genomic O
DNA O
library O
allowed O
us O
to O
isolate O
an O
EcoRI B
- O
EcoRI B
fragment O
containing O
6 O
kb O
of O
the O
5 O
' O
- O
flanking O
region O
, O
the O
open O
reading O
frame O
and O
4 O
kb O
of O
the O
3 O
' O
- O
flanking O
region O
of O
the O
alpha2C4 B
gene I
. O

Similarly O
, O
interfering O
with O
MEKK B
, O
which O
lies O
upstream O
of O
JNK1 B
, O
using O
a O
dominant O
negative O
expression O
vector O
reduced O
MMP B
- I
9 I
promoter I
activity O
over O
the O
same O
concentration O
range O
which O
repressed O
the O
AP B
- I
1 I
- O
thymidine B
kinase I
CAT B
reporter O
construct O
. O

There O
was O
no O
difference O
in O
serum B
albumin I
and O
transferrin B
levels O
, O
but O
serum B
prealbumin I
levels O
in O
the O
group O
fed O
early O
were O
more O
desirable O
than O
those O
of O
the O
control O
group O
( O
from O
15 O
. O
8 O
+ O
/ O
- O
2 O
. O
5 O
mg O
/ O
dl O
to O
28 O
. O
9 O
+ O
/ O
- O
3 O
. O
8 O
mg O
/ O
dl O
vs O
from O
18 O
. O
0 O
+ O
/ O
- O
2 O
. O
0 O
mg O
/ O
dl O
to O
25 O
. O
9 O
+ O
/ O
- O
3 O
. O
9 O
mg O
/ O
dl O
) O
. O

There O
was O
no O
difference O
in O
serum B
albumin I
and O
transferrin B
levels O
, O
but O
serum B
prealbumin I
levels O
in O
the O
group O
fed O
early O
were O
more O
desirable O
than O
those O
of O
the O
control O
group O
( O
from O
15 O
. O
8 O
+ O
/ O
- O
2 O
. O
5 O
mg O
/ O
dl O
to O
28 O
. O
9 O
+ O
/ O
- O
3 O
. O
8 O
mg O
/ O
dl O
vs O
from O
18 O
. O
0 O
+ O
/ O
- O
2 O
. O
0 O
mg O
/ O
dl O
to O
25 O
. O
9 O
+ O
/ O
- O
3 O
. O
9 O
mg O
/ O
dl O
) O
. O

This O
constant O
expression O
profile O
, O
coupled O
with O
the O
observation O
that O
over O
- O
expression O
of O
mSin3A B
does O
not O
augment O
the O
anti B
- I
Myc I
activity O
of O
Mxi1 B
- O
SR O
in O
the O
rat O
embryo O
fibroblast O
( O
REF O
) O
transformation O
assay O
, O
suggests O
that O
mSin3A B
is O
not O
a O
limiting O
factor O
in O
the O
regulation O
of O
Myc B
superfamily I
function O
. O

Surprisingly O
, O
although O
Mist1 B
binds O
to O
E O
- O
boxes O
in O
vivo O
, O
the O
Mist1 B
protein I
lacks O
a O
functional O
transcription O
activation O
domain O
. O

As O
exogenously O
expressed O
PKR B
can O
form O
heterodimers O
with O
endogenous B
PKR I
, O
the O
results O
obtained O
on O
the O
functional O
characterization O
of O
mutant O
forms O
of O
PKR B
have O
been O
taken O
with O
caution O
. O

The O
clr1 B
locus I
regulates O
the O
expression O
of O
the O
cryptic B
mating I
- I
type I
loci I
of I
fission I
yeast I
. O

Instead O
, O
HBx B
is O
shown O
to O
activate O
the O
cyclin B
A I
promoter I
, O
induce O
cyclin B
A I
- O
cyclin B
- I
dependent I
kinase I
2 I
complexes O
, O
and O
promote O
cycling O
of O
growth O
- O
arrested O
cells O
into O
G1 O
through O
a O
pathway O
involving O
activation O
of O
Src B
tyrosine I
kinases I
. O

Growth B
hormone I
exerts O
its O
effects O
on O
the O
ovarian O
follicular O
cycle O
directly O
or O
by O
local O
production O
of O
insulin B
- I
like I
growth I
factor I
1 I
( O
IGF B
- I
1 I
) O
. O

An O
insertion O
sequence O
element O
( O
IS1170 O
) O
was O
identified O
upstream O
of O
the O
nimC B
gene I
. O

Most O
significantly O
, O
the O
cyclin B
E I
- O
Cdk2 B
complex O
is O
maximally O
active O
at O
the O
G1 O
/ O
S O
transition O
, O
and O
overexpression O
of O
cyclin B
E I
decreases O
the O
time O
it O
takes O
the O
cell O
to O
complete O
G1 O
and O
enter O
S O
phase O
. O

Most O
significantly O
, O
the O
cyclin B
E I
- O
Cdk2 B
complex O
is O
maximally O
active O
at O
the O
G1 O
/ O
S O
transition O
, O
and O
overexpression O
of O
cyclin B
E I
decreases O
the O
time O
it O
takes O
the O
cell O
to O
complete O
G1 O
and O
enter O
S O
phase O
. O

Structural O
organization O
of O
the O
human B
Elk1 I
gene I
and O
its O
processed O
pseudogene B
Elk2 I
. O

In O
addition O
, O
while O
GCN1 B
is O
required O
in O
vivo O
for O
phosphorylation O
of O
eIF B
- I
2 I
alpha I
by O
GCN2 B
, O
cell O
extracts O
from O
gcn1 B
delta I
strains O
contained O
wild O
- O
type O
levels O
of O
GCN2 B
eIF B
- I
2 I
alpha I
- O
kinase O
activity O
. O

Polymorphisms O
in O
the O
CCR5 B
genes I
of O
African O
green O
monkeys O
and O
mice O
implicate O
specific O
amino O
acids O
in O
infections O
by O
simian O
and O
human O
immunodeficiency O
viruses O
. O

Although O
no O
detectable O
phenotypes O
are O
associated O
with O
a O
disruption O
allele O
of O
ABP1 B
, O
mutations O
that O
create O
a O
requirement O
for O
this O
protein O
have O
now O
been O
isolated O
in O
the O
previously O
identified O
gene B
SAC6 I
and O
in O
two O
new O
genes O
, O
SLA1 B
and O
SLA2 B
. O

The O
detergent O
- O
solubilized O
complex O
oxidizes O
caldariella O
quinol O
at O
high O
rates O
and O
is O
completely O
inhibited O
by O
cyanide O
and O
by O
quinolone O
analogs O
, O
potent O
inhibitors O
of O
quinol B
oxidases I
. O

Furthermore O
, O
CL100 B
suppresses O
the O
[ O
val12 O
] O
ras B
- O
induced O
activation O
of O
MAP B
kinase I
in O
a O
cell O
- O
free O
system O
from O
Xenopus O
oocytes O
. O

The O
vaccinia O
virus O
D6R B
open O
reading O
frame O
encodes O
the O
small O
subunit O
of O
the O
heterodimeric O
vaccinia B
virus I
early I
transcription I
factor I
( O
VETF B
) O
that O
activates O
transcription O
of O
early B
genes I
in O
vitro O
. O

We O
show O
that O
GCNF B
binds O
to O
one O
of O
the O
two O
DRO O
sequences O
in O
the O
Prm1 B
promoter I
, O
and O
to O
the O
DRO O
sequence O
in O
the O
Prm2 B
promoter I
in O
a O
specific O
manner O
. O

We O
show O
that O
GCNF B
binds O
to O
one O
of O
the O
two O
DRO O
sequences O
in O
the O
Prm1 B
promoter I
, O
and O
to O
the O
DRO O
sequence O
in O
the O
Prm2 B
promoter I
in O
a O
specific O
manner O
. O

The O
gamma B
- I
GCS I
gene I
is O
expressed O
ubiquitously O
and O
induced O
coordinately O
with O
NAD B
( I
P I
) I
H I
: I
quinone I
oxidoreductase I
( I
1 I
) I
( O
NQO1 B
) O
and O
glutathione B
S I
- I
transferase I
Ya I
( O
GST B
Ya I
) O
in O
response O
to O
xenobiotics O
and O
antioxidants O
. O

It O
is O
concluded O
that O
the O
predominant O
action O
of O
LSD O
on O
the O
female O
copulatory O
response O
is O
not O
mediated O
by O
increased O
dopamine B
receptor I
activity O
but O
that O
the O
LSD O
effect O
might O
be O
modulated O
by O
decreased O
dopaminergic O
activity O
. O

We O
have O
previously O
identified O
LIT1 B
, O
a O
paternally O
expressed O
antisense O
RNA O
within O
the O
KvLQT1 B
locus I
through O
a O
positional O
screening O
approach O
using O
human O
monochromosomal O
hybrids O
. O

The O
predicted O
amino O
acid O
sequence O
of O
the O
FlaB2 B
polypeptide I
was O
92 O
% O
identical O
to O
that O
of O
T B
. I
pallidum I
FlaB2 I
, O
with O
a O
76 O
% O
identity O
at O
the O
nucleotide O
level O
. O

Thus O
, O
the O
potential O
induction O
of O
this O
gene O
rearrangement O
by O
E1A B
gene I
therapy O
is O
unlikely O
to O
be O
clinically O
significant O
in O
the O
treatment O
of O
advanced O
malignant O
disease O
. O

Activation O
of O
tyrosine B
kinase I
- I
containing I
receptors I
, O
heterotrimeric B
G I
proteins I
, O
and O
protein B
kinase I
C I
enhanced O
the O
activities O
of O
both O
MEK B
isoforms I
in O
293 O
and O
PC12 O
cells O
. O

The O
Fugu O
rubripes O
( O
Fugu O
) O
gene O
fragment O
was O
used O
to O
isolate O
the O
GH B
gene I
from O
a O
Fugu O
genomic O
library O
. O

Similar O
tissue O
- O
specific O
patterns O
are O
observed O
with O
a O
fusion O
between O
the O
caufliflower B
mosaic I
virus I
35S I
RNA I
promotor I
and O
the O
GUS B
gene I
. O

We O
constructed O
a O
series O
of O
chimeric O
genes O
containing O
part O
of O
the O
first O
exon O
and O
increasingly O
longer O
5 O
' O
flanking O
sequences O
of O
the O
ODC B
gene I
fused O
to O
either O
bacterial B
chloramphenicol I
acetyltransferase I
( O
CAT B
) O
or O
luciferase B
reporter I
genes I
. O

The O
analysis O
predicted O
that O
progressive O
increases O
in O
serum O
creatinine O
or O
aspartate B
transaminase I
activity O
will O
result O
in O
only O
a O
50 O
% O
reduction O
of O
clearance O
. O

DNA O
sequence O
of O
the O
UL6 B
to O
UL20 B
genes I
of O
infectious O
laryngotracheitis O
virus O
and O
characterization O
of O
the O
UL10 B
gene I
product I
as O
a O
nonglycosylated O
and O
nonessential O
virion O
protein O
. O

Coimmunoprecipitation O
analysis O
suggests O
that O
these O
residues O
likely O
contribute O
to O
the O
multimerization O
function O
required O
for O
homomeric O
complex O
formation O
or O
heteromeric O
complex O
formation O
with O
p50 B
in O
that O
no O
association O
of O
p65 B
delta I
with O
itself O
or O
with O
p50 B
was O
evident O
. O

The O
potential O
biological O
significance O
of O
the O
identified O
structural O
motif O
shared O
by O
the O
human B
CCR5 I
, O
CCR3 B
, O
CCR2B B
and O
other O
GPCRs B
is O
discussed O
. O

Furthermore O
, O
the O
rapid O
light O
- O
mediated O
increase O
of O
CPRF B
proteins I
was O
insensitive O
to O
transcriptional O
inhibitors O
, O
suggesting O
that O
a O
post O
- O
transcriptional O
mechanism O
controls O
CPRF B
accumulation O
. O

The O
protein O
encoded O
by O
the O
NF2 B
gene I
has O
a O
similarity O
to O
ezrin B
, O
radixin B
and O
moesin B
( O
ERM B
) O
proteins O
that O
link O
membrane O
proteins O
to O
the O
cytoskeleton O
. O

Expression O
of O
a O
cDNA O
clone O
in O
yeast O
containing O
a O
large O
portion O
of O
the O
open O
reading O
frame O
produced O
cAMP B
PDEase I
activity O
identical O
in O
properties O
to O
the O
Drosophila O
enzyme O
affected O
by O
the O
dnc B
mutation I
. O

Expression O
of O
a O
cDNA O
clone O
in O
yeast O
containing O
a O
large O
portion O
of O
the O
open O
reading O
frame O
produced O
cAMP B
PDEase I
activity O
identical O
in O
properties O
to O
the O
Drosophila O
enzyme O
affected O
by O
the O
dnc B
mutation I
. O

FdsR B
purified O
to O
homogeneity O
after O
overexpression O
of O
fdsR B
in O
E O
. O
coli O
is O
a O
130 O
kDa O
homotetramer O
binding O
to O
the O
fds B
control O
region O
located O
between O
the O
fdsR B
and O
fdsG B
genes I
. O

Binding O
of O
ZAP B
- I
70 I
to O
phospho O
- O
TAMs O
is O
notable O
for O
the O
high O
level O
of O
cooperativity O
between O
the O
two O
SH2 B
domains I
, O
which O
individually O
demonstrate O
low O
affinity O
interaction O
with O
the O
ligand O
. O

The O
leukotriene B
receptor I
antagonist O
zafirlukast O
inhibits O
sulfur O
dioxide O
- O
induced O
bronchoconstriction O
in O
patients O
with O
asthma O
. O

Parathyroid B
hormone I
responses O
of O
cyclic O
AMP O
- O
, O
serum O
- O
and O
phorbol O
ester O
- O
responsive O
reporter O
genes O
in O
osteoblast O
- O
like O
UMR O
- O
106 O
cells O
. O

HNF4alpha7 B
mRNA I
is O
also O
found O
in O
totipotent O
embryonic O
stem O
cells O
. O

Penicillamine O
- O
induced O
myasthenia O
gravis O
associated O
with O
antibodies O
to O
acetylcholine B
receptor I
. O

LCCH1 B
was O
identical O
to O
the O
Rdl B
gene I
, O
a O
known O
GABA B
receptor I
subunit I
gene I
from O
D O
. O
melanogaster O
, O
whereas O
LCCH2 B
and O
LCCH3 B
were O
novel O
D O
. O
melanogaster O
sequences O
that O
exhibited O
structural O
similarity O
to O
other O
members O
of O
the O
ligand B
- I
gated I
chloride I
channel I
gene I
family I
. O

By O
a O
combination O
of O
alternative O
promoter O
usage O
and O
exon O
splicing O
, O
each O
ROR B
gene I
generates O
several O
isoforms O
that O
differ O
only O
in O
their O
amino O
terminus O
. O

The O
PEP4 B
gene I
was O
isolated O
from O
a O
genomic O
DNA O
library O
by O
complementation O
of O
the O
pep4 B
- I
3 I
mutation O
. O

The O
Tat B
protein I
coded O
by O
human O
immunodeficiency O
virus O
( O
HIV O
) O
is O
a O
strong O
activator O
of O
viral O
gene O
expression O
from O
the O
long O
terminal O
repeat O
( O
LTR O
) O
. O

Production O
of O
VT O
was O
also O
examined O
retrospectively O
in O
32 O
E O
. O
coli O
strains O
of O
serotype O
O26 O
: O
H11 O
isolated O
from O
children O
with O
diarrhoea O
; O
eight O
( O
25 O
% O
) O
of O
them O
produced O
moderate O
to O
high O
levels O
of O
verotoxin B
1 I
despite O
several O
years O
storage O
in O
vitro O
. O

Promoter O
activity O
of O
the O
proliferating B
- I
cell I
nuclear I
antigen I
gene I
is O
associated O
with O
inducible O
CRE B
- I
binding I
proteins I
in O
interleukin B
2 I
- O
stimulated O
T O
lymphocytes O
. O

Thus O
G17 B
targets O
the O
c B
- I
fos I
promoter I
CArG I
sequence I
via O
Rho B
A I
- O
dependent O
pathways O
, O
and O
Rho B
A I
appears O
to O
play O
an O
important O
role O
in O
the O
regulation O
of O
the O
trophic O
action O
of O
G17 B
. O

Thus O
G17 B
targets O
the O
c B
- I
fos I
promoter I
CArG I
sequence I
via O
Rho B
A I
- O
dependent O
pathways O
, O
and O
Rho B
A I
appears O
to O
play O
an O
important O
role O
in O
the O
regulation O
of O
the O
trophic O
action O
of O
G17 B
. O

These O
results O
demonstrate O
that O
m2 B
receptors I
couple O
to O
both O
G B
alpha I
i2 I
and O
G B
alpha I
i3 I
in O
vivo O
and O
that O
this O
interaction O
is O
integral O
to O
both O
positive O
and O
negative O
regulatory O
pathways O
leading O
to O
activation O
of O
PLC B
and O
desensitization O
of O
receptor O
signaling O
. O

The O
fru B
gene I
has O
seven O
exons O
spanning O
15 O
- O
kb O
encoding O
two O
transcripts O
with O
ORFs O
of O
841 O
and O
695 O
amino O
acids O
. O

HC B
- I
toxin I
exerts O
a O
potent O
cytostatic O
effect O
on O
plant O
and O
animal O
cells O
by O
inhibiting O
histone B
deacetylase I
. O

The O
human O
RIL B
gene I
: O
mapping O
to O
human O
chromosome O
5q31 O
. O
1 O
, O
genomic O
organization O
and O
alternative O
transcripts O
. O

